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ABSTRACT 
MOLECULAR AND GENOMIC BASED INSIGHTS INTO THE EVOLUTION OF 
ENTEROCOCCUS FAECIUM FROM COMMENSAL TO HOSPITAL-ADAPTED 
PATHOGEN 
Publication No. _______ 
Jessica Rhea Galloway-Peña, B.A. 
Supervisory Professor: Barbara E. Murray, M.D. 
The basis for the recent transition of Enterococcus faecium from a primarily commensal 
organism to one of the leading causes of hospital-acquired infections in the United States is not 
yet understood. To address this, the first part of my project assessed isolates from early 
outbreaks in the USA and South America using sequence analysis, colony hybridizations, and 
minimal inhibitory concentrations (MICs) which showed clinical isolates possess virulence and 
antibiotic resistance determinants that are less abundant or lacking in community isolates. I also 
revealed that the level of ampicillin resistance increased over time in clinical strains. By 
sequencing the pbp5 gene, I demonstrated an ~5% difference in the pbp5 gene between strains 
with MICs <4ug/ml and those with MICs >4µg/ml, but no specific sequence changes correlated 
with increases in MICs within the latter group. A 3-10% nucleotide difference was also seen in 
three other genes analyzed, which suggested the existence of two distinct subpopulations of E. 
faecium. This led to the second part of my project analyzing concatenated core gene sequences, 
SNPs, the 16S rRNA, and phylogenetics of 21 E. faecium genomes confirming two distinct 
clades; a community-associated (CA) clade and hospital-associated (HA) clade. Molecular 
clock calculations indicate that these two clades likely diverged ~ 300,000 to > 1 million years 
vi 
 
ago, long before the modern antibiotic era. Genomic analysis also showed that, in addition to 
core genomic differences, HA E. faecium harbor specific accessory genetic elements that may 
confer selection advantages over CA E. faecium. The third part of my project discovered 6 E. 
faecium genes with the newly identified “WxL” domain. My analyses, using RT-PCR, western 
blots, patient sera, whole-cell ELISA, and immunogold electron microscopy, indicated that E. 
faecium WxL genes exist in operons, encode bacterial cell surface localized proteins, that WxL 
proteins are antigenic in humans, and are more exposed on the surface of clinical isolates 
versus community isolates (even though they are ubiquitous in both clades). ELISAs and 
BIAcore analyses also showed that proteins encoded by these operons bind several different 
host extracellular matrix proteins, as well as to each other, suggesting a novel cell-surface 
complex. In summary, my studies provide new insights into the evolution of E. faecium by 
showing that there are two distantly related clades; one being more successful in the hospital 
setting. My studies also identified operons encoding WxL proteins whose characteristics could 
also contribute to colonization and virulence within this species.  
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[1] BACKGROUND 
[1.1] Enterococcus spp.  
 Enterococci were previously classified as group D streptococci via the Lancefield 
serological typing system (Murray, 1997). In the 1980’s, enterococci were removed from the 
genus Streptococcus and a new genus, Enterococcus, was created based on 16S rRNA and 
DNA-rDNA hybridizations (Arias and Murray, 2008; Klein, 2003). The genus Enterococcus 
consists of over 30 species of facultatively anaerobic, low G+C content, lactic acid producing, 
Gram-positive cocci (Fisher and Phillips, 2009; Willems and van Schaik, 2009). Enterococcus 
species have historically been used widely in the food industry and as probiotics, but over the 
past 30 years have become the third most common organisms recovered from the nosocomial 
environment (Foulquie Moreno et al., 2006; Hidron et al., 2008). Enterococcus species can be 
found in environmental, animal, insect, nematode and human sources, existing as an intrinsic 
part of both animal and human microflora. The most common two species found in the human 
gastrointestinal tract, as well as the two predominate species that cause infections, are 
Enterococcus faecalis and Enterococcus faecium (Fisher and Phillips, 2009; Hidron et al., 
2008).  
[1.1.2] Infections and Prevalence  
 The most common infections caused by enterococci are urinary tract infections, 
bacteremia, endocarditis, soft tissue or wound infections, and peritonitis/intra-abdominal 
infections (Murray, 1990). Although, E. faecalis has historically accounted for 80-90% of all 
enterococcal clinical isolates, the most recent data indicates that E. faecium currently accounts 
for approximately 30-40% of all enterococcal clinical isolates (Hidron et al., 2008; Murray, 
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1997). Thirty years ago, E. faecium was rarely encountered in human infections and considered 
a harmless commensal. However, reports of outbreaks of E. faecium began to be reported in the 
United States in the 1980’s, and now are a predominant cause of hospital-acquired infections 
(Bush et al., 1989; Coudron et al., 1984; Eliopoulos et al., 1988; Grayson et al., 1991; Sapico et 
al., 1989). This dissertation serves to propose reasons for the transition of E. faecium from a 
harmless commensal to a formidable nosocomial pathogen through antibiotic resistance, 
particular virulence determinants, and a genomic background difference separating commensal 
and clinical isolates into two distinct clades.  
[1.2] Antibiotic Resistance in Enterococcus faecium 
 Currently, 80% of all clinical E. faecium recovered in the United States are resistant to 
vancomycin, and an even higher 90% are resistant to ampicillin (Hidron et al., 2008). In 
addition to resistance to the two predominant therapies against enterococcal infections, E. 
faecium has a number of intrinsic resistances, such as to cephalosporins, clindamycin, and low-
level aminoglycoside resistance. Moreover, E. faecium has a number of acquired resistances 
that are thought to emerge via plasmids and transposons from other organisms. As part of the 
normal gastrointestinal flora, these organisms are therefore exposed to antibiotic selective 
pressure when any infections are treated. Such antibiotics include ciprofloxacin, tetracycline, 
chloramphenicol, trimethoprim, and high-level resistance to aminoglycosides. All of these 
scenarios together make E. faecium infections incredibly difficult to treat via monotherapy, and 
almost eliminates the chance for synergistic bactericidal activity (Murray, 1997). More 
recently, E. faecium has also been reported to be resistant to more recently available antibiotics 
such as linezolid and daptomycin (Arias and Murray, 2008).  
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[1.2.1] Ampicillin Resistance 
 A study analyzing the progression of ampicillin resistance in E. faecium was first 
reported in a 22-year study using isolates from one hospital in Boston (Grayson et al., 1991). 
Although it is well known that ampicillin minimal inhibitory concentrations (MICs) of clinical 
E. faecium are much higher than they were 30 years ago, there has been no study that includes 
isolates from the earliest outbreaks of ampicillin resistant E. faecium from all over the United 
States. 
 It has long been thought that the expression of a low affinity class B penicillin-binding 
protein (PBP5) is involved in decreased ampicillin susceptibility (Fontana et al., 1985; 
Williamson et al., 1985). In general, penicillin-binding proteins are involved in peptidoglycan 
polymerization. Class B penicillin binding proteins (PBPs) are specifically D-D-transpeptidases 
that cooperate with glycosyltransferases to synthesize peptidoglycan (Zapun et al., 2008). PBP5 
has low affinity for penicillins and can assume the transpeptidase function when other, more 
penicillin-susceptible PBPs are inhibited by a beta-lactam, leading to this species’ intrinsic low-
level resistance (Fontana et al., 1985). In some isolates, it seems that intermediate levels of 
resistance occur from increased expression of PBP5 (Fontana et al., 1994; Klare et al., 1992), 
whereas some clinical strains exhibiting higher MICs contain a very low affinity PBP5 (at least 
10-times lower affinity) (Rybkine et al., 1998; Zorzi et al., 1996). Moreover, it has been shown 
that the gene encoding the low-affinity PBP5 can be transferred horizontally, suggesting the 
possibility that the low-affinity PBP5 can be circulated between clinical isolates (Rice et al., 
2005).  
Several amino acid changes (alone or in combination) in PBP5 have been correlated 
with its decreased affinity for β-lactams, although these have differed from study to study 
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(Ligozzi et al., 1996; Rybkine et al., 1998; Zorzi et al., 1996). For many of these correlation-
based studies, it is not known if the strains were even somewhat related. Furthermore, in studies 
based on mutations in isogenic strains, the mutations resulted in only modest increases in MIC, 
and thus do not explain the full extent of resistance (Rice et al., 2004; Sifaoui et al., 2001; Zorzi 
et al., 1996). Therefore, whether specific amino acid variations can be correlated with 
increasing MICs displayed in clonally related clinical strains has yet to be determined.  
[1.2.2] Vancomycin Resistance 
 Due to the increased prevalence of ampicillin resistance and high-level resistance to 
aminoglycosides in E. faecium in the 1980’s, glycopeptides such as vancomycin represented 
one of the last therapeutic options during that time (Bonten et al., 2001). The first vancomycin 
resistant isolate was isolated in Europe in 1986 (Uttley et al., 1988). Vancomycin resistant E. 
faecium (VREfm) was reported in the United States soon thereafter, where outbreaks have 
continued since (although outbreaks of VREfm were delayed in Europe until relatively 
recently) (Arias and Murray, 2012). The basic mechanism of action of vancomycin is that it 
disrupts cell wall synthesis by binding to pentapeptide peptidoglycan precursors, specifically 
the terminal dipeptide D-ala-D-ala (Murray, 1997). Enterococci become vancomycin-resistant 
by generating pentapeptide precursors with alternate termini, either D-ala-D-lactate (Van A, B 
,and D) or D-ala-D-serine (VanC, E, G, and L). A number of Van gene clusters have been 
identified that are responsible for this mechanism of resistance. The vanA gene cluster is the 
one most commonly found in clinical isolates, and is typically associated with the transposon 
Tn1546 (Arias and Murray, 2008; Bonten et al., 2001; Murray, 1997).  
 Although VREfm have been reported in many countries all over the world, studies over 
the past several years have shown that the epidemiology of VREfm is quite different between 
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the United States and Europe. In the United States, colonization and infections by VREfm are 
associated with hospitals and correlate with increased antibiotic usage. It is thought that the 
epidemiology in United States hospitals is influenced by several clinically-associated variables 
(such as antibiotic pressure and environmental contamination), leading to patient colonization 
(Bonten et al., 2001).   
In contrast, VREfm infections are not as prevalent in the hospitals in Europe as they are 
in the United States. However, there seems to be a community and animal reservoir of VREfm 
in Europe that is lacking in the United States. So, although VREfm is an uncommon cause of 
nosocomial infections in most parts of Europe until recently, colonization with VREfm in 
healthy individuals and animals is common. Some scientists explain this phenomenon with the 
use of the glycopeptide avoparcin in animal husbandry and agriculture in Europe (Bonten et al., 
2001) Thus, although vancomycin resistant isolates exist in the community in Europe, these are 
not often causes of nosocomial infections. In contrast, United States VREfm are important 
nosocomial pathogens that commonly colonize hospitalized patients, but these isolates do not 
come from a community reservoir (Bonten et al., 2001). This observation begs the question: 
what are the differences in these two groups of isolates? 
[1.3] Virulence Determinants of Enterococcus faecium 
 To date, many of the potential virulence determinants that have been described in E. 
faecium are members of a class of surface proteins called MSCRAMMs (microbial surface 
components recognizing adhesive matrix molecules), which are typically adhesins and pili. 
MSCRAMM–like proteins include a secretion signal sequence, a region with immunoglobulin-
like folds that is usually the ligand-binding domain, and a C-terminal LPxTG-like motif that is 
recognized and cleaved by sortases (transpeptidase enzymes) which covalently attach the 
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protein to the cell-wall peptidoglycan  (Hendrickx et al., 2009a; Hendrickx et al., 2007; 
Sillanpaa et al., 2008). It is thought that these proteins contribute to virulence by conferring 
attachment to host tissues and increase the colonizing ability of the strains that contain them 
(Hendrickx et al., 2009a; Sillanpaa et al., 2009a).  
[1.3.1] Enterococcal Surface Protein 
 The esp gene of E. faecium (espEfm), encoding an enterococcal surface protein, has 
been shown to play a role in biofilm formation, experimental urinary tract infection, and 
endocarditis (Heikens et al., 2007; Leendertse et al., 2009; Heikens et al., 2011). The esp gene 
encodes an MSCRAMM-like protein and is located on a putative pathogenicity island (Leavis 
et al., 2004). Expression of esp has been associated with initial adherence and biofilm 
formation on abiotic surfaces, because insertional mutants were attenuated in these processes 
(Heikens et al., 2007). In addition,  infections with esp-positive cells were shown to transiently 
aggravate urinary tract infections in mice (Leendertse et al., 2009) and an esp-deficient mutant 
was attenuated in experimental endocarditis (Heikens et al., 2011). However, isogenic mutants 
failed to demonstrate a role for Esp in peritonitis (Leendertse et al., 2009) and GI colonization 
(Heikens et al., 2009) .  
[1.3.2] Hyl-containing Plasmid 
 The hyl gene of E. faecium (hylEfm which encodes a protein with homology to a family 
84 glycosyl hydrolase) was postulated as a potential virulence factor due to the observation that 
it was found in some VREfm clinical strains, but not found in strains from community origins 
(fecal samples from healthy  volunteers, animals, probiotics, and sewage) (Rice et al., 2003). 
The hyl-like gene was shown to be on a plasmid which increased the ability of strains to 
colonize the murine gut (Rice et al., 2009).  Another study also showed that the hylEfm gene was 
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carried on large plasmids which were readily transferred from clinical strains to recipient E. 
faecium strain, possibly due to the presence of pilA (fms21) (Kim et al., 2010). The conjugative 
transfer of one hyl-containing plasmid conferred resistance to vancomycin (vanA) as well as 
increased lethality in the mouse peritonitis model (Arias et al., 2009). However, it was 
determined that the hyl gene, itself, does not contribute to peritonitis and the other gene(s) 
located on this plasmid possibly responsible for the increased virulence and colonization are 
currently being determined (Panesso et al., 2011). 
 [1.3.3] Collagen binding adhesin of Enterococcus faecium (Acm) 
 Acm (adhesin of collagen from E. faecium) is an MSCRAMM that interacts primarily 
with collagen type I, and secondarily with collagen type IV (Nallapareddy et al., 2008a; 
Nallapareddy et al., 2008b; Nallapareddy et al., 2003). Although acm is present in almost all 
strains isolated, it has been shown that a functional Acm is expressed exclusively by those with 
clinical origins. On the other hand, pseudogenes were often found in strains from community 
origins, where a premature stop codon disrupts collagen binding (Nallapareddy et al., 2008b). 
In a mixed infection endocarditis model, it was shown that the vegetations on the heart valves 
consisted of approximately 3 times as many wild-type cells as acm deletion mutant cells and 
that the acm deletion mutant was attenuated in initial adherence and colonization of the heart 
valves (Nallapareddy et al., 2008a). In addition, sera from patients with endocarditis contain 
anti-Acm IgG antibodies (Nallapareddy et al., 2008a). All this evidence together has shown that 
Acm likely plays a role in pathogenesis, namely in endocarditis, and elicits an antibody 
response.  
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[1.3.4] Other MSCRAMMs that are Putative Adhesins and Pili 
Analysis of the draft genome of TX16 revealed the presence of 15 genes, called fms 
genes (E. faecium surface proteins), encoding proteins with MSCRAMM-like qualities thought 
to be putative adhesins or pili. Eleven of these 15 MSCRAMMs clustered into four pilus-like 
gene clusters, each with an associated class C sortase. Nine of the eleven showed homology to 
the Ebp pili of E. faecalis and contained pilus assembly motifs (Sillanpaa et al., 2008).  Two of 
these, encoded by fms9 (pilB) and fms21 (pilA), have been shown to polymerize into a high-
molecular-mass protein bands in western blots and to polymerize into pili at the cell surface 
using electron microscopy (Hendrickx et al., 2008; Sillanpaa et al., 2008). Three of the 
predicted pili showing homology to Ebp pili in E. faecalis (encoded by empABCfm in E. 
faecium) have been shown to be involved in biofilm formation and virulence in the murine 
model of urinary tract infections, and endocarditis (Sillanpaa et al., 2010). In addition, Scm 
(second collagen adhesin of E. faecium), also known as Fms10, has been shown to bind 
primarily to collagen type V, and less so to collagen type I and fibrinogen (Sillanpaa et al., 
2008).  
[1.4] Population Biology of Enterococcus faecium 
 With E. faecium outbreaks reported on 5 continents and seemingly different 
characteristics in E. faecium between the United States and Europe (especially in regards to 
antibiotic resistance as discussed previously), there was an urgency to adapt molecular typing 
methods in order to understand the epidemiology of these hospital outbreaks. One of the first 
molecular typing methods was pulsed-field gel electrophoresis (PFGE), which is still 
considered the “gold standard” for short term hospital epidemiology (Murray, 1990). In order 
to study the genetic relatedness between strains from different origins (human vs. animal), 
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amplified fragment length polymorphism analysis (AFLP) was used (Willems et al., 2000). In 
2002, a multi-locus sequence typing (MLST) scheme was proposed for E. faecium, as had been 
developed for 30+ organisms at the time, to determine global population biology (Homan et al., 
2002). These three methodologies have given us much of the information we have about the 
population structure of E. faecium to date.  
[1.4.1] Origin/Host-specific Clonal Complexes 
 Although PFGE and AFLP gave scientists their first insight into the population structure 
of E. faecium, showing different clones and host specific genetic lineages, both methods were 
unsuitable for reproducible data exchange worldwide (Jureen et al., 2004a; Werner et al., 2003; 
Willems et al., 2000). The first studies using MLST of E. faecium confirmed the genogroups 
previously found using AFLP, including a hospital-related genogroup (Homan et al., 2002). 
Subsequent studies using MLST and the eBURST algorithm on E. faecium isolates from 
multiple sources revealed that hospital outbreak isolates clustered to a sub-population 
designated C1, which was renamed clonal complex 17 based on the thought that the founder of 
this lineage was ST17 (Leavis et al., 2006a; Top et al., 2007; Top et al., 2008; Willems et al., 
2005). Further studies showed a strong correlation between the clonal complex 17 (CC17) 
genetic lineage and ampicillin resistance, quinolone resistance, the pathogenicity island (PAI) 
containing esp, the hyl gene, and a number of surface proteins containing the LPxTG-motif  
(Hendrickx et al., 2007; Leavis et al., 2006a; Leavis et al., 2006b; Nallapareddy et al., 2008b; 
Rice et al., 2003; Sillanpaa et al., 2009a; Willems et al., 2001). Based on these studies, it was 
predicted that CC17 was responsible for the worldwide emergence of nosocomial VREfm 
(Leavis et al., 2006a).  
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 It was soon found, however, that inferring evolutionary descent using eBURST is 
unreliable for organisms that have high rates of population recombination, such as E. faecium 
(Turner et al., 2007). Although eBURST is no longer generally accepted to determine ancestry, 
MLST is still an acceptable typing method for E. faecium.  It still stands that clinically-derived 
isolates are of particular sequence types (STs) (ST17, or single or double locus variants of 
ST17) which are not found in community isolates (Didelot and Falush, 2007; Willems et al., 
2011; Willems and van Schaik, 2009). Other studies using different modeling such as neighbor-
net trees (CLONALFRAME) and Bayesian modeling (BAPS), confirmed the suspicions of 
Turner et al. by showing that major hospital clones that were previously linked by eBURST 
grouped separately (Didelot and Falush, 2007; Tang et al., 2009), nullifying the idea that E. 
faecium hospital-associated isolates evolved recently from a single common ancestor that was 
ST17.  
[1.4.2] Genome-based Insights into the Evolution of E. faecium 
 Comparative genomic hybridization using isolates from diverse backgrounds in a mixed 
whole genome array also supported the existence of a specific hospital-specific subpopulation. 
CC17 isolates overlapped with this phylogenomic group, as well as non-CC17 isolates from 
clinical origins, demonstrating that horizontal transfer of genes involved in colonization and 
infection is not limited to the CC17-related genogroup. It was also proposed in this work that 
~150 genes, transposases and IS elements, specifically IS16, were enriched in hospital isolates, 
possibly conferring genomic plasticity to these strains (Leavis et al., 2007). This was confirmed 
by another study that showed IS16 was exclusively found in hospital-associated isolates of E. 
faecium; specifically CC17-related strains (Werner et al., 2011).  
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 A study using pyrosequencing of 7 draft genomes determined a genome-based 
phylogeny based on ~650 orthologs conserved in different strains (van Schaik et al., 2010; van 
Schaik and Willems, 2010). Although this study suggested that human infection isolates were 
different from human commensal isolates based on conserved genes (not accessory genomes), 
there was only one isolate from the commensal group, making these data unreliable. However, 
this study did show as high as a 12% difference in gene content between two closely related 
strains by conserved genome analysis, highlighting the importance of the gain and loss of 
mobile genetic elements (van Schaik et al., 2010; van Schaik and Willems, 2010).  
 Approximately 30+ E. faecium strains have been sequenced, partially assembled, and 
annotated (Palmer et al., 2010). Only one other genome (the vanB ST17 Aus0004) besides the 
TX16 (DO) genome discussed in this dissertation has been fully assembled and published (Lam 
et al., 2012). So, although partially assembled draft genomes have given us important insights 
into the evolution of E. faecium, the availability of two complete and closed genomes is more 
advantageous to compare and understand the genetic features that may explain the emergence 
of this species as a nosocomial pathogen.  
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[2] CHAPTER 1 
Molecular Epidemiology, Clonality, and Antibiotic Resistance Analysis of 
Early Enterococcus faecium in the United States and South America 
[2.1] CHAPTER 1 INTRODUCTION 
The emergence of multi-resistant E. faecium world-wide and hospital outbreaks on 
several continents were previously attributed to a particular genetic lineage designated CC17 
(Leavis et al., 2006a).  However, recent publications (Turner et al., 2007) suggest that 
clustering of MLST-based allelic profiles using eBURST is unreliable for  phylogenetic 
prediction of E. faecium due to its relatively high recombination rates. Nevertheless, certain 
STs (ST16, ST17, ST18, and ST19) are prominent among hospital- associated isolates, and are 
typically associated with CC17. CC17 genogroup isolates are characterized by ampicillin 
resistance and frequently resistant to vancomycin. CC17 strains also have higher rates than 
non-CC17 isolates of putative virulence determinants and colonization factors such as the 
hylEfm-containing plasmid, espEfm, and genes encoding MSCRAMMs (Hendrickx et al., 2007; 
Leavis et al., 2004; Rice et al., 2003; Sillanpaa et al., 2008; Sillanpaa et al., 2009a; Willems et 
al., 2001).   
  Although outbreaks of ampicillin-resistant E. faecium in the United States were first 
reported in the early 1980’s (Bush et al., 1989; Coudron et al., 1984; Sapico et al., 1989), 
clonality and molecular genetics of early ampicillin resistant E. faecium (AREfm) and VREfm 
United States isolates had not been characterized. Similarly, in South America, VREfm 
infections and isolates with CC17 related STs have been reported since 1998 (Dalla Costa et 
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al., 1998; Marin et al., 1998), yet there are limited data regarding the population genetics or 
presence of the potential virulence determinants in E. faecium in South America.  
This chapter discusses three related published studies. In the first study (Galloway-Pena 
et al., 2009), 53 early clinical isolates collected in the United States between 1971 and 1994 
were analyzed for the MLST, the presence of putative virulence genes, and their resistance to 
ampicillin, vancomycin, gentamicin and streptomycin. Among these isolates, 16 different STs 
were identified in 9 different regions of the United States. It was found that the earliest CC17 
related isolates have been circulating since 1982. Characteristics of CC17 isolates over this 
time period included increasing ampicillin resistance, the increased presence of hylEfm and 
espEfm, the emergence of vancomycin resistance, and the presence of multiple fms genes.  
The second study, which includes selected data from a prospective surveillance study 
(Panesso et al., 2010) using isolates from 32 hospitals and four countries, is included with the 
aim of characterizing the molecular genetics of enterococci circulating in northern South 
America. Genotyping was performed on the 35 VREfm isolates (out of the 760 enterococci 
recovered) using PFGE and MLST. These isolates were also evaluated for the presence of the 
same 16 putative virulence genes assessed in the previous study (fms genes, espEfm, and 
hylEfm). Eleven pulsotypes were found among the VREfm isolates, and most isolates belonged 
to sequence types 412 and 18. The fms5-6-9 and fms11-19-16 clusters were detected in all 
VREfm isolates isolated from this region. However, espEfm and hylEfm were detected in only 
69% and 23% of the isolates, respectively. Therefore, the recent population genetics of VREfm 
in South America appear to parallel those of the early U.S, isolates in the first study. These data  
suggest that more CC17-related E. faecium may disseminate in this region in the coming years, 
and result in multiple outbreaks as they have in the United States. 
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  The third study reflects back on the first study which showed that ampicillin resistance 
has increased steadily over the past three decades within United States (Galloway-Pena et al., 
2011). This study found that out of 41 ampicillin resistant isolates analyzed, 9 isolates with 
MICs < 4µg/ml have a PBP5 consensus sequence that is distinctly different from the PBP5 
consensus of the 32 isolates with MICs > 4µg/ml, with ~5% difference between these. 
However, we were not able to definitively determine consistent amino acid changes that 
correlated with specific increases in the MICs of ampicillin. After analysis of pbp5 and three 
other genes encoding cell wall/surface proteins to determine if this 5% difference was specific 
to pbp5, it was determined that there were two distinct evolutionary groups for each gene.  
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[2.2] CHAPTER 1 MATERIALS AND METHODS 
[2.2.1] United States bacterial isolates and species-specific polymerase chain 
reaction.  
A total of 53 E. faecium isolates were selected from our collection of >450 E. 
faecium clinical (~75% of the collection) and nonclinical isolates (~25% of the 
collection; including community, fecal, and animal isolates) collected between 
1970 and the present from diverse origins and geographic locations with >15 
countries represented. To confirm the identity of the isolates, species-specific 
amplification of the D-alanyl-D-alanine ligase gene (ddl) was used (Dutka-Malen 
et al., 1995) in addition to initial biochemical tests. The isolates were selected 
based on a set of pre-determined criteria which included: (1) the earliest United 
States E. faecium isolates in our collection; (2) isolates recovered from clinical 
samples, with the majority representing nosocomial outbreaks (Bush et al., 1989; 
Coudron et al., 1984; Eliopoulos et al., 1988; Grayson et al., 1991; Handwerger et 
al., 1993; Sapico et al., 1989); and (3) diversity in geographical origin, with 9 
different areas in the United States represented (see section 2.3.1 Table 3). 
(Galloway-Pena et al., 2009)  
[2.2.2] South American specimen collection and testing.  
A multicenter study was performed from February 2006 through February 2008 to 
evaluate the molecular epidemiology of enterococci in four South American 
countries. Each participating tertiary-care hospital (a total of 32 hospitals, from 
the Latin American Network of Antimicrobial Resistance) in Colombia (22 
hospitals in six cities), Ecuador (5 hospitals in one city), Peru´ (3 hospitals in one 
city), and Venezuela (2 hospitals in one city) collected consecutive enterococcal 
isolates (duplicate organisms from the same patient were excluded). The samples 
were collected by the clinical laboratory from each participating hospital and 
corresponded to samples from hospitalized patients in Colombia, Peru´, and 
Venezuela. In Ecuador, the clinical laboratory also collected samples from 
ambulatory services and outpatient clinics. The isolates originated from the 
following clinical specimens: blood, urine, secretions from surgical wounds, 
peritoneal fluid, abdominal abscesses, joint aspirates, osteomyelitis aspirates, 
pleural fluid, pericardial effusion, cerebral abscesses, and cerebrospinal fluid 
(CSF). In an attempt to avoid isolates that likely represented colonization, 
enterococci recovered from sputum, rectal swabs, catheters, or skin (unless they 
originated in an infected surgical wound) were excluded. Each hospital identified 
the microorganisms by using either automated methods (performed with the Vitek 
or MicroScan system) or manual methods. (Panesso et al., 2010) 
[2.2.3] Genomic DNA isolation, multi-locus sequence typing, and pulsed-field gel 
electrophoresis.  
With the use of the DNeasy Blood and Tissue Kit (Qiagen), genomic DNA was 
extracted from 5-mL cultures incubated overnight in brain-heart infusion broth 
(Difco Laboratories). Polymerase chain reaction (PCR) and multilocus sequence 
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typing (MLST) were performed as described elsewhere (Homan et al., 2002).  
Fragments of 7 housekeeping genes (atpA, ddl, gdh, purk, gyd, pstS, and adk) 
were sequenced, allelic profiles were obtained, and a sequence type (ST) was 
designated for each unique allelic profile based on the MLST website 
(http://efaecium.mlst.net). For select isolates that had a pulsotype identical to that 
of typed strains recovered from the same area or during the same outbreak, only 
purK was sequenced, and an inferred sequence type was given. Pulsed-field gel 
electrophoresis (PFGE) was performed as described elsewhere (Nallapareddy et 
al., 2008b). (Galloway-Pena et al., 2009) 
 [2.2.4] Susceptibility testing.  
Susceptibilities to ampicillin and vancomycin and high-level resistance to gentamicin 
and streptomycin were determined using standard agar dilution methods. In accordance 
with Clinical and Laboratory Standards Institute guidelines, minimal inhibitory 
concentrations (MICs) of 16 mg/mL for ampicillin and 32 mg/mL for vancomycin were 
considered to be resistant. Isolates for which growth on plates occurred at 
concentrations of 500 mg/mL gentamicin and 2000 mg/mL streptomycin were 
considered to have high-level resistance. (Galloway-Pena et al., 2009) 
 [2.2.5] Colony hybridization and van gene PCR.   
Preparation of colony lysates on nylon membranes and hybridization under high-
stringency conditions were performed as described elsewhere (Singh et al., 1998). 
DNA probes for hylEfm, espEfm, and the 14 fms genes were made using primers 
published elsewhere (Rice et al., 2003; Sillanpaa et al., 2009b) and found in Table 
1. Of note, all isolates in the present study had the acm gene (fms8) that encodes a 
collagen-binding adhesin, consistent with our previous finding of its presence in 
the vast majority of clinical isolates (Nallapareddy et al., 2008b). These probes 
were radiolabelled using the RadPrime DNA labeling system (Invitrogen). 
Vancomycin-resistant isolates were tested for the presence of vanA and vanB 
genes using the oligonucleotides and conditions described elsewhere (Dutka-
Malen et al., 1995). (Galloway-Pena et al., 2009) 
TABLE 1. Primers used in this study for colony hybridizations of putative MSCRAMMs 
and virulence factors.  
Oligonucleotide Sequence 5-3 Length of the amplicon (bp) 
Fms1F ACCAAAGCCAGACGAAATAGAAGAAG 898 
Fms1R ATTGTTTTGGTCAGGTGCATCATAGA  
Fms5F ATGTTTACCGCAGAAGCAAC 766 
Fms5R ACTTGTATCCGTTGGCTGTT  
Fms9F GAGGAGACAGCAGCTCAAG 1674 
Fms9R TGTACCTTTGTGTTTATTTGGTA  
Fms10F GAAACATACATTCCTAAAGACCCTGG 921 
17 
 
Fms10R ACCATTGTCGCTGATAAATATT  
Fms11F TGCTAACCAAACGACAGAGGAGAC 832 
Fms11R TTGTGCAAAAGAATAGCCCGTTAC  
Fms13F GAAGAAGTCGCACAAAAAC 1494 
Fms13R TGACCCGCGTTTCATATTCG  
Fms14F CTGGCGAAATTACGACTATGCTACTA 924 
Fms14R GTCGCTTTATTATCTCCTTCTTTTAC    
Fms15F GAGTCTTTAGCAGAACAGCCAGAGCG 1734 
Fms15R TCGATTGTCACTATTCACAAG  
Fms16F GCCGTATCACCTACACCAG 1206 
Fms16R GATTCCTTTAGGTTGGTTATC  
Fms17F ATGAAAATGATGGCTTGGCT 828 
Fms17R GGATGATGACCTCGATTCTC  
Fms18F ATTGATGTGGAAACTGAGGG 1227 
Fms18R TCCTTCTGGAGCCTCTACT  
Fms19F GTGTGGAAGACGCACAAAGA 350 
Fms19R GGGACTTTATCCCCATCTGC  
Fms20F CATTGTTTGGGTTAAAAACAG 804 
Fms20R TCAGCTTAGAGCTTCCTCCT  
Fms21F CTTATTGGAATGTTAGGAATCAT 758 
Fms21R TCAGTAGCAGTCAGCTTTCC  
EspEfmF    TTGCTAATGCTAGTCCACGACC 945 
EspEfmR GCGTCAACACTTGCATTGCCGA  
HylEfmF GAGTAGAGGAATATCTTAGC 661 
HylEfmR AGGCTCCAATTCTGT  
AcmF CAGGCAGAGATATCAGCAG    1474 
AcmR ATTCTCATTTGTAACGACTAGC  
 
Table from (Galloway-Pena et al., 2009) 
 
[2.2.6] Statistical analysis.  
 
The difference between CC17 and non-CC17 isolates, in terms of distributions of 
the fms genes, hylEfm, espEfm, ampicillin resistance, and vancomycin resistance 
were compared using 2-tailed
 
Fisher's exact test. P <0.05 was considered to 
denote statistical
 
significance. (Galloway-Pena et al., 2009) 
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[2.2.7] Bacterial isolates and pbp5 gene sequencing.  
Twenty-nine isolates from our previous study (Galloway-Pena et al., 2009) were 
chosen to represent each major outbreak, ampicillin MIC, and sequence type by 
MLST; these isolates were collected between 1971 and 1993. The complete pbp5 
gene (GenBank accession no. ZP_00603984) of the 29 isolates was sequenced 
using the primers found in Table 2. Many of these isolates were known to be in 
the CC17 genogroup. Twelve additional strains isolated between 1985 and 2006 
were studied because they have sequenced genomes or a sequenced pbp5 region. 
(Galloway-Pena et al., 2011)  
[2.2.8] Other gene comparisons and phylogenetic studies.  
Three other genes were studied to determine if the variability found in pbp5 was 
comparable to the variability of other genes that encode putative surface proteins 
within the same genomes and if the isolates with these genes grouped the same 
with these genes as with pbp5. The additional genes analyzed were pbp2 
(GenBank accession no. ZP_03980638), gls20 (Choudhury et al., 2011)(GenBank 
accession no. ZP_03981586), and wlcA (GenBank accession no. ZP_03980840) (a 
gene we are currently studying which is related to the Enterococcus faecalis WxL 
genes (Brinster et al., 2007a; Brinster et al., 2007b)). Using the sequence from E. 
faecium strain TX1330, we blasted the accessible genomes of E. faecium isolated 
in the United States available on the Broad Institute or NCBI website for each 
gene. Each of the genes was aligned using ClustalW and the percent difference 
between the nucleotide and amino acids analyzed. The nucleotide sequence for 
each gene was then analyzed using MEGA 4.0.2 software and phylogenetic 
UPGMA (unweighted-pair group method using average linkages) trees were 
constructed for each gene (see 2.3.2 Figures 4 and 5). Only strains with sequenced 
genomes isolated in the United States were used, as this began as a study to 
compare the sequenced U.S. isolates. In addition, we also did not include any 
sequences of genes that were ambiguous, poor sequence quality, or incomplete. 
(Galloway-Pena et al., 2011)   
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TABLE 2. Primers used in this study to sequence the complete pbp5 gene of Enterococcus 
faecium.  
Primer Name Primer Sequence (5’-3’) Amplicon Size  
Efmpbp5-1outsideF GGAATGACAAGCAAGAGAAGGAGG  522nts 
Efmpbp5-1F ATGAAAAGAAGTGACAAGCACGGC 493nts 
Efmpbp5-1R CTTACTTTGTCATTTCCTTC  
Efmpbp5-2F GAAGGAAATGACAAAGTAAG 466nts 
Efmpbp5-2R GTCCCACGAAGATCCTTATCAAAAGCC  
Efmpbp5-3F GGCTTTTGATAAGGATCTTCGTGGGAC 563nts 
Efmpbp5-3R CCCATTTTCAACGTTTCTTGTGCC  
Efmpbp5-4F GGCACAAGAAACGTTGAAAATGGG 584nts 
Efmpbp5-4R TTATTGATAATTTTGGTTGAGGTATTG  
Efmpbp5-4outsideR CGCCACAGTCCTTTTACTGTAC 619nts 
Rpbp5_1F GCAAAGATGAATACCTCATTAGG 357nts 
Rpbp5_1R CAAAGTAATCGGGTTGTACCCAGC  
Rpbp5_2F CAGAACTTCCAGCTGGAGCTAC 413nts 
Rpbp5_2R GATCATAGCTTGGAGAGCTAGC  
Rpbp5_3F GCGACAGGTTATGCTCCTGG 423nts 
Rpbp5_3R GAATACATTGCTGCTTGCTGGATAGG  
 
Table from (Galloway-Pena et al., 2011) 
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[2.3] CHAPTER 1 RESULTS  
[2.3.1] Analysis of Clonality and Antibiotic Resistance among Early Clinical Isolates of 
Enterococcus faecium in the United States.  
Research on the emergence of ampicillin and vancomycin resistance and the origins of 
hospital-associated genogroups are mainly European studies (Leavis et al., 2006a; Lester et al., 
2008; Willems et al., 2005). Outbreaks of ampicillin-resistant E. faecium were reported as early 
as the 1980’s in the United States (Bush et al., 1989; Coudron et al., 1984; Sapico et al., 1989), 
yet studies on the population genetics of early ampicillin and vancomycin resistant isolates 
from the United States have not been done. In this study, I analyzed early United States E. 
faecium for the emergence of putative virulence genes and antibiotic resistance in relation to 
their clonality in order to better understand the epidemiology of early ampicillin resistant E. 
faecium outbreaks in the United States. A chronological timeline summarizing the key events 
discussed below can be found in Figure 1. Additionally, illustrations summarizing the 
comparisons between CC17 isolates and non-CC17 isolates for the presence of ampicillin 
resistance, vancomycin resistance, and putative virulence genes can be found in Figures 2 and 
3. 
Although not a prospective collection, the isolates used in the present 
study (Table 3) represent isolates causing most of the published E. faecium 
outbreaks occurring up to 1994, as well as early reports of ampicillin-resistant and 
vancomycin-resistant strains in the United States. In chronological order, the 
earliest isolates available to us were from the 1970s and were recovered at the 
Massachusetts General Hospital in Boston during a 22-year study at this 
institution (Grayson et al., 1991). The isolates recovered in the 1970s were both 
ampicillin and vancomycin susceptible, and MLST analysis revealed that they did 
not belong to the CC17 genogroup. Instead they were ST296, ST25, or purK 
allele 8 (NEDH 4901 and NEDH 4586 have an identical pulsotype; data not 
shown). Colony hybridization analysis showed that these isolates did not contain 
the putative virulence determinants hylEfm or espEfm and harbored only 8 to 9 of the 
14 fms genes (Table 4). High-level resistance to streptomycin was displayed in 2 
of these isolates.  
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Two published studies reported infections due to ampicillin-resistant E. 
faecium between 1981 and 1987. We obtained 7 isolates from one study 
performed at Rancho Los Amigos Medical Center in Downey, California, 
between January 1981 and September 1987 (Miranda et al., 1991; Sapico et al., 
1989).  This was one of the first reports of an increased presence of ampicillin 
resistance (MICs 16- 32 µg/mL). We found high-level resistance to streptomycin 
in some of the isolates; however, none had high-level resistance to gentamicin, 
and all were vancomycin susceptible. Six of the isolates were ST92, ST476 or 
contained purK allele 2 (RLA-5 and RLA-7 had an identical pulsotype, whereas 
RLA-1, RLA-2, and RLA-3 had an identical pulsotype; data not shown and 
(Miranda et al., 1991)), which indicated that they were not related to the CC17 
genogroup. The hylEfm and espEfm genes were not present, and the fms gene profile 
showed these isolates were missing the predicted pilus operon fms11-19-16, 
putative accessory pilin fms20, and putative adhesin fms18. One isolate was 
ST280 (within the CC17 genogroup) and contained all 14 of the fms genes; the 
exact year (between 1981 and 1987) this organism was isolated is unknown.  
We also found that CC17 genogroup isolates from the second study 
performed during this time frame were responsible for an E. faecium outbreak in a 
neonatal intensive care unit at the Medical College of Virginia in Richmond in 
1982  (Coudron et al., 1984; Miranda et al., 1991). This outbreak was the first for 
which bacteremia and meningitis due to multi-resistant E. faecium were 
described. Seven isolates from this outbreak were studied, and we found that all 
either belonged to ST17, as determined by MLST, or harbored the purK allele 1 
(MCV161 and 130 had an identical pulsotype, whereas MCV264, MCV211, and 
MCV255 had an identical pulsotype; data not shown and (Miranda et al., 1991)). 
This outbreak was different from the California outbreak in that ampicillin MICs 
were slightly higher, ranging from 32 µg/mL to 64 µg/mL. This is the first time 
that E. faecium with high-level resistance to gentamicin was observed in our study 
and, to our knowledge, in the United States. These early isolates contained all of 
the fms genes; only one isolate from this outbreak had the espEfm gene, and none 
had the hylEfm gene. 
We examined ten isolates recovered in 4 different states between 1986 and 
1988. Two isolates were from 2 different hospitals in Boston, Massachushetts 
(Eliopoulos et al., 1988; Grayson et al., 1991), 1 from a nosocomial outbreak of E. 
faecium at Miriam Hospital in Providence, Rhode Island (Boyce et al., 1992), 3 
from Charlotte Memorial Hospital in Charlotte, North Carolina (Stratton et al., 
1987), and 4 from the University of Wisconsin at Madison clinics (Spiegel, 1988). 
One isolate from the Children’s Hospital Medical Center in Boston, 
Massachushetts, had been obtained because of its reported high-level resistance to 
gentamicin (Eliopoulos et al., 1988). This isolate was found to be ST112 and 
therefore did not belong to CC17; it was isolated in 1986, had an intermediate 
ampicillin MIC of 8 µg/mL, and lacked the ebpfm operon fms1-5-9 but had the 
espEfm gene. Another isolate from Boston, recovered in 1988 at New England 
Deaconess Hospital, had a new ST (ST473) with purK allele 8, was ampicillin 
resistant (MIC 32 µg/mL), and lacked the putative adhesins scm (fms 10), fms15 
and fms18. Four of the 10 isolates recovered during this period were within the 
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CC17 genogroup, specifically ST18, ST19, or purK allele 1 (M-1634 and W-
27358 had an identical pulsotype; data not shown). The others were ST10, ST25 
or a new ST (ST474). Four isolates from locations other than Boston were 
ampicillin resistant (3 were in the CC17 genogroup and 1 was not) with MICs of 
16 µg/mL to 64 µg/mL. The majority (7) of the 10 isolates showed high-level 
resistance to streptomycin, but only 1 has high-level resistance to gentamicin.  All 
4 CC17 genogroup isolates contained all fms genes, 3 contained the espEfm gene, 
and 2 contained hylEfm. The 2 isolates that contained the hylEfm gene were isolated 
in 1986; this is the first appearance of the hylEfm gene in the present study. 
In addition to the 10 isolates described above, 6 isolates from the Medical 
College of Pennsylvania in Philadelphia, all of which were isolated in 1988, were 
also studied (Bush et al., 1989). These isolates were from a surveillance study that 
showed an increase in penicillin resistance and an inability to treat some of these 
isolates with combination gentamicin/penicillin therapy. We found that 6 isolates 
were within the CC17 genogroup with ST16, ST17, or purK allele 1 (FA295 and 
FA287 had an identical pulsotype while FA232 and FA191 had a similar 
pulsotype; data not shown and (Miranda et al., 1991)) and had all 14 fms genes. 
They were all ampicillin resistant and vancomycin susceptible, with ampicillin 
MICs of 32 -128 µg/mL.  High-level resistance to streptomycin was present in 5 
of the isolates, whereas high-level resistance to gentamicin was found in 3 of the 
isolates during this time period. Five of the isolates contained the espEfm gene, but 
none contained the hylEfm gene.  
We also had available isolates from 2 published outbreaks occurring 
during 1990-1991 (Grayson et al., 1991; Handwerger et al., 1993): 4 isolates were 
obtained from Boston (2 from New England Deaconess Hospital and 2 from the 
22-year review study at Massachusetts General Hospital) (Grayson et al., 1991) 
and 8 isolates were obtained from a nosocomial outbreak of multiresistant E. 
faecium at Beth Israel Hospital in New York (Handwerger et al., 1993). This was 
the first time we documented vancomycin-resistant isolates in the present study. 
Isolates from both outbreaks were all representatives of the CC17 genogroup, 
(specifically ST16-ST18) or harbored the purK allele 1 (SH-4, 5 and 10 had 
identical pulsotypes, whereas SH-6, SH-9, SH-11, SH-13 and SH-14 had similar 
pulsotypes; data not shown and (Handwerger et al., 1993)). The majority of 
isolates were ampicillin resistant, with their MICs (range, 32-256 µg/mL) even 
higher than those for the isolates recovered from outbreaks occurring in the late 
1980s. The isolates from Boston were vancomycin susceptible, whereas the 
isolates from New York exhibited vancomycin resistance conferred by the vanA 
gene with MICs of 256-512 µg/mL. Both outbreaks had isolates with high-level 
resistance to both gentamicin and streptomycin.  Interestingly, all isolates in both 
outbreaks contained hylEfm and espEfm, highlighting a marked increase in the 
presence of these 2 genes. Furthermore, most contained all 14 fms genes, except 
that none of the isolates from New York had the putative accessory pilus 
encoding gene fms20. 
Last, we also studied 8 isolates recovered in Houston, Texas, at 2 different 
hospitals between 1992 and 1994 (Coque et al., 1996). Five isolates were within 
the hospital-associated CC17 genogroup, with ST20, ST17, and purK allele 1 
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represented (VREH-1 and 4 had similar pulsed-field types; data not shown). 
These isolates exhibited ampicillin resistance with MICs of 32-128 µg/mL, and 2 
exhibited vanA-type vancomycin resistance (MIC, 512µg/ml). The majority of 
isolates (5 of 8) exhibited high-level resistance to streptomycin, but only 1 isolate 
had high-level resistance to gentamicin. The Texas CC17 genogroup isolates had 
the majority of fms genes, except for fms20 and fms18. The hylefm and espefm genes 
were detected in only 1 of these isolates. We also identified a new CC17 
genogroup-related ST (ST475) in this group of isolates represented by isolate 
TX1399, a single locus variant of ST17 in the ddl allele. This isolate was 
susceptible to both ampicillin and vancomycin but had the same fms, hylEfm, and 
espEfm gene profile as the other CC17 isolates from Texas. Two of the strains that 
were isolated were not within the CC17 genogroup (ST71 and purK allele 8). 
Both were ampicillin and vancomycin susceptible, and 1 showed high-level 
resistance to streptomycin; these 2 isolates lacked the hylEfm and espEfm genes and 
contained only 7 or 8 of the 14 fms genes. All of the important events that 
occurred over time in the isolates in this study are summarized in Figure 1. 
(Galloway-Pena et al., 2009) 
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TABLE 3.  Relevant background and characteristics of the early clinical United States E. faecium isolates included in this 
study.  
Isolate Name(s) Location  Year Antibiotic resistance(s)
a
  ST
b,c,d,e
 purK References 
NEDH 4901/TX2050
 
Boston, MA 1971 AMP
S
, VAN
S
, STR
HLR
 296 8 (Grayson et 
al., 1991; 
Miranda et 
al., 1991) 
NEDH 4586/TX2051
 
Boston, MA 1971 AMP
S
, VAN
S
  (296) 8 (Grayson et 
al., 1991; 
Miranda et 
al., 1991) 
NEDH 758/TX2052 Boston, MA 1973 AMP
S
, VAN
S
, STR
HLR
   25 6 (Grayson et 
al., 1991; 
Miranda et 
al., 1991) 
RLA-1/TX2058
 
Downey, CA 1981-87 AMP
R
, VAN
S
, STR
HLR 
476
e 
2 (Miranda et 
al., 1991; 
Sapico et al., 
1989) 
RLA-2/TX2059
 
Downey, CA 1981-87 AMP
R
, VAN
S
, STR
HLR
 (476)
e 
2 (Miranda et 
al., 1991; 
Sapico et al., 
1989) 
RLA-3/TX2060
 
Downey, CA 1981-87 AMP
R
, VAN
S
, STR
HLR
 (476)
e 
2 (Miranda et 
al., 1991; 
Sapico et al., 
1989) 
RLA-4/TX2061
 
Downey, CA 1981-87 AMP
R
, VAN
S
, STR
HLR 
92 2 (Miranda et 
25 
 
al., 1991; 
Sapico et al., 
1989) 
RLA-5/TX2062
 
Downey, CA 1981-87 AMP
R
, VAN
S 
92 2 (Miranda et 
al., 1991; 
Sapico et al., 
1989) 
RLA-7/TX2064
 
Downey, CA 1981-87 AMP
R
, VAN
S
 (92) 2 (Miranda et 
al., 1991; 
Sapico et al., 
1989) 
RLA-6/TX2063
 
Downey, CA 1981-87 AMP
R
, VAN
S
, STR
HLR
 280
c 
1 (Miranda et 
al., 1991; 
Sapico et al., 
1989) 
MCV130/TX2029
 
Richmond, VA 1982 AMP
R
, VAN
S
 17
c
 1 (Coudron et 
al., 1984; 
Miranda et 
al., 1991) 
MCV161/TX2031
 
Richmond, VA 1982 AMP
R
, VAN
S
 (17)
c 1 (Coudron et 
al., 1984; 
Miranda et 
al., 1991) 
MCV211/TX2033
 
Richmond, VA 1982 AMP
R
, VAN
S
, STR
HLR
 17
c 
1 (Coudron et 
al., 1984; 
Miranda et 
al., 1991) 
MCV255/TX2035
 
Richmond, VA 1982 AMP
R
, VAN
S
 (17)
c 
1 (Coudron et 
al., 1984; 
Miranda et 
al., 1991) 
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MCV/264/TX2036
 
Richmond, VA 1982 AMP
R
, VAN
S
, STR
HLR
 (17)
c 
1 (Coudron et 
al., 1984; 
Miranda et 
al., 1991) 
MCV266/TX2034
 
Richmond, VA 1982 AMP
R
, VAN
S
, STR
HLR
 17
c 
1 (Coudron et 
al., 1984; 
Miranda et 
al., 1991) 
MCV268/TX2038
 
Richmond, VA 1982 AMP
R
,VAN
S
, GEN
HLR
, STR
HLR
 17
c 
1 (Coudron et 
al., 1984; 
Miranda et 
al., 1991) 
NEDH-87-P1/TX2053 Boston, MA 1986 AMP
S
, VAN
S
, GEN
HLR
, STR
HLR
 112 18 (Eliopoulos et 
al., 1988; 
Miranda et 
al., 1991) 
W-5586/TX2008 Charlotte, NC 1986 AMP
R
, VAN
S
, STR
HLR
 10 6 (Stratton et 
al., 1987) 
W-27358/TX2016
 
Charlotte, NC 1986 AMP
R
, VAN
S
 18
c 
1 (Stratton et 
al., 1987) 
M-1634/TX2000
 
Charlotte, NC 1986 AMP
R
, VAN
S
, STR
HLR
 (18)
c 
1 (Stratton et 
al., 1987) 
UWHC-9802/TX2041 Madison, WI 1987-88 AMP
S
, VAN
S
, STR
HLR
   25 6 (Miranda et 
al., 1991; 
Spiegel, 
1988) 
UWHC-4827/TX2042 Madison, WI 1987-88 AMP
S
, VAN
S
, STR
HLR
   19
c 
1 (Miranda et 
al., 1991; 
Spiegel, 
1988) 
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UWHC-112/TX2043 Madison, WI 1987-88 AMP
S
, VAN
S
, STR
HLR
   25 6 (Miranda et 
al., 1991; 
Spiegel, 
1988) 
UWHC-2145/TX2046 Madison, WI 1987-88 AMP
S
, VAN
S
 474
e 
4 (Miranda et 
al., 1991; 
Spiegel, 
1988) 
NEDH SF-76/TX2054 Boston, MA 1988 AMP
R
, VAN
S
 473
e 
8 (Grayson et 
al., 1991; 
Miranda et 
al., 1991) 
875-D/TX2048 Providence, RI 1988 AMP
R
, VAN
S
, STR
HLR
 18
c 
1 (Boyce et al., 
1992) 
FA287/TX2024
 
Philadelphia, PA 1988 AMP
R
, VAN
S
, GEN
HLR
, STR
HLR
 16
c 
1 (Bush et al., 
1989; 
Miranda et 
al., 1991) 
FA295/TX2023
 
Philadelphia, PA 1988 AMP
R
, VAN
S
, GEN
HLR
, STR
HLR
 (16)
c 
1 (Bush et al., 
1989; 
Miranda et 
al., 1991) 
FA280/TX2025
 
Philadelphia, PA 1988 AMP
R
, VAN
S
, STR
HLR
 16
c 
1 (Bush et al., 
1989; 
Miranda et 
al., 1991) 
FA191/TX2027
 
Philadelphia, PA 1988 AMP
R
, VAN
S
, STR
HLR
 17
c 
1 (Bush et al., 
1989; 
Miranda et 
al., 1991) 
28 
 
FA232/TX2022
 
Philadelphia, PA 1988 AMP
R
, VAN
S
, GEN
HLR
, STR
HLR
 (17)
c 
1 (Bush et al., 
1989; 
Miranda et 
al., 1991) 
FA185/TX2026
 
Philadelphia, PA 1988 AMP
R
, VAN
S
 17
c 
1 (Bush et al., 
1989; 
Miranda et 
al., 1991) 
A358/TX2067
 
Boston, MA 1990 AMP
R
, VAN
S
, GEN
HLR
, STR
HLR
 17
c 
1 (Singh et al., 
1996) 
A490/TX2069
 
Boston, MA 1990 AMP
R
, VAN
S
, GEN
HLR
, STR
HLR
 17
c 
1 This study 
A360/TX2068
 
Boston, MA 1990 AMP
R
, VAN
S
, GEN
HLR
, STR
HLR
 17
c 
1 This study 
A491/TX2070
 
Boston, MA 1990 AMP
R
, VAN
S
, GEN
HLR
, STR
HLR
 17
c 
1 This study 
SH-4/TX2429
 
New York, NY 1990-91 AMP
R
, VAN
S
, GEN
HLR
, STR
HLR
 18
c 
1 (Handwerger 
et al., 1993) 
SH-5/TX2430
 
New York, NY 1990-91 AMP
R
, VAN
R
 (18)
c 
1 (Handwerger 
et al., 1993) 
SH-10/TX2435
 
New York, NY 1990-91 AMP
R
, VAN
R
, GEN
HLR
, STR
HLR
 (18)
c 
1 (Handwerger 
et al., 1993) 
SH-11/TX2436
 
New York, NY 1990-91 AMP
R
, VAN
R
, GEN
HLR
, STR
HLR
 16
c 
1 (Handwerger 
et al., 1993) 
SH-6/TX2431
 
New York, NY 1990-91 AMP
S
, VAN
R
, GEN
HLR
, STR
HLR
 (16)
c 
1 (Handwerger 
et al., 1993) 
SH-9/TX2434
 
New York, NY 1990-91 AMP
R
, VAN
R
, GEN
HLR
, STR
HLR
 (16)
c 
1 (Handwerger 
et al., 1993) 
SH-13/TX2438
 
New York, NY 1990-91 AMP
R
, VAN
R
, STR
HLR
 (16)
c 
1 (Handwerger 
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et al., 1993) 
SH-14/TX2439
 
New York, NY 1990-91 AMP
R
, VAN
R
, GEN
HLR
, STR
HLR
 (16)
c 
1 (Handwerger 
et al., 1993) 
VREH-1/TX2416
 
Houston,TX 1992 AMP
R
, VAN
R
, GEN
HLR
, STR
HLR
 20
c 
1 (Korten et al., 
1994) 
VREH-4/TX2419
 
Houston, TX 1992 AMP
R
, VAN
R
 (20)
c 
1 This study 
VREH-5/TX2420 Houston, TX 1992 AMP
R
, VAN
S
, STR
HLR
 17
c 
1 This study 
SEH1a/TX1361 Houston, TX 1993-94 AMP
S
, VAN
S
, STR
HLR
 71
 
2 (Coque et al., 
1996) 
SEH7/TX1371 Houston, TX 1993-94 AMP
R
, VAN
S
, STR
HLR
 17
c 
1 (Coque et al., 
1996) 
SEH33/TX1399 Houston, TX 1993-94 AMP
S
, VAN
S
 475
c,e 
1 (Coque et al., 
1996) 
SEH41/TX1405 Houston, TX 1993-94 AMP
R
, VAN
S
, STR
HLR
 17
c 
1 (Coque et al., 
1996) 
SEH36/TX1401 Houston, TX 1993-94 AMP
S
, VAN
S
 ND
d 8 (Coque et al., 
1996) 
aSuperscript “R” denotes resistance, “S” denotes susceptible, and “HLR” denotes high-level resistance, bST numbers in parenthesis 
denote the inferred sequence type based on having the same purK allele and an identical pulsotype to a typed isolate, 
c
ST numbers that 
are considered to be within the CC17 genogroup, 
d
ND denotes not done, 
e
New STs designated in this study. 
Adapted from (Galloway-Pena et al., 2009) 
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FIGURE 1. Key events that occurred in the early clinical United States isolates of this study. The MICs listed correspond to the 
highest ampicillin MIC from each outbreak. The following abbreviations are used in this figure: high-level resistance to streptomycin 
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(STR
HLR
), high-level resistance to gentamicin (GEN
HLR
), ampicillin resistance (AMP
R
) and vancomycin resistance (VAN
R
).  Figure 
from (Galloway-Pena et al., 2009). 
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TABLE 4. Results for early clinical United States isolate colony hybridizations.  
Isolate name/alternate 
designation 
es
p
E
fm
 
h
yl
E
fm
 
fm
s 
1
 
fm
s 
5
 
fm
s 
9
 
fm
s 
1
1
 
fm
s 
1
9
 
fm
s 
1
6
 
fm
s 
1
4
 
fm
s 
1
7
 
fm
s 
1
3
 
fm
s 
2
1
 
fm
s 
2
0
 
S
cm
a 
fm
s 
1
5
 
fm
s 
1
8
 
a
cm
b
 
NEDH 4901/TX2050
 
  + + + + + + +   + +    + 
NEDH 4586/TX2051
 
  + + + + + + +   + +    + 
NEDH 758/TX2052         + + + + + + + + + 
RLA-1/TX2058
 
  + + +      + +  + +  + 
RLA-2/TX2059
 
  + + +      + +  + +  + 
RLA-3/TX2060
 
  + + +      + +  + +  + 
RLA-4/TX2061
 
  + + +    + + + +  + +  + 
RLA-5/TX2062
 
  + + +      + +  + +  + 
RLA-7/TX2064
 
  + + +      +   + +  + 
RLA-6/TX2063
 
  + + + + + + + + + + + + + + + 
MCV130/TX2029
 
  + + + + + + + + + + + + + + + 
MCV161/TX2031
 
  + + + + + + + + + + + + + + + 
MCV211/TX2033
 
  + + + + + + + + + + + + + + + 
MCV255/TX2035
 
  + + + + + + + + + + + + + + + 
MCV/264/TX2036
 
  + + + + + + + + + + + + + + + 
MCV266/TX2034
 
  + + + + + + + + + + + + + + + 
MCV268/TX2038
 
+  + + + + + + + + + + + + + + + 
NEDH-87-P1/TX2053 +     + + +  + + + + + + + + 
W-5586/TX2008         + + + + + + +  + 
W-27358/TX2016
 
+ + + + + + + + + + + + + + + + + 
M-1634/TX2000
 
+ + + + + + + + + + + + + + + + + 
UWHC-9802/TX2041         + + +   + +  + 
UWHC-4827/TX2042   + + + + + + + + + + + + + + + 
UWHC-112/TX2043   + + + + + + + + + + + + +  + 
UWHC-2145/TX2046         + +  + + +   + 
NEDH SF-76/TX2054   + + + + + + + + + + +    + 
875-D/TX2048 +  + + + + + + + + + + + + + + + 
FA287/TX2024
 
+  + + + + + + + + + + + + + + + 
FA295/TX2023
 
+  + + + + + + + + + + + + + + + 
FA280/TX2025
 
+  + + + + + + + + + + + + + + + 
FA191/TX2027
 
+  + + + + + + + + + + + + + + + 
FA232/TX2022
 
+  + + + + + + + + + + + + + + + 
FA185/TX2026
 
  + + + + + + + + + + + + + + + 
A358/TX2067
 
+ + + + + + + + + + + + + + + + + 
A490/TX2069
 
+ + + + + + + + + + + + + + + + + 
A360/TX2068
 
+ + + + + + + + + + + + + + + + + 
A491/TX2070
 
+ + + + + + + + + + + + + + + + + 
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SH-4/TX2429
 
+ + + + + + + + + + + +  + + + + 
SH-5/TX2430
 
+ + + + + + + + + + + +  + + + + 
SH-10/TX2435
 
+ + + + + + + + + + + +  + + + + 
SH-11/TX2436
 
+ + + + + + + + + + + +  + + + + 
SH-6/TX2431
 
+ + + + + + + + + + + +  + + + + 
SH-9/TX2434
 
+ + + + + + + + + + + +  + + + + 
SH-13/TX2438
 
+ + + + + + + + + + + +  + + + + 
SH-14/TX2439
 
+ + + + + + + + + + + +  + + + + 
VREH-1/TX2416
 
+ + + + + + + + + + + +  + + + + 
VREH-4/TX2419
 
  + + + + + + + + + +  + + + + 
VREH-5/TX2420   + + + + + + + + + + + + +  + 
SEH1a/TX1361   + + +    + + +   + +  + 
SEH7/TX1371   + + + + + + + + + + + + +  + 
SEH33/TX1399   + + + + + + + + + + + + +  + 
SEH41/TX1405   + + + + + + + + + + + + +  + 
SEH36/TX1401      + + + + + + +     + 
a
The scm gene is fms10, 
b
The acm gene is fms8 
 
Table from (Galloway-Pena et al., 2009) 
 
 
FIGURE 2. A comparison between early United States CC17 isolates and non-CC17 
isolates for the presence of ampicillin resistance, vancomycin resistance, the espEfm gene, 
and the hylEfm gene. * P < 0.05 against non-CC17 isolates in our study. ** P < 0.005 against 
non-CC17 isolates in our study. *** P < 0.0005 against non-CC17 isolates in our study. Figure 
from (Galloway-Pena et al., 2009). 
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FIGURE 3. A comparison between CC17 and non-CC17 isolates for the presence of the 
putative adhesins and pili (fms) genes in early United States E. faecium isolates. fms1-5-9 
is the ebpfm operon while fms11-19-16 and fms14-17-13 are putative pilus operons. fms21 has 
been shown to encode pili while fms20 is considered its accessory protein. fms10, also known 
as scm, is a collagen binding adhesin while fms18 and fms15 are thought to encode putative 
adhesins.* P < 0.05 against non-CC17 isolates in our study. ** P < 0.005 against non-CC17 
isolates in our study. *** P < 0.0005 against non-CC17 isolates in our study. Figure from 
(Galloway-Pena et al., 2009) 
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[2.3.2] Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecium in South 
American Hospitals.  
  VREfm infections have been reported in South America since 1998 (Dalla Costa et al., 
1998; Marin et al., 1998). The overall prevalence of VREfm in South America has been found 
to be much lower (9.7%) than that in the United States (Arias et al., 2003; Moet et al., 2007).  
The emergence of CC17-related E. faecium in South America (Khan et al., 2009; Lopez et al., 
2009; Willems et al., 2005) introduced the need for a prospective study addressing the limited 
data regarding the population genetics of enterococci circulating in the northern region of South 
America. Therefore, in collaboration, I helped to characterize 35 VREfm isolated in the Andean 
region of South America at the molecular level. 
Of the 760 enterococci isolates collected, 35 E. faecium isolates were vancomycin 
resistant via the vanA gene cluster. Eleven different PFGE banding patterns were found with a 
single PFGE banding pattern prevalent in each country (Table 5) (although some isolates from 
different countries had related PFGE patterns). MLST analysis of isolates representing each 
PFGE type revealed that the most frequent ST was ST412. Other STs seen in northern South 
America included ST17, ST18, ST125, ST203, ST280, ST282, and ST494, all of which are 
related in the CC17 genogroup.  
As done with the United States isolates, the thirty-five South American VREfm isolates 
were investigated for the presence of various putative virulence genes frequently found in 
CC17 isolates using DNA probes found in Table 1 for hylEfm, espEfm, and the 14 fms genes as 
discussed in section [2.2.5]. The results of colony hybridizations are shown in Figure 4. The 
four putative MSCRAMM clusters were often present with the fms5-6-9 (pilB) and fms11-19-
16 putative pilus clusters present in all South American VREfm isolates (Figure 4). The scm 
36 
 
gene, encoding a collagen adhesin, was present in more than 90% of the isolates. All other fms 
genes were highly represented at rates ranging from 67% to 97% of the VREfm isolates. 
Additionally, the espEfm and hylEfm genes were detected in 69% and 23% of isolates, 
respectively. 
 
TABLE 5. Molecular typing of the vancomycin resistant E. faecium isolates collected from 
the Andean region of South America. 
Country of Origin PFGE Type  MLST 
Colombia  A 412 
Colombia A  
Colombia C 18 
Colombia C  
Colombia C  
Colombia C  
Colombia C  
Colombia C  
Colombia C  
Colombia E 125 
Ecuador  D 17 
Ecuador  D  
Ecuador  D  
Ecuador  D  
Ecuador  I 203 
Peru  A 412 
Peru  B 412 
Peru  B  
Peru  B  
Peru  B  
Peru  B  
Peru  B  
Peru  E 125 
Peru  F 280 
Peru  F  
Peru  G 280 
Peru  H 282 
Peru  J 494 
Peru  K 18 
Venezuela  A 412 
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Venezuela  A  
Venezuela  A  
Venezuela  A  
Venezuela  A  
Venezuela  A  
 
Adapted from (Panesso et al., 2010) 
 
 
 
 
 
FIGURE 4. Frequency of putative virulence genes in 35 VR E. faecium isolates from the 
Andean region of South America. The numbers on the left-hand side indicate the four clusters 
of genes encoding characterized putative proteins of the enterococcal pili. Figure from (Panesso 
et al., 2010) 
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[2.3.3] Analysis of PBP5 of Early United States Enterococcus faecium Isolates: Sequence 
Variation Alone Does Not Explain Increasing Ampicillin Resistance Over Time.  
In the first study (section 2.3.1), it was found that ampicillin MICs of hospital-
associated E. faecium isolates from the United States have increased steadily over the 
past thirty years. Isolates were ST17, or a related ST. Thus, this study (Galloway-Pena et 
al., 2011) tried to determine if specific amino acid variations could be correlated with 
increasing MICs using strains from similar lineages (an attempt to reduce background 
differences). 
Up to 98 single nucleotide polymorphisms (Table 6), up to 73 silent 
polymorphisms (Table 7) and up to 20 amino acid variations (Table 8) were found 
when comparing isolates with an ampicillin MIC < 4µg/ml and those with an MIC 
of ampicillin >4µg/ml, resulting in an approximately 5% nucleotide difference. 
All strains with MICs < 4µg/ml (pbp5-S group) had an almost identical amino 
acid profiles, while all strains with MICs >4µg/ml   (pbp5-R group) had amino 
acid profiles which were different from the first group and which were almost 
identical to each other and to the transferable low affinity PBP5 found in the E. 
faecium strain C68 (~99-100% sequence identity) (Carias et al., 1998; Rice et al., 
2001).  The consensus sequence (Table 8) of the amino acids that differed 
between the two groups was derived for the strains with an MIC< 4µg/ml and 
those with an MIC >4µg/ml, and is consistent with the sequences previously 
reported (Ligozzi et al., 1996; Rice et al., 2001; Rybkine et al., 1998).  
By analyzing the silent polymorphisms sites found when comparing pbp5-
S and pbp5-R strains, we found that pbp5-R strains use the same codon at all 
silent polymorphism sites whereas the pbp5-S and hybrid strains may use two 
different codons for an amino acid at a particular position (18 out of 73 silent 
polymorphisms) (Table 6 and 7). (Galloway-Pena et al., 2011) 
 
TABLE 6. Single nucleotide polymorphisms at each nucleotide position of the consensus 
sequence of pbp5 in the 29 United States strains analyzed. Adapted from (Galloway-Pena et 
al., 2011). See next 3 pages. Variation within the same group (pbp5-S or pbp5-R) is highlighted 
in gray). 
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Strain 63 71 78 79 10
1
1
0
8
1
4
4
1
6
8
1
7
4
1
9
7
2
0
2
2
0
7
2
1
6
2
5
5
2
6
4
2
8
2
2
9
8
3
0
6
3
3
0
3
4
2
3
4
5
4
2
9
4
3
0
4
5
0
4
5
3
4
9
5
5
0
4
5
1
4
5
2
5
5
2
9
5
4
3
5
6
1
5
8
5
5
9
4
6
0
3
1231501 T T A A G C G A A G G G A A A C G A T T C A A G T T G A C T G C T C G
Com15 T T A A G C G A A G G G A A A C G A T T C A A G T T G A C T G C C C G
Com12 T T A A G C G A A G G G A A A C G A T T C A A G T T G A C T G C C C G
TX1401 T T A A G C G A A G G G A A A C G A T T C A A G T T G A C T G C T C G
1141733 T T A A G C G A A G G G A A A C G A T T C A A G T T G A C T G C C C G
TX2050 T T A A G C G A A G G G A A A C G A T T C A A G T T G A C T G C T C G
TX2042 C C G G A T G G A A G A G G G T C G C C T T C A C C A G T A T A C T A
TX2043 C C G G A T A G G A G A G G G T C G C C T T C A C C A G T A T A C T A
D366 C C G G A T A G G A G A G G G T C T C C T T C A C C A G T A T A C T A
TX1399 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2053 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX0016 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2058 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2062 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2063 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2008 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2061 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2029 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2067 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2016 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX1371 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2033 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2034 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2038 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2024 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2025 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2027 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2068 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2069 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX1405 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
1230933 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
1231408 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
1231410 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2436 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2416 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2420 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2022 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
1231502 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
TX2070 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
C68 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A
H80721 C C G G A T A G G A A A G T G T C G C C T T C A C C A G T A T A C T A  
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Strain 60
9
6
1
1
6
3
6
6
4
5
6
4
6
6
4
8
6
8
1
7
7
1
8
1
9
8
6
4
8
9
7
9
0
0
9
0
3
9
1
2
9
4
2
9
5
1
9
6
3
9
7
0
9
8
1
9
9
0
1
0
0
2
1
0
1
1
1
0
1
7
1
0
2
0
1
0
4
7
1
0
6
8
1
0
9
5
1
1
9
4
1
2
0
1
1
2
2
4
1
2
8
1
1
3
6
2
1
3
7
7
1
3
8
9
1
3
9
6
1231501 G A C T G A T C A A A A T A T A C A C G G C C A A C G C G A C T G T T
Com15 G A C T G A T C A A A A T A T A C A C G G C C A A C G C G A C T G T T
Com12 G A C T G A T C A A A A T A T A C A C G G C C A A C G C G A C T G T T
TX1401 G A C T G A T C A A A A T A T A C A C G G C C A A C G C G A C T G T T
1141733 G A C T G A T C A A A A T A T A C A C G G C C A A C G C G A C T G T T
TX2050 G A C T G A T C A A A A T A T A C A C G G C C A A C G C G A C T G T T
TX2042 A A G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2043 A A G C T C G T G G T C A G A G T G A A A T T C G T A T T G T C T G C
D366 A G G C T C G T G G T C A G A G T G A A A T T C G T A T T A T C T G C
TX1399 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2053 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX0016 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2058 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2062 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2063 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2008 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2061 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2029 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2067 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2016 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX1371 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2033 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2034 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2038 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2024 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2025 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2027 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2068 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2069 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX1405 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
1230933 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
1231408 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
1231410 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2436 A G G C T C G T G G T C A G A G T T A A A T T C G T A T G G T C T G C
TX2416 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2420 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
TX2022 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
1231502 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G T T C T G C
TX2070 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G G T C T G C
C68 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G A T C T G C
H80721 A G G C T C G T G G T C A G A G T G A A A T T C G T A T G A T C T G C  
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Strain 13
9
9
1
4
0
0
1
4
0
1
1
4
0
6
1
4
0
7
1
4
0
8
1
4
1
0
1
4
4
0
1
4
5
9
1
4
6
0
1
4
6
4
1
4
8
5
1
4
9
1
1
4
9
4
1
4
9
7
1
5
0
1
1
5
0
6
1
5
0
9
1
5
4
8
1
5
8
1
1
5
9
0
1
6
2
6
1
7
6
2
1
8
4
5
1
8
9
2
1
8
9
6
1
9
2
9
1
9
4
4
1
9
5
6
1
9
9
5
2
0
0
5
2
0
0
6
2
0
0
7
2
0
1
6
1231501 - - - - - - G T A T G G G T C G T G C G T A G A A A C A T T C C C A
Com15 - - - - - - G T A T G G G T C G T G C G T A G A A A C A T T C C C A
Com12 - - - - - - G T A T A G G T C G T G C G T A G A A A C A T T G C C A
TX1401 - - - - - - G T A T G G G T C G C A T T C G T G T G T T C C T C G G
1141733 - - - - - - G T A T A G G T C G T G C G T A G A A A C A T T C T C A
TX2050 - - - - - - G T A T G G G T C G T G C G T A G G A A T T C C C C G G
TX2042 - - - - - - A C A T A T A A T A C A T T C G G G T A T T C C C C C G
TX2043 - - - - - - A C A T A T A A T A C A T T C G G G A A T T C C C C G G
D366 - - - - - - A C A C A T A A T A C A T T C G G G A A T T C C C C G G
TX1399 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C T C G G
TX2053 - - - - - - A C G C A T A A T A C A T T C G G G T G T T C C T C G G
TX0016 - - - - - - A C A T A T A A T A C A T T C G G G A G T T C C T C G G
TX2058 - - - A T G A C G C A T A A T A C A T T C G T G T G T T C C T C G G
TX2062 - - - A T G A C G C A T A A T A C A T T C G T G T G T T C C T C G G
TX2063 - - - - - - A C G C A T A A T A C A T T C G T G T G T T C C T C G G
TX2008 A G T - - - A C A C A T A A T A C A T T C G G G T G T T C C T C G G
TX2061 - - - A T G A C G C A T A A T A C A T T C G T G T G T T C C T C G G
TX2029 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C T C G G
TX2067 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C T C G G
TX2016 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C T C G G
TX1371 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C T C G G
TX2033 - - - - - - A C G C A T A A T A C A T T C G T G T G T T C C T C G G
TX2034 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C T C G G
TX2038 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C T C G G
TX2024 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C T C G G
TX2025 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C T C G G
TX2027 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C T C G G
TX2068 - - - - - - A C G C A T A A T A C A T T C G T G T G T T C C T C G G
TX2069 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C T C G G
TX1405 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C C T C G
1230933 - - - - - - A C G C A T A A T A C A T T C G T G T G T T C C T C G G
1231408 A G T - - - A C G C A T A A T A C A T T C G G G T G T T C C T C G G
1231410 A G T - - - A C G C A T A A T A C A T T C G G G T G T T C C T C G G
TX2436 - - - - - - A C G C A T A A T A C A T T C G T G T G T T C C T C G G
TX2416 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C C T C G
TX2420 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C T C G G
TX2022 - - - - - - A C A C A T A A T A C A T T C G T G T G T T C C T C G G
1231502 A G T - - - A C G C A T A A T A C A T T C G G G T G T T C C T C G G
TX2070 - - - A T G A C G C A T A A T A C A T T C G T G T G T T C C T C G G
C68 A G T - - - A C G C A T A A T A C A T T C G G G T G T T C C T C G G
H80721 A G T - - - A C G C A T A A T A C A T T C G G G T A T T C C T C G G  
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TABLE 7. Analysis of silent polymorphisms and the codon usage differences between pbp5-S, hybrid, and pbp5-R strains. 
 Position Amino Acid Strains Codon Used  Position Amino Acid Strains Codon Used  Position Amino Acid Strains Codon Used
21 Isoleucine pbp-S AUU 26 Alanine pbp-S GCA 36 Tyrosine pbp-S UAC
Hybrid AUC Hybrid GCG Hybrid UAU
pbp-R AUC pbp-R GCG pbp-R UAU
48 Threonine pbp-S ACG 56 Leucine pbp-S UUA 58 Lysine pbp-S AAA
Hybrid ACG/ACA Hybrid UUG Hybrid AAA/AAG
pbp-R ACA pbp-R UUG pbp-R AAG
69 Serine pbp-S UCG 72 Alanine pbp-S GCA 88 Glutamine pbp-S CAA
Hybrid UCA Hybrid GCG Hybrid CAG
pbp-R UCA pbp-R GCG pbp-R CAG
94 Alanine pbp-S GCC 102 Serine pbp-S UCA 110 Aspartic A pbp-S GAU
Hybrid GCU Hybrid UCG/UCU Hybrid GAC
pbp-R GCU pbp-R UCG pbp-R GAC
114 Tyrosine pbp-S UAU 115 Serine pbp-S AGC 143 Glycine pbp-S GGA
Hybrid UAC Hybrid AGU Hybrid GGU
pbp-R UAC pbp-R AGU pbp-R GGU
150 Glutamine pbp-S CAG 151 Proline pbp-S CCU 165 Serine pbp-S AGU
Hybrid CAA Hybrid CCC Hybrid AGC
pbp-R CAA pbp-R CCC pbp-R AGC
168 Threonine pbp-S ACG 175 Asparagine pbp-S AAC 181 Glycine pbp-S GGG
Hybrid ACA Hybrid AAU Hybrid GGU
pbp-R ACA pbp-R AAU pbp-R GGU
187 Threonine pbp-S ACC 195 Valine pbp-S GUU/GUC 198 Serine pbp-S AGC
Hybrid ACA Hybrid GUC Hybrid AGU
pbp-R ACA pbp-R GUC pbp-R AGU
201 Glycine pbp-S GGG 203 Glycine pbp-S GGG 212 Alanine pbp-S GCC
Hybrid GGA Hybrid GGA Hybrid GCG
pbp-R GGA pbp-R GGA pbp-R GCG
215 Serine pbp-S UCU 227 Alanine pbp-S GCU 257 Isoleucine pbp-S AUC
Hybrid UCC Hybrid GCG Hybrid AUU
pbp-R UCC pbp-R GCG pbp-R AUU
273 Glutamine pbp-S CAA 288 Lysine pbp-S AAA 299 Glycine pbp-S GGA
Hybrid CAG Hybrid AAG Hybrid GGU
pbp-R CAG pbp-R AAG pbp-R GGU
300 Arginine pbp-S CGA 301 Serine pbp-S UCU 304 Glutamic A pbp-S GAA
Hybrid CGC Hybrid UCA Hybrid GAG
pbp-R CGC pbp-R UCA pbp-R GAG
314 Threonine pbp-S ACU 317 Glycine pbp-S GGA 321 Isoleucine pbp-S AUC
Hybrid ACA Hybrid GGG Hybrid AUU
pbp-R ACA pbp-R GGG pbp-R AUU  
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 Position Amino Acid Strains Codon Used  Position Amino Acid Strains Codon Used  Position Amino Acid Strains Codon Used
327 Valine pbp-S GUC 330 Lysine pbp-S AAG 334 Glutamic A pbp-S GAG
Hybrid GUA Hybrid AAA Hybrid GAA
pbp-R GUA pbp-R AAA pbp-R GAA
337 Valine pbp-S GUC 339 Asparagine pbp-S AAC 340 Glycine pbp-S GGA
Hybrid GUU Hybrid AAU Hybrid GGC
pbp-R GUU pbp-R AAU pbp-R GGC
349 Alanine pbp-S GCA 356 Phenylalanine pbp-S UUC 365 Serine pbp-S UCG
Hybrid GCG Hybrid UUU Hybrid UCA
pbp-R GCG pbp-R UUU pbp-R UCA
398 Aspartic A pbp-S GAC 408 Glutamine pbp-S CAA 427 Isoleucine pbp-S AUC
Hybrid GAU Hybrid CAG/CAA Hybrid AUU
pbp-R GAU pbp-R CAG pbp-R AUU
454 Aspartic A pbp-S GAU 459 Serine pbp-S UCG 463 Threonine pbp-S ACU
Hybrid GAC Hybrid UCU Hybrid ACG
pbp-R GAC pbp-R UCU pbp-R ACG
465 Valine pbp-S GUU 468 Valine pbp-S GUG 478 Isoleucine pbp-S AUU
Hybrid GUC Hybrid GUA Hybrid AUC
pbp-R GUC pbp-R GUA pbp-R AUC
486 Alanine pbp-S GCA/GCG 493 Glycine pbp-S GGG 495 Lysine pbp-S AAG
Hybrid GCA Hybrid GGU Hybrid AAA
pbp-R GCA pbp-R GGU pbp-R AAA
497 Phenylalanine pbp-S UUC 500 Glycine pbp-S GGU/GGC 501 Leucine pbp-S UUG/UUA
Hybrid UUU Hybrid GGC Hybrid UUA
pbp-R UUU pbp-R GGC pbp-R UUA
514 Isoleucine pbp-S AUC/AUU 528 Asparagine pbp-S AAU/AAC 540 Glutamine pbp-S CAA/CAG
Hybrid AUU Hybrid AAC Hybrid CAG
pbp-R AUU pbp-R AAC pbp-R CAG
613 Proline pbp-S CCA/CCG 630 Lysine pbp-S AAA/AAG 641 Asparagine pbp-S AAC/AAU
Hybrid CCG Hybrid AAG Hybrid AAU
pbp-R CCG pbp-R AAG pbp-R AAU
646 Glycine pbp-S GGA/GGU 650 Valine pbp-S GUU/GUC 663 Threonine pbp-S ACU/ACC
Com15-E Hybrid GGU Hybrid GUC Hybrid ACC
GAA pbp-R GGU pbp-R GUC pbp-R ACC
670 Leucine pbp-S UUA/UUG
Hybrid UUG
pbp-R UUG  
 
Table from (Galloway-Pena et al., 2011) 
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TABLE 8. Amino Acid Changes Between Ampicillin Susceptible and Resistant 
Enterococcus faecium Stains from the United States.  
 
Amino Acid Position
24 27 34 66 68 85 100 144 172 177 204 216 324 466' 485 496 499 525 586 629 667
Consensus: MIC < 4µg/ml
MIC Strain MLST V S R G A E E K T L D A T – M N A E V E P
0.5-1 (n=3)
a
1231501 52
Com15 583
Com12 107 A
2 (n=1) TX1401
b
ND
c
L V S
1141733 327 S
4 (n=4) TX2050 296 V
TX2042
b
19
d
A G Q E Q Q A I S A K T D V
TX2043
b 
25 A G Q E Q Q A I S A K T D
D366
b 
25 A G Q E Q Q A I G S A K I D
Consensus: MIC > 4µg/ml
A G Q E T D Q Q A I G S A – T K T D L V S
8 (n=2) TX1399 475
d
TX2053 112 V
16 (n=5) TX0016 18
d
M V E
TX2058 476 D A
TX2062 92 D A
TX2063 280
d
A
TX2008 10 S V
32 (n=5) TX2061 92 D A
TX2029 17
d
TX2067 17
d
TX2016 18
d
TX1371 17
d
64 (n=9) TX2033 17
d
A
TX2034 17
d
TX2038 17
d
TX2024 16
d
TX2025 16
d
TX2027 17
d
TX2068 17
d
A
TX2069 17
d
A
TX1405 17
d
L
128 (n=7) 1230933 18
d
A
1231408 582
d
S A V
1231410 17
d
S A V
TX2436 16
d
A
TX2416 20
d
L
TX2420 17
d
TX2022 ND
256 (n=4) 1231502 203
d
S A V
TX2070 17
d
D A
C68 16
d
S A V
H80721 ND S A V
 Table from (Galloway-Pena et al., 2011) 
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TABLE 8. Continued 
a 
the number of isolates with a specific ampicillin MIC is indicated by (n=), 
b
 indicates a 
“hybrid” type pbp5 gene, c ND denotes that the multi-locus sequence type was not determined, 
d
 indicates an ST17, single locus variant of ST17, or double locus variant of ST17, and 
therefore considered to be in the CC17 genogroup 
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Interestingly, some strains (e.g. TX2042) with an MIC of 4µg/ml had a “hybrid-
like” PBP5 (indicated in Table 8) with some of the amino acids matching the consensus 
of the more susceptible strains, while most of the protein sequence matched the 
consensus of the resistant strains. One strain with an MIC of 2µg/ml (TX1401) had the 
consensus sequence of susceptible strains, except for the last three consensus sequence 
amino acids 586, 629 and 667, which coincided with the consensus of the resistant 
strains. TX1401 was the only strain predicted to have derived its sequence via 
homologous recombination using the maximum chi-squared test with putative 
recombination sites at bases 1888 (P=0.009) and 1587 (P=0.016) with approximately 
the first three-fourths of the sequence resembling the pbp5-S and the last part 
resembling pbp5-R strains. 
Amino acid changes near the active site predicted in previous publications 
(Jureen et al., 2004b; Klibi et al., 2008; Ligozzi et al., 1996; Poeta et al., 2007; Rice et 
al., 2004; Rybkine et al., 1998; Sifaoui et al., 2001; Zorzi et al., 1996) that were thought 
to be the cause of high-level resistance include an additional serine after amino acid 
position 466 (Ser-466’) and Met-485-Ala/Thr. Ser-466’ was found in three of the four 
most highly resistant isolates (MIC of ampicillin, 256µg/ml) and two isolates with an 
ampicillin MIC of 128µg/ml but also in one low-level resistant strain (e.g. TX2008) 
with an MIC of 16µg/ml, indicating there is not an absolute association between these 
changes and high-level resistance. Interestingly, some strains (both low-level and high-
level ampicillin resistant) also had an insertion of an aspartic acid residue instead of a 
serine at position 466’ (e.g., TX2058 and TX2070), which is located in the loop that 
forms the outer edge of the active site. Both residues are polar, so they may have the 
same effect, although aspartic acid is negatively charged, while serine is neutral. It was 
theorized by Sauvage et al. that the insertion at residue 466’ may displace the Val-465 
in the active site, reducing accessibility for penicillin, affecting substrate specificity 
(Sauvage et al., 2002). Although these variations were only found in resistant isolates, 
whether there was a serine or aspartic acid at this position did not seem to correlate with 
specific increases in MICs. However, the presence of a Ser-466’ or Asp-466’ in 
combination with Ala-485 was found in all four isolates with an MIC of 256µg/ml and 
therefore, while it may not be sufficient, it may be required to achieve this high level of 
ampicillin resistance. It is thought that removal of the bulky methionine at position 485 
would allow for conformational freedom near the Ser-480-Asp-Asn active site, resulting 
in a less efficient acylation process (Sauvage et al., 2002).  Although there are a number 
of amino acid differences between pbp5-S and pbp5-R strains (as well as silent 
polymorphisms) in the membrane anchor (1-45), N-terminal extension (46-162), and N-
terminal domain (163-345) these are unlikely to be of great significance since the 
transpeptidase domain is at the C-terminus (346-680), although we cannot rule out this 
possibility.  Of note, however, all of the amino acid differences among the resistant 
strains do occur in the transpeptidase domain.  
Outside of the Ser/Asp-466’ and Ala-485, no single amino acid variation, 
or combination thereof, correlated with specific ampicillin MICs or the 
progressive increase in MICs seen in United States outbreak isolates with an 
ampicillin MIC > 4ug/ml. Table 8 groups the isolates by MIC and shows how 
each isolate’s PBP5 differs from the consensus sequence. Interestingly, strain 
background did not seem to correlate with the differences seen in the pbp5 
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sequence, as multiple variations were found within the same ST, and the same 
sequence variation was found in multiple STs. However, the more resistant strains 
are of STs found in the hospital-associated CC17 genogroup, as to be expected 
(Galloway-Pena et al., 2009) (CC17 genogroup isolates are footnoted in Table 8).  
The finding that most E. faecium strains with an MIC >4µg/ml had a 
primary sequence highly divergent from the sequences of those that had an MIC 
<4µg/ml is similar to what has been found in Streptococcus pneumoniae, except 
that the pbp1, pbp2b, and pbp2x sequence in resistant clinical isolates revealed 
mosaic genes, with blocks of sequences that differed up to 23% (Zapun et al., 
2008).  To determine if the 5% variation and division of isolates into two groups 
(Figure 5) was restricted to pbp5, or if this was a difference that could be found 
on a larger genomic scale, we looked at three other genes, including pbp2, 
encoding proteins thought to be on the cell surface and, thus, possibly more likely 
to change compared to more conserved housekeeping genes.  The sequences of 
gls20, wlcA, and pbp2 from the 11 sequenced USA isolates available on the Broad 
Institute and NCBI were analyzed (Figure 6). The isolates also fell into two 
distinct lineages based on each of the other three genes, with up to a 3% 
nucleotide difference for gls20, up to a 7% difference for pbp2, and up to a 10% 
difference for wlcA between the two groups. These two lineages generally 
corresponded with the pbp5-S
 
and pbp5-R groups, which also corresponded to a 
CC17 genogroup (ST17, plus single locus variants, and/or double locus variants 
of it) and a non-CC17 genogroup.   While most of the time the isolates in the 
pbp5-S
 
and pbp5-R groups also grouped together using the other three genes, this 
was not always the case (Figure 6). For example, Efm 1231501 groups with the 
pbp5-R group using pbp2 and wlcA genes, despite being a non-CC17 isolate, and 
with the pbp5-S group for pbp5 and gls20. Efm 1231408 grouped with the pbp5-S
 
group using wlcA, even though it is a CC17 genogroup isolate, and with the pbp5-
R for pbp5, pbp2 and gls20. (Galloway-Pena et al., 2011) 
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 TX2029 MIC32 ST17
 TX2067 MIC32 ST17
 TX2027 MIC64 ST17
 TX2024 MIC64 ST16
 TX2022 MIC128 STND
 TX2016 MIC32 ST18
 TX1399 MIC8 ST475
 TX1371 MIC32 ST17
 TX2034 MIC64 ST17
 TX2420 MIC128 ST17
 TX1405 MIC64 ST17
 TX2416 MIC128 ST20
 Efm1230933 MIC128 ST18
 TX2436 MIC128 ST16
 TX2033 MIC64 ST17
 TX2058 MIC16 ST476
 TX2063 MIC16 ST280
 TX2068 MIC64 ST17
 TX2069 MIC64 ST17
 TX2070 MIC256 ST17
 C68 MIC256 ST16
 Efm1231410 MIC128 ST17
 H80721 MIC256 STND
 Efm1231408 MIC128 ST582
 TX2008 MIC16 ST10
 TX2025 MIC64 ST16
 TX0016 MIC16 ST18
 Efm1231502 MIC256 ST203
 D366 MIC4 ST25
 TX2042 MIC4 ST19
 TX1401 MIC2 STND
 Efm1141733 MIC2 ST327
 TX1330 MIC1 ST107
 Com12 MIC1 ST107
 Com15 MIC0.5 ST583
 Efm1231501 MIC1 ST52
 TX2050 MIC4 ST296
0.0000.0020.0040.0060.0080.0100.0120.014   
FIGURE 5. PBP5 phylogeny coincides with MIC. A UMPGA tree of PBP5 was constructed 
using the amino acid sequence from all strains analyzed in this study.  PBP5 splits isolates into 
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two groups using the amino acid sequence and these two groups coincide with the MIC. 
Isolates with an ampicillin MIC < 4µg/ml all group together in the lower branch of the tree 
(pbp5-S group) (except for TX2050, which has an MIC = 4µg/ml), while all isolates with an 
MIC >4µg/ml group together in the top branch of the tree (pbp5-R group). The minimal 
inhibitory concentration in micrograms per milliliter and multi-locus sequence type is listed 
next to the strain name. STND designates an ST that was not done. Figure from (Galloway-
Pena et al., 2011). 
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FIGURE 6. UPGMA trees of four E. faecium genes shows isolates generally fall into two distinct lineages. 
UPGMA trees of pbp5 (2A), gls20 (2B), pbp2 (2C), and wlcA (2D) are depicted using the sequenced USA isolates and available on 
the Broad Institute or NCBI.  In order to determine if other genes showed the same two groupings as pbp5 (designated pbp5-S and 
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pbp5-R) (2A), UPGMA trees of gls20 (2B), pbp2 (2C), and wlcA (2C) were made. The boxes indicate isolates that share the ampicillin 
pbp5-S (MIC < 4µg/ml) consensus. The sequence for wlcA of Efm1231502 was unavailable. Figure from (Galloway-Pena et al., 
2011).
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[2.4] CHAPTER 1 DISCUSSION 
 ST17 isolates were clearly present in United States hospitals by 1982 (Table 4 and 
Figure 1), predating the earliest published CC17 genogroup isolate (recovered in Great Britain) 
by seven years and predating the previously earliest known United States CC17 related isolate 
(DO/ TX16) by nine years (http://efaecium. mlst.net).  The key characteristics of these early 
United States CC17 genogroup isolates were 1) ampicillin resistance, 2) high-level resistance to 
streptomycin, and 3) the presence of the fms genes (Table 3, Table 4, and Figure 1).  
In addition to the earliest CC17 outbreak isolates, all the United States isolates within 
the CC17 genogroup analyzed were found to contain similar fms gene profiles with all isolates 
harboring at least 13/14 fms genes (either fms20 or fms18 missing). This result was clearly 
different from non-CC17 United States isolates, which were found to contain only five to nine 
fms genes (P-values ranging from 0.001 to 0.029 except for fms20) (Table 4 and Figure 3).  
Although espEfm was present in one of the earliest ST17 isolates (TX2038 isolated in 
1982), it was not found in most of the early outbreak isolates analyzed. However, its presence 
in CC17 isolates versus non-CC17 isolates was statistically significant (P = 0.0002) (Figure 2). 
This finding suggests that espEfm, was likely acquired at different times during E. faecium’s 
hospital-adaptation (most likely through horizontal transfer). The fact that fms genes were 
present earlier raises the possibility that these pili and adhesins played more of a role in E. 
faecium’s early adaptation to becoming a more prominent opportunistic pathogen then espEfm, 
at least in the United States.  
Additional testing for the hylEfm gene indicates that its presence (P = 0.001 for CC17 
versus non-CC17) increased around the late 1980’s (Table 4, Figure 1, and Figure 2).  In 
addition, vancomycin resistance (P = 0.044 for CC17 versus non-CC17) first appeared in 1990 
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and was due to the acquisition of the vanA gene cluster among the CC17 genogroup United 
States isolates (Table 3, Figure 1, and Figure 2), supporting the emergence of vancomycin 
resistance occurring after ampicillin resistance. Therefore, one might hypothesize that early 
United States ampicillin resistant hospital-associated isolates carrying fms genes, subsequently 
acquired espEfm and/or the hylEfm-containing plasmid, which can also contain vancomycin and 
gentamicin resistance determinants.  The sum of these attributes likely contributed to the recent 
success of E. faecium as a nosocomial pathogen.  
Comparable findings were found when a similar analysis was performed on South 
American VREfm isolates. Although VREfm prevalence in South America is still low 
compared to the United States, the VREfm isolates have genotypic and phenotypic 
characteristics similar to the United States isolates studied: (i) South American VREfm are 
mostly CC17 related isolates (mostly belonging to ST412 and ST18) and (ii) a high percentage 
of the South American CC17 related VREfm isolates contain MSCRAMM genes (fms genes) 
and hylEfm (Table 5 and Figure 4).  
One observation of my collaborators was that in some of the South American isolates, 
the fms20-fms21 cluster existed on the same transferrable plasmid as the hylEfm gene, which 
often contains vanA, conferring vancomycin resistance, and aac(6’)-aph(2”), conferring 
gentamicin resistance (Kim et al., 2010; Panesso et al., 2010) Interestingly, almost all of the 
VREfm United States isolate studies also exhibited high-level resistance to gentamicin and 
harbored the hylEfm gene (Table 3 and 4). These similarities in results suggest that the recent 
population genetics of VREfm in northern South America reflects the early isolates responsible 
for hospital outbreaks in the United States.  Due to this finding, one might predict an increase 
in the incidence of infections caused by CC17-related E. faecium in South America over the 
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next decade as this clone continues to expand and evolve by the horizontal transfer of plasmid 
associated virulence factors and antibiotic resistance determinants.  
Although ampicillin resistance was present significantly more often in United States 
CC17 isolates versus non-CC17 isolates (P = 0.0007), 8 out of the 41 United States ampicillin 
resistant isolates were not STs related to CC17, showing that not all ampicillin resistant isolates 
are closely related (Table 3, Figure 1, and Figure 2). E. faecium isolates intrinsically resistant to 
β-lactam antibiotics (Arias and Murray, 2008) were sporadically reported as early as 1965 
(Willems et al., 2005). However, reports of highly ampicillin resistant E. faecium isolates 
causing infections did not occur until the 1980’s (Boyce et al., 1992; Bush et al., 1989; 
Coudron et al., 1984; Eliopoulos et al., 1982; Sapico et al., 1989). The hypothesis that the 
presence of ampicillin resistance was one of the first steps of hospital-adaptation by E. faecium 
is supported by the finding that ampicillin resistance existed in the earliest CC17 outbreak 
isolates (Leavis et al., 2006a). Only two of the United States CC17 related isolates analyzed in 
this study were found to be ampicillin susceptible according to CLSI guidelines (MIC < 
16µg/ml).  
Furthermore, it was found that ampicillin MICs incrementally increased over time 
within the United States CC17 related isolates (Table 3, Figure 1, and Table 8). This finding 
suggested further mutations or overexpression of the ancestral pbp5 gene might have evolved 
in the hospital-adapted isolates, decreasing the susceptibility to ampicillin. Previous 
publications suggested that particular substitutions present in combination could amplify 
resistance levels (Poeta et al., 2007; Rice et al., 2004) as well as the ability of clinical isolates to 
transfer a low-affinity PBP5 (Rice et al., 2005). Therefore, we set out to determine if either of 
these scenarios was true.  
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Although there is a PBP5 consensus sequence among isolates with higher ampicillin 
MICs (Table 8), the increases in MIC seen among strains with the pbp5-R sequences could not 
be explained using sequence correlation. Thus, other factors such as regulation of expression or 
translational modifications are likely to be involved. But, overall the results suggest that the 
presence of a basic consensus sequence of a more resistant PBP5 that is different from the 
ancestral PBP5 is needed to obtain high MICs of ampicillin in hospital-associated E. faecium 
(Table 7, and Figure 5).  
We also observed the same genomic variability seen in the pbp5 genes in three other 
genes studied, suggesting that strain background might be a factor in the ability to obtain higher 
MICs or cause infections. The observation that pbp5, pbp2, gls20, and wlcA have sequences 
that phylogenetically branch into two similar groups, suggested that there are two distinct 
evolutionary lineages of E. faecium (Figure 5 and 6). Moreover, the data showing that 
switching occurred between groups depending on the gene (i.e., that the other genes were not 
always associated with the same group as seen with the pbp5 gene) (Figure 5 and 6), suggests a 
horizontal exchange of genes between individual isolates of the two lineages. The hypothesis of 
two distinct E. faecium clades, one community-associated and another hospital-associated, will 
be further discussed in Chapter 2. 
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[3] CHAPTER 2  
Genomic Analyses Demonstrate a Distant Separation of the Hospital and 
Community-Associated Clades of Enterococcus faecium 
[3.1] CHAPTER 2 INTRODUCTION 
Early population biology studies suggested that clinical E. faecium strains belonged to a 
genetic lineage named CC17 (Leavis et al., 2006a; Top et al., 2008; Willems et al., 2011) that is 
distinct from non-clinically associated clonal groups. However, studies using Bayesian 
modeling and other methods subsequently reported that eBURST-based clustering is inaccurate 
for determining evolutionary decent for species with high levels of recombination (like E. 
faecium) (Didelot and Falush, 2007; Tang et al., 2009; Turner et al., 2007; Willems and van 
Schaik, 2009). Even so, other studies using mixed whole-genome array, AFLP, and 
pyrosequencing still indicated the existence of two different host-specific subpopulations, 
(distinguished by antibiotic resistance, distinct STs, and the accessory genome) in which one 
subgroup consists primarily of hospital-associated strains and the other community-associated 
strains (Leavis et al., 2007; van Schaik et al., 2010; van Schaik and Willems, 2010).  
Many publications argue that the accessory genome of hospital-associated strains is the 
driving force behind the evolution of this organism, rather than evolutionary descent (Leavis et 
al., 2007; van Schaik et al., 2010). However, underlying differences in the core genome were 
indicated by pyrosequencing (van Schaik et al., 2010) and by the results discussed in the last 
chapter where strains separated into two divergent groups based on the genes gls20,  pbp5, 
pbp2, and wlcA (Galloway-Pena et al., 2011).  So, even though mobile genetic elements, 
antibiotic resistance, and virulence determinants may well contribute to persistence in the 
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hospital environment, the data also suggest there might be fundamental differences between the 
two subpopulations at the level of the core genome that could be the foundation for E. 
faecium’s success as a nosocomial pathogen.    
This chapter discusses data from two published studies. The first study (Galloway-Pena et 
al., 2012)  reflects on the recent studies discussed above which pointed to the existence of two 
subpopulations of E. faecium, one containing primarily commensal/community-associated (CA) 
strains and one containing mostly clinical or hospital-associated (HA) strains. As discussed in the 
previous chapter, we previously found a 3-10% difference between four genes from HA-clade 
strains vs. CA-clade strains, including 5% difference between pbp5-R allele of HA strains and 
pbp5-S allele of CA strains, further supporting the two clade concept.  In order to further 
investigate the differences in the core genome of these subpopulations, we analyzed 100 genes 
from 21 E. faecium genome sequences. Concatenated sequences, SNPs, and individual gene 
analysis of the 100 genes all identified two distinct groups.  Concatenated sequences differed 3.5-
4.2% between the two clades. Molecular clock calculations using sSNP analysis suggest that the 
two clades diverged ~300,000 to > 1 million years ago, depending on the mutation rate used. 
These data confirm the existence of two clades of E. faecium at the core genomic level and show 
that their divergence was a distant evolutionary event.  
The second study (Qin et al., 2012) includes selected data from our report of the 
complete genome sequence of the E. faecium strain TX16. Whole genome comparison, 
phylogenetic, and gene content similarity analyses of TX16 with 21 E. faecium draft genomes 
confirmed the CA and HA clades found through the 100 core gene analysis. This study also 
revealed many mobile genomic loci unique to the HA clade, such as IS elements and 
transposons. It was also found that antibiotic resistance genes are enriched in HA-clade strains 
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whereas CRISPRs (Clustered Regularly Interspaced Short Palindromic Repeats) are enriched in 
the CA-clade.  
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[3.2] CHAPTER 2 MATERIALS AND METHODS 
[3.2.1] Selection of 100 orthologs.  
Genome sequences of 21 E. faecium available from NCBI were studied (Table 9). To 
investigate whether there is a clear separation at the genome level into distinct groups, 
we selected 100 orthologs (Table 10). These 100 orthologs were selected based on 
position (spread over different regions of the chromosome) and their presence in all 
strains as housekeeping genes or putative non-antigenic genes, including ribosomal 
proteins (Figure 7). Ortholog groups of E. faecium genomes were identified using 
OrthoMCL program using BLASTP E value of 1e-5 and default MCL inflation 
parameter of 1.5 with 80% sequence identity and 60% match length cutoffs. However, 
only those genes with the same size in base pairs were chosen. (Galloway-Pena et al., 
2012) 
[3.2.2] Comparative DNA sequence analysis.  
The 100 chosen orthologs nucleotide sequences were concatenated into one continuous 
sequence for each of the 21 E. faecium strains and a pair wise analysis using the Poisson 
correction method (Zuckerkandl, 1965) on MEGA 4.0.2 software was performed  
(Kumar et al., 2008; Tamura et al., 2007). UPGMA phylogenetic trees (Sneath and 
Sokal, 1962) were constructed using the ClustalW alignment of the concatenated 
sequence (Chenna et al., 2003; Larkin et al., 2007; Thompson et al., 1994). The 
divergence score was calculated by taking the distance of the branch lengths between 
two strains, divided by the total distance (or sum of all the branch lengths) and 
multiplying by 100 (Kumar et al., 2008). In addition, each individual gene for the 21 
genomes was also analyzed separately using ClustalW and UPGMA trees were 
generated using MEGA 4.0.2. software and analyzed to see which branch it segregated 
to (community or hospital clade) (Chenna et al., 2003; Kumar et al., 2008; Tamura et 
al., 2007; Thompson et al., 1994). If there were not two distinct branches, the gene was 
excluded from this analysis (8 of the 100 were excluded, leaving 92 genes). (Galloway-
Pena et al., 2012) 
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TABLE 9. The sequence type, country, date, and source of isolation for the 21 sequenced 
E. faecium genomes used in this study.  
Strain STa Countryb year Source Accession # 
C68 16 USA (OH) 1998 Endocarditis patient (blood) ACJQ00000000 
Com12 107 USA  2006 Healthy volunteer fecal sample ACBC00000000 
Com15 583 USA  2006 Healthy volunteer fecal sample ACBD00000000 
D344SRF 21 France 1985 Clinical isolate ACZZ00000000 
E980 94 Netherlands 1998 Healthy volunteer fecal sample ABQA01000001 
E1039 42 Netherlands 1998 Healthy volunteer fecal sample ACOS00000000 
E1071 32 Netherlands 2000 Hospitalized patient fecal sample ABQI01000001 
E1162 17 France 1997 Blood Culture of Hospitalized 
Patient 
ABQJ00000000 
E1636 106 Netherlands 1961 Blood Culture of Hospitalized 
Patient 
ABRY01000001 
E1679 114 Brazil 1998 Swab of Vascular Catheter Tip ABSC01000001 
TX16 18 USA (TX) 1992 Endocarditis patient (blood) ACIY00000000 
TX82 17 USA (TX) 1999 Endocarditis patient (blood) AEBU00000000 
TX0133 17 USA (TX) 2006 Endocarditis patient (blood) AECH00000000 
TX1330 107 USA  1994 Healthy volunteer fecal sample ACHL00000000 
U0317 78 Netherlands 2005 UTI of Hospitalized Patient (Urine) ABSW01000001 
1141733 327 unk. unk. Blood Culture of Hospitalized 
Patient 
ACAZ00000000 
1230933 18 unk. unk. Wound Swab of Hospitalized 
Patient 
ACAS00000000 
1231408  582 unk. unk. Blood Culture of Hospitalized 
Patient 
ACBB00000000 
1231410 17 unk. unk. Skin and Soft Tissue Infection  ACBA00000000 
1231501 52 unk. unk. Blood Culture of Hospitalized 
Patient 
ACAY00000000 
1231502 203 unk. unk. Blood Culture of Hospitalized 
Patient 
ACAX00000000 
a
 ST is the sequence type by multilocus sequence typing 
b
 “unk.” means the information for this isolate is unknown 
 
Table from (Galloway-Pena et al., 2012) 
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TABLE 10. 100 core genes chosen for analysis and concatenation in this study.  
ORF Start
d 
End S
t
ra n
d
 Size 
(bp) Name Description 
HMPREF0351_10005
c 
4312 6258 + 1947 gyrB DNA topoisomerase subunit B 
HMPREF0351_10009
b 
9872 10108 + 237 rpsR ribosomal protein S18 
HMPREF0351_10017 20752 22482 - 1731 poxB pyruvate oxidase 
HMPREF0351_10054 58163 60250 + 2088 fusA protein-synthesizing GTPase 
HMPREF0351_10068
a,b 
67123 67491 + 369 rplN  ribosomal protein L14 
HMPREF0351_10078
b 
71325 72620 + 1296 secY 
preprotein translocase subunit 
SecY 
HMPREF0351_10083
b 
74767 75705 + 939 rpoA RNA polymerase subunit alpha 
HMPREF0351_10125
b 
123688 123909 + 222 metG methionine--tRNA ligase 
HMPREF0351_10135 131070 133715 + 2646 mutS 
DNA mismatch repair protein 
MutS 
HMPREF0351_10137 135863 136423 + 561 maf septum formation protein Maf 
HMPREF0351_10164 162881 164251 - 1371 dinF MATE family protein 
HMPREF0351_10231
b
 229498 229698 + 201 rpmI ribosomal protein L35 
HMPREF0351_10244
a,c 
240647 241726 + 1080 pepA 
M42 family glutamyl 
aminopeptidase 
HMPREF0351_10375 354375 355688 + 1314 yieG 
NCS2 family purine:cation 
symporter 
HMPREF0351_10389
c 
374025 374741 + 717 glpF2 MIP family channel protein 
HMPREF0351_10406 389976 390635 + 660 rcfA 
CRP/FNR transcriptional 
regulator 
HMPREF0351_10439 429479 430207 + 729  integral membrane protein 
HMPREF0351_10460 453947 454675 - 729 agrA 
accessory gene regulator protein 
A 
HMPREF0351_10474
b 
471998 472561 + 564 efp elongation factor P 
HMPREF0351_10476 473048 474307 + 1260 lysA diaminopimelate decarboxylase 
HMPREF0351_10493 491476 492381 + 906  
AraC family transcriptional 
regulator 
HMPREF0351_10496 493430 494326 + 897  LysM family surface protein 
HMPREF0351_10540 536179 537375 - 1197 telA tellurite resistance protein 
HMPREF0351_10568 567155 568342 + 1188 ftsW cell division membrane protein  
HMPREF0351_10578
a 
575515 575985 + 471 iscU  Fe-S cluster formation protein  
HMPREF0351_10611 612012 612923 + 912 ppiA peptidylprolyl isomerase 
HMPREF0351_10633 631143 631583 + 441 ntd 
nucleoside 
deoxyribosyltransferase 
HMPREF0351_10659 664118 664564 - 447 nrdI ribonucleotide reductase 
HMPREF0351_10683 684086 685021 + 936 murB N-acetylmuramate dehydrogenase 
HMPREF0351_10719 723392 725002 + 1611 pyrG CTP synthase 
HMPREF0351_10743
b 
745909 746256 + 348 yabA regulator of replication initiation  
HMPREF0351_10765
b 
770338 770646 + 309 rplU ribosomal protein L21 
HMPREF0351_10791 791519 793711 + 2193 pbpA penicillin-binding protein 1 
HMPREF0351_10798 801185 801862 + 678 alr2 alanine racemase 
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HMPREF0351_10801 803629 804336 + 708 divIVA 
cell division initiation protein 
DivIVA 
HMPREF0351_10810 813420 816122 + 2703 sigL RNA polymerase sigma subunit  
HMPREF0351_10903
a,c 
877677 878897 + 1221 tagH teichoic acid ABC superfamily  
HMPREF0351_10938 914820 915452 + 633  LuxR family response regulator 
HMPREF0351_10945 920237 920845 + 609 sodA superoxide dismutase 
HMPREF0351_10961
b 
937960 938226 + 267 ptsH 
PTS family porter component 
HPr 
HMPREF0351_10976 950670 952049 + 1380 accC biotin carboxylase 
HMPREF0351_11002 982334 984118 + 1785 pyk pyruvate kinase 
HMPREF0351_11005
b 
985868 986047 + 180 rpmF ribosomal protein L32 
HMPREF0351_11081
c 
1066164 1067351 + 1188 tufA2 elongation factor EF1A 
HMPREF0351_11103 1091135 1091356 - 222 fer ferredoxin 
HMPREF0351_11142 1127033 1127824 + 792 codY 
CodY family transcriptional 
regulator 
HMPREF0351_11157 1143520 1144467 + 948  
LacI family transcriptional 
regulator 
HMPREF0351_11204 1187269 1188564 + 1296 purB adenylosuccinate lyase 
HMPREF0351_11221
a 
1205721 1207247 + 1527 araG L-arabinose ABC superfamily  
HMPREF0351_11245 1232977 1233516 + 540 comEB competence protein ComEB 
HMPREF0351_11282 1267078 1268121 + 1044 pheS2 phenylalanine--tRNA ligase  
HMPREF0351_11311 1296129 1298126 + 1998 tktA transketolase 
HMPREF0351_11315
c 
1300562 1301008 + 447 fur2 
Fur family transcriptional 
regulator 
HMPREF0351_11316 1301281 1302633 + 1353 nox NADH dehydrogenase 
HMPREF0351_11335 1321937 1323286 + 1350 rhlB ATP-dependent RNA helicase 
HMPREF0351_11369
a 
1356073 1356927 + 855 aroE shikimate dehydrogenase 
HMPREF0351_11548 1517751 1520360 - 2610 clpB S14 family endopeptidase Clp 
HMPREF0351_11556 1526794 1527720 - 927 dnaI primosomal protein DnaI 
HMPREF0351_11568 1538758 1540938 - 2181 tex S1 domain RNA-binding protein 
HMPREF0351_11610 1583663 1585222 + 1560 eriC 
CPA2 family cation:proton 
antiporter 
HMPREF0351_11619
a,c 
1593185 1594474 - 1290 tig cell division trigger factor 
HMPREF0351_11642 1618069 1618800 - 732 racX aspartate racemase 
HMPREF0351_11679 1657393 1659102 - 1710 proS proline--tRNA ligase 
HMPREF0351_11694 1673135 1674364 - 1230 arcA arginine deiminase 
HMPREF0351_11718
b 
1693974 1695869 - 1896 asnB asparagine synthase  
HMPREF0351_11738 1712076 1713422 - 1347 pgi glucose-6-phosphate isomerase 
HMPREF0351_11759 1733232 1733942 - 711 alsD acetolactate decarboxylase 
HMPREF0351_11836
b 
1805300 1805575 - 276 rpsP ribosomal protein S16 
HMPREF0351_11857
c 
1824675 1825649 - 975 cbh3 choloylglycine hydrolase 
HMPREF0351_11894 1855186 1856484 - 1299 asnS asparagine--tRNA ligase 
HMPREF0351_11904
a 
1864309 1865616 + 1308 dacA 
S11 D-Ala-D-Ala 
carboxypeptidase 
HMPREF0351_11979
c 
1928482 1929453 - 972 phoH phosphate starvation-inducible  
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HMPREF0351_12018
c 
1972203 1972880 - 678 phoU phosphate regulatory protein 
HMPREF0351_12030 1984852 1985403 - 552 yfiA ribosome-associated inhibitor  
HMPREF0351_12057 2005959 2006195 - 237 secG 
Sec family Type I secretory 
protein  
HMPREF0351_12066 2013386 2014576 - 1191 pgk phosphoglycerate kinase 
HMPREF0351_12075
c 
2021207 2021827 - 621 rpoE2 RNA polymerase subunit delta 
HMPREF0351_12120 2067231 2068871 + 1641 sfcA malate dehydrogenase  
HMPREF0351_12172 2114033 2114770 - 738 glpQ2 glycerophosphodiesterase  
HMPREF0351_12186 2126586 2129231 - 2646 valS valine--tRNA ligase 
HMPREF0351_12209 2155856 2156365 + 510 pgpA phosphatidylglycerophosphatase 
HMPREF0351_12250 2197932 2199041 + 1110 msmK maltose ABC superfamily  
HMPREF0351_12258
c 
2205177 2207186 - 2010 metG2 methionine--tRNA ligase 
HMPREF0351_12275 2222997 2224433 - 1437 bglB2 beta-glucosidase 
HMPREF0351_12305 2246582 2247934 + 1353 murE UDP- ligase 
HMPREF0351_12332 2275213 2276637 - 1425 araA L-arabinose isomerase 
HMPREF0351_12354
c 
2300216 2300500 - 285 groES chaperone GroES 
HMPREF0351_12371 2316689 2317333 - 645  
GntR family transcriptional 
regulator 
HMPREF0351_12412 2352668 2353534 - 867 rrmA 23S rRNA methyltransferase A 
HMPREF0351_12423 2364403 2365056 - 654 mecA 
competence negative regulator 
MecA 
HMPREF0351_12437 2384535 2385794 - 1260 cypX cytochrome P450 
HMPREF0351_12458 2401433 2402482 - 1050 comGB competence protein ComGB 
HMPREF0351_12497 2452371 2453228 - 858 cscK3 fructokinase 
HMPREF0351_12540 2508096 2509289 - 1194 metK methionine adenosyltransferase 
HMPREF0351_12545 2520662 2522773 - 2112 ftsH M41 family endopeptidase FtsH 
HMPREF0351_12572 2552543 2553157 - 615 gmk guanylate kinase 
HMPREF0351_12605
c 
2587423 2588580 - 1158  PilT domain protein 
HMPREF0351_12650 2625999 2626466 - 468 dps DNA-binding protein Dps 
HMPREF0351_12682 2667041 2668387 - 1347 gor2 glutathione-disulfide reductase 
HMPREF0351_12694 2688720 2689610 - 891 spo0J 
stage 0 DNA-binding protein 
spoOJ 
a 
Genes left out of the individual gene analysis (i.e. genes that did not show clade distinctions) 
b 
Genes that do not have non-synonymous changes in their encoded protein 
c 
Genes that have non-synonymous changes in their encoded protein, but are not clade specific  
d
 Refers to the nucleotide start and end sites on the DO (TX16) chromosome  
e 
An empty cell indicates a KEGG number was not identified 
Table from (Galloway-Pena et al., 2012) 
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FIGURE 7. Position of the 100 genes analyzed on the TX16 (DO) chromosome. The 
chromosomal map of the Enterococcus faecium genome of the endocarditis isolate TX16, 
commonly referred to as DO. The arrows represent the 100 genes chosen for clade and SNP 
analysis and their position on the chromosome. The red arrows depict genes transcribed in the 
forward orientations, and blue arrows depict genes transcribed in the reverse orientation. The 
general locations of a subset of the 100 genes are labeled. Figure from (Galloway-Pena et al., 
2012) 
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[3.2.3] SNP analysis.  
To further investigate the differences among E. faecium strains, all SNP differences 
were extracted from the aligned 21 concatenated sequences and were concatenated into 
one continuous DNA sequence for each strain, compared to each other for nucleotide 
identity and divergence, and an UPGMA tree was constructed using the same 
methodology stated previously. We also calculated the number of SNPs that were strain 
specific (defined as found in only one strain) versus those found in two or more strains.  
The number of non-synonymous changes was analyzed and it was determined in which 
genes they existed. Strain specific amino acid changes were excluded. We then 
identified clade-specific non-synonymous changes, defined as those changes that were 
present in at least two community-associated E. faecium strains but not in E. faecium 
strains within the HA clade, or present in 14 of the HA strains but not in the community 
strains. (Galloway-Pena et al., 2012) 
[3.2.4] Molecular clock estimation.  
The molecular clock estimation requires four components, the number of synonymous 
SNPs, the number of potential SNP sites, the mutation rate, and the number of 
generations per year (Foster et al., 2009; Lenski et al., 2003; Van Ert et al., 2007). In 
order to estimate the rate of evolution of the two subpopulations, the number of 
synonymous SNPs (sSNPs) from the 100 gene analysis determined above was used. 
The potential sSNP sites were calculated by finding all three-base codons that could be 
used within the 100 genes and adding together all the sSNP sites from each codon.  The 
median number of sSNPs between the strains within a clade was used to calculate the 
molecular clock for strains within a clade. Similarly, the median number of sSNPs for 
each clade was used to compare between the two clades. Since the synonymous 
mutation rate for E. faecium is unknown, a synonymous mutation rate of 1.4 x 10
-10
 
mutations per base pair per generation based on mutation rates from Escherichia coli 
was used (Foster et al., 2009; Lenski et al., 2003). The number of generations per year 
of Enterococcus species in the host or in the environment is also unknown, so a range of 
possible generation times 100, 200, and 300 was used, also based on E. coli (Foster et 
al., 2009; Lenski et al., 2003).  Estimates for a closer relative Bacillus anthracis are 
approximately 43 generations per year and its mutation rate is 5.2 x 10
-10
, and this 
higher mutation rate was also used (Foster et al., 2009; Lenski et al., 2003; Van Ert et 
al., 2007). The following equation was used to determine the time of divergence for 
each comparison: the number of sSNP/ (the number of possible sSNP sites x mutation 
rate x the number of generations per year x 2). The “2” in the denominator of the 
equation is used to account for the time of divergence of the two genomes, or the two 
groups compared (Achtman et al., 2004; Foster et al., 2009; Van Ert et al., 2007). 
(Galloway-Pena et al., 2012) 
[3.2.5] Analysis of the 16S rRNA and estimation of the time of divergence.  
The 16S rRNA gene was sequenced using the universal 16S rRNA primers B27F, 785F, 
805R, and primers designed for outside the 16S rRNA gene for E. faecium, 16SEfmOS 
F1 5’-ATCGCAAGATTGTTCGAAC -3’, and 16S EfmOSR2 5’-
CTTAGAAAGGAGGTGATCCAG -3’. The entire 16S rRNA of TX16 (DO) and 
TX1330, as representatives of the two clades, were resequenced. Sequences were 
66 
 
extracted from all other strains using the NCBI sequence. Strains that had an incomplete 
16S rRNA sequence (E1636, 1231502, Com12, Com15, 1230933, TX0133A, E1039, 
and TX82) were also resequenced. The sequences were aligned and compared using 
MEGA 4.0.2 software. The SNPs and percent nucleotide difference between the strains 
were determined, and the determination of time for divergence was based on a 1% 
change per 25 million years ago for 16S rRNA (Ochman and Wilson, 1987). 
(Galloway-Pena et al., 2012) 
[3.2.6] Genome characterization.  
BLASTN and BLASTX as well as ISfinder server (Varani et al., 2011) were used to 
identify IS sequences and transposons in the TX16 chromosome and plasmids. Genomic 
regions with homology to IS and transposon sequences from both BLAST analyses 
were verified with the gene annotation of TX16. Both BLAST searches identified many 
small regions as a part of IS elements and transposons. Regions with shorter than 60% 
match length to reference sequences were excluded from further analysis. Identified 
genes/regions by analyses above were also used to perform the BLAST search against 
the other 21 E. faecium genomes to investigate whether there are clade specific 
presences or absences. (Qin et al., 2012) 
Six genomes that had yet to be studied for CRISPR-loci were analyzed for CRISPR loci 
(TX1330, TX16, TX82, TX0133A, D344SRF, and C68). We searched for CRISPR loci 
in the six genomes by performing BLAST using the sequences from the ORFs 
previously described for CRISPR-loci in E. faecium EFVG_01551 to EFVG_01555 
(Palmer and Gilmore, 2010), as well as using CRISPRfinder (http://crispr.u-
psud.fr/Server/CRISPRfinder.php) and the CRT program (Bland et al., 2007) to detect 
prophage CRISPR palindromic repeats in TX16. (Qin et al., 2012) 
[3.2.7] Ortholog, phylogenetic and multi-locus sequence typing (MLST) analysis.  
Protein ortholog groups of E. faecium genomes were identified using OrthoMCL 
program (Li et al., 2003) using BLASTP E value of 1e-5 and default MCL inflation 
parameter of 1.5 with 80% sequence identity and 60% match length cutoffs. The match 
length percentage was set relatively low because all the genomes except TX16 are draft 
sequences. The dissimilarity in gene content among the E. faecium genomes was 
calculated using Jaccard distance (1- Jaccard coefficient) as described previously 
(Suzuki et al., 2011), and the Jaccard distance matrix was used for hierarchical 
clustering using the unweighted pair group method with arithmetic mean (UPGMA). 
Single-copy orthologs with the same length in all strains were chosen for phylogenetic 
analysis after removing genes that may have undergone recombination detected by PHI 
program (Bruen et al., 2006). Multiple sequence alignments were performed by MAFFT 
program (Katoh et al., 2002) and the topology of the phylogenetic tree was inferred by 
maximum-likelihood algorithm using PhyML (Guindon et al., 2010) with bootstrap 
value of 100. 16S rRNA phylogenetic analysis was performed in another manuscript 
(Galloway-Pena et al., 2012). iTOL program (Letunic and Bork, 2007) was used for 
phylogenetic tree visualization. (Qin et al., 2012) 
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The in silico multi-locus sequence types were determined either by extracting the allele 
types of adk, atpA, ddl, gdh, gyd, pstS, and purK from the genomic sequence, or using 
the allele numbers previously obtained through experimentation (Galloway-Pena et al., 
2011). The allele numbers and sequence types were used to construct an UPGMA 
dendogram using S.T.A.R.T.2 software (http://pubmlst.org/). (Qin et al., 2012) 
[3.2.8] Identification of putative virulence-associated genes and antibiotic resistance 
determinants.  
Putative virulence genes were identified by BLASTP of E. faecium ORF protein 
sequences to the enterococcal virulence factors in the Virulence Factors Database 
(VFDB) (Chen et al., 2005), and hits were manually inspected. (Qin et al., 2012) 
To identify  antibiotic resistance genes, BLASTN was performed using the nucleotide 
sequences of 13 antibiotic resistance genes including cat (chloramphenicol O-
acetyltransferase) using the EfmE1071_2206 sequence which is an ortholog to the cat 
gene found on the E. faecium plasmid pRUM (Grady and Hayes, 2003) ermA (rRNA 
adenine N-6-methyltransferase) using the EfmE1679_0214 sequence and located on 
Tn554 (Murphy et al., 1985); ermB (rRNA adenine N-6-methyltransferase) using the 
EfmE1071_2296 sequence, an ortholog to the ermB gene found on the E. faecalis 
plasmids pRE25 and pSL1(Schwarz et al., 2001); aad6 (aminoglycoside 6-
adenylyltransferase) using the EfmE1071_1021 sequence an ortholog to the genes 
found on the E. faecalis plasmid pEF418 (Genbank:AF408195); aad9 (streptomycin 
3’’-adenylyltransferase) using EfmE1679_0213 sequence and located on Tn554 
(Murphy et al., 1985); aadE (aminoglycoside 6-adenylyltransferase) using 
EfmU0317_2169 sequence an ortholog to the gene found on the E. faecalis plasmid 
pRE25 (Schwarz et al., 2001); aacA-aphD (bifunctional aminoglycoside modifying 
enzyme) using the EfmU0317_2161 sequence; tetL using the EfmE1071_1017 
sequence (Burdett et al., 1982); tetM using the EfmE1162_0404 sequence (Burdett et 
al., 1982); vanA using the EfmE1071_0104 to EfmE1071_0110 sequence which is 
identical to the vanA gene cluster found on Tn1546 (Arthur et al., 1993); gyrA using 
EfmE1679_2520 to determine amino acid changes of E87K/G or S83R/Y/I (Leavis et 
al., 2006b); parC using EfmE1679_0369 to determine amino acid changes of E86K or 
S82R/I (Leavis et al., 2006b); and pbp5 (GenBank accession no. ZP_00603984) to 
search for the low-affinity pbp5 consensus sequence (Galloway-Pena et al., 2011; Rice 
et al., 2004). (Qin et al., 2012) 
68 
 
[3.3] CHAPTER 2 RESULTS 
As discussed in section 3.1, fundamental differences at the core genome level have been 
suggested in previous publications (van Schaik et al., 2010) and this was supported by the 
finding in the previous chapter that strains separated clearly into two distinct groups based on 
four genes, with a 3% nucleotide difference for gls20, 5% for pbp5, 7% for pbp2, and 10% for 
wlcA between strains in the two groups. In this section, SNP, phylogenetic, and 16S rRNA 
analyses showed differences between HA-clade strains and CA-clade strains throughout the 
core genome. These core genomic differences were then used to make molecular clock 
estimations to show that divergence of these two clades was a distant evolutionary event. 
Additionally, data are shown from a second study in which whole-genomic (using the TX16 
closed genome and 20 draft genomes) analyses confirmed that there are differences between the 
HA- clade and CA- clade throughout the core genome. Using these genome sequences, CA and 
HA-clade isolates were further analyzed for the presence of unique IS elements, transposons, 
antibiotic resistance determinants, CRISPRS and putative virulence determinants. 
[3.3.1] Analysis of 100 genes from 21 E. faecium genomes illustrates the differences in core 
genome components of two clades.  
A total of 1608 orthologs (defined as >80% identity and aligning to >60% match length) 
were common to all 21 genomes; 638 of these had the same DNA length in the 
available sequences from all the genomes analyzed. The 100 gene sequences chosen 
(Table 10 and Figure 7) had > 95% identity and were concatenated into a 106,818bp 
nucleotide sequence for each of the strains (information on genomes listed in Table 9). 
The comparisons between all the strains were determined and are shown in Table 11.  
(Galloway-Pena et al., 2012) 
TABLE 11. Percent identity and divergence score matrix of the 100 concatenated gene 
nucleotide sequence. (on next page) Table from (Galloway-Pena et al., 2012).
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 1141733 *** 99.8 98.9 98.8 99.8 96.8 95.9 96 96.2 96 95.8 95.9 95.9 96.1 96 95.9 96 95.9 95.9 95.8 96 
 Com12 0.2 *** 98.9 98.9 100 96.7 96 96 96.2 96 95.8 95.9 96 96.2 96 95.9 96 96 95.9 95.9 96 
 Com15 1.1 1.1 *** 99.2 98.9 96.6 95.9 96 96.2 96.1 95.8 95.9 95.9 96.2 96.1 96 96.1 96 96 95.9 96.1 
 E980 1.2 1.1 0.8 *** 98.9 96.6 96.2 96.3 96.5 96.3 96 96.2 96.2 96.5 96.3 96.2 96.3 96.2 96.2 96.2 96.3 
 TX1330 0.2 0 1.1 1.1 *** 96.7 96 96 96.2 96 95.8 95.9 96 96.2 96 95.9 96 96 95.9 95.9 96 
 1231408 3.3 3.4 3.5 3.5 3.4 *** 98.9 98.8 98.4 98.9 98.7 98.8 98.9 98.5 98.8 98.9 98.5 98.7 98.9 98.9 98.9 
 1230933 4.2 4.2 4.2 3.9 4.2 1.1 *** 99.9 99.2 99.8 99.6 99.7 100 99.2 99.6 99.8 99.4 99.6 99.8 99.8 99.8 
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1231410 4.1 4.1 4.1 3.9 4.1 1.2 0.1 *** 99.2 99.8 99.7 99.6 99.9 99.2 99.6 99.9 99.3 99.5 99.9 99.8 99.8 
1231501 3.9 3.9 3.9 3.6 3.9 1.6 0.8 0.9 *** 99.1 99 99.3 99.2 99.2 99.1 99.2 99.4 99.2 99.2 99.3 99.1 
1231502 4.1 4.1 4.1 3.8 4.1 1.1 0.2 0.2 0.9 *** 99.5 99.5 99.8 99.2 99.7 99.7 99.2 99.5 99.7 99.7 100 
C68 4.4 4.4 4.4 4.1 4.4 1.3 0.4 0.3 1 0.5 *** 99.5 99.6 99 99.5 99.8 99.2 99.4 99.8 99.7 99.5 
D344SRF 4.3 4.2 4.2 3.9 4.2 1.2 0.3 0.4 0.7 0.5 0.5 *** 99.7 99.2 99.5 99.7 99.7 99.7 99.7 99.8 99.5 
 TX16 4.2 4.2 4.2 3.9 4.2 1.1 0 0.1 0.8 0.2 0.4 0.3 *** 99.2 99.6 99.8 99.4 99.5 99.8 99.8 99.8 
 E1039 4 4 3.9 3.7 4 1.5 0.8 0.8 0.8 0.8 1 0.8 0.8 *** 99.2 99.2 99.5 99.2 99.2 99.2 99.2 
 E1071 4.1 4.1 4.1 3.8 4.1 1.2 0.4 0.4 0.9 0.3 0.5 0.5 0.4 0.8 *** 99.7 99.3 99.6 99.7 99.6 99.7 
 E1162 4.2 4.2 4.2 3.9 4.2 1.1 0.2 0.1 0.8 0.3 0.2 0.3 0.2 0.8 0.3 *** 99.4 99.6 100 99.9 99.7 
 E1636 4.1 4.1 4.1 3.8 4.1 1.5 0.6 0.7 0.6 0.8 0.8 0.3 0.6 0.5 0.7 0.6 *** 99.5 99.4 99.5 99.2 
 E1679 4.2 4.2 4.2 3.9 4.2 1.3 0.4 0.5 0.8 0.5 0.6 0.3 0.5 0.8 0.4 0.4 0.5 *** 99.6 99.7 99.5 
 TX82 4.2 4.2 4.2 3.9 4.2 1.1 0.2 0.1 0.8 0.3 0.2 0.3 0.2 0.8 0.3 0 0.6 0.4 *** 99.9 99.7 
 TX0133A 4.3 4.3 4.3 4 4.3 1.1 0.2 0.2 0.7 0.3 0.3 0.2 0.2 0.8 0.4 0.1 0.5 0.3 0.1 *** 99.7 
 U0317 4.1 4.1 4.1 3.8 4.1 1.2 0.2 0.2 0.9 0 0.5 0.5 0.2 0.8 0.3 0.3 0.8 0.5 0.3 0.3 *** 
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TABLE 11 (continued). 
a 
The numbers in yellow are the percent identity and divergence scores of the CA strains 
b 
The numbers in blue are the percent identity and divergence scores of the hybrid strain 
c 
The numbers in green are the percent identity and divergence scores of the HA strains 
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 E1162
 TX82
 1231410
 TX0133A
 1230933
 TX16
 1231502
 U0317
 E1071
 C68
 E1636
 D344SRF
 E1679
 1231501
 E1039
 1231408
 Com15
 E980
 1141733
 Com12
 TX1330
0.0000.0050.0100.0150.020  
FIGURE 8. UPGMA phylogenetic tree of the concatenated 100 gene sequence (106,818 
bp). The results are based on a pair-wise analysis of the concatenated 100 gene nucleotide 
sequence for each of the 21 E. faecium strains using the Poisson correction method in 
MEGA4.0.2 software. An UPGMA tree was constructed depicting the evolutionary distance 
between these sequences. The tree is drawn to scale with the branch lengths representing the 
evolutionary distances, the scale can be seen at the bottom of the tree. Figure from (Galloway-
Pena et al., 2012) 
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The nucleotide percent identities among the strains within the CA clade (in 
yellow) ranged from 98.9%-100%, and the divergence scores from 0-1.2; the nucleotide 
percent identities between the strains in the HA clade (in green) range from 99-100% 
and the divergence scores from 0-1 (Table 11). However, when the two clades were 
compared to each other, the percent identities ranged from 95.8-96.5% and the 
divergence scores from 3.6-4.3 (Table 11). Therefore, 1141733, Com12, Com15, E980, 
and TX1330 are more closely related to each other than to the other 16 E. faecium 
strains and  in turn, these 16 strains were found to be more related to each other than to 
the above 5 strains, reinforcing the grouping into two distinct clades.   
The phylogenetic tree constructed using the concatenated sequences is shown in 
Figure 8.  The tree separates the genomes into two distinct groups with one group 
consisting primarily of the strains from healthy volunteer fecal samples (Com12, 
Com15, TX1330, and E980), while most of the strains from clinical samples were in the 
other branch. Similar to previous terminology (Leavis et al., 2007; van Schaik et al., 
2010), we designated these two branches the community-associated (CA) clade and the 
hospital-associated (HA) clade, respectively. There were, however, two exceptions. 
Strain 1141733 (which is a blood culture from a hospitalized patient) grouped in the 
branch with the commensal, fecal strains, and E1039, which is a healthy volunteer fecal 
sample, grouped with the clinical strains. 
One E. faecium strain, 1231408 (in blue), isolated from the blood of a 
hospitalized patient, was found to have a “hybrid” genome sequence of both groups. 
The sequence between ORF No. 10017 and 10683 of 1231408 was found to be more 
similar to the sequences of strains in the CA clade whereas the rest of the 1231408 
sequence was more similar to E. faecium strains in the HA clade. The overall percent 
identities of 1231408 ranged from 98.4-98.9% against HA clade strains and 96.7-96.8% 
against CA clade strains with divergence scores ranging from 1.1-1.6 against HA clade 
strains, and 3.3-3.5 against CA clade strains (Table 11). 
The sequences of the individual genes from each of the 21 genomes were also 
compared and UPGMA trees constructed (data not shown) to create 100 individual 
trees; 92 of the 100 genes split the genomes into two distinct groups, while the other 8 
genes were either 100% conserved or the sequences were not distinct enough to give 
two clear grouping. For each genome, we counted the genes that segmented into the HA 
clade or the CA clade (Table 12).  The CA clade strains ranged from strain 1141733 
with 92 of 92 genes in the CA clade to E980 with 84/92 genes in the CA clade and 8/92 
genes within the HA clade.  The HA clade strains ranged from D344SRF, TX82, 
TX0133, E1162, and C68, all with 92/92 genes grouping with the HA clade strains, to 
E1039 with 86/92 genes grouping with the HA clade and 6/92 genes in the CA clade. 
The hybrid strain 1231408 had 66/92 genes group with the HA clade and the other 26 
with the CA clade, consistent with the percent identity and divergence scores above.  
The encoded proteins of the 100 genes were also concatenated, resulting in a 
35,606 amino acid sequence. The percent identities and divergence scores were 
tabulated as well as a UPGMA phylogenetic tree constructed for the concatenated 
protein sequence (Table 13 and Figure 9, respectively). As expected, the results were 
similar to the nucleotide results, grouping the strains into two distinct clades. 
(Galloway-Pena et al., 2012) 
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TABLE 12. Clade analysis of 91 individual genes. 
Community Clade Hospital Clade Hybrid Clade 
1141733 (92 + 0)
a 
C68 (0 + 92) 1231408 (26 + 66) 
66) Com12 (91 + 1) D344SRF  (0 + 92)  
TX1330 (91 + 1) E1162 (0 + 92)  
Com15 (90 + 2) TX82 (0 + 92)  
E980 (84 + 8) TX0133 (0 + 92)  
 TX16 (1 + 91)  
 1230933 (1 + 91)  
 1231410 (1 + 91)  
 E1071 (2 + 90)  
 E1636  (2 + 90)  
 E1679 (4 + 88)  
 U0317 (4 + 88)  
 1231502 (4 + 88)  
 E1039 (5 + 87)  
 1231501 (5 + 87)  
a 
Numbers in parentheses are given as number of genes which grouped with the community-
associated clade plus the number of genes that grouped with the hospital-associated clade. 
Table from (Galloway-Pena et al., 2012). 
 
 
 
 
 
 
 
 
 
TABLE 13.  Percent identity and divergence score matrix of the concatenated amino acid 
sequence. (on next page) Table from (Galloway-Pena et al., 2012). 
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 1141733 *** 99.8 99.6 99.5 99.8 99.1 98.7 98.7 98.8 98.7 98.7 98.7 98.7 98.8 98.7 98.7 98.7 98.7 98.7 98.7 98.7 
 Com12 0.2 *** 99.5 99.6 100 99.1 98.7 98.7 98.8 98.7 98.7 98.7 98.7 98.8 98.7 98.7 98.8 98.7 98.7 98.7 98.8 
 Com15 0.4 0.5 *** 99.6 99.5 99 98.7 98.7 98.8 98.7 98.7 98.7 98.7 98.8 98.7 98.7 98.7 98.7 98.7 98.7 98.7 
 E980 0.5 0.4 0.4 *** 99.6 99 98.8 98.8 98.9 98.8 98.8 98.8 98.8 98.9 98.8 98.8 98.8 98.8 98.8 98.8 98.8 
 TX1330 0.2 0 0.5 0.4 *** 99.1 98.7 98.7 98.8 98.7 98.7 98.7 98.7 98.8 98.7 98.7 98.8 98.7 98.7 98.7 98.8 
 1231408 0.9 0.9 1 1 0.9 *** 99.5 99.5 99.3 99.5 99.5 99.4 99.5 99.3 99.5 99.5 99.3 99.4 99.5 99.5 99.5 
 1230933 1.3 1.3 1.3 1.2 1.3 0.5 *** 100 99.7 99.9 99.9 99.8 99.9 99.7 99.9 99.9 99.7 99.8 99.9 99.9 99.9 
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1231410 1.3 1.3 1.3 1.2 1.3 0.5 0 *** 99.7 99.9 99.9 99.8 99.9 99.7 99.9 100 99.7 99.8 100 99.9 99.9 
1231501 1.2 1.2 1.2 1.1 1.2 0.7 0.3 0.3 *** 99.7 99.7 99.6 99.7 99.7 99.6 99.7 99.7 99.6 99.7 99.7 99.7 
1231502 1.3 1.3 1.3 1.2 1.3 0.5 0.1 0.1 0.3 *** 99.9 99.8 99.9 99.7 99.9 99.9 99.7 99.8 99.9 99.9 100 
C68 1.3 1.3 1.3 1.2 1.3 0.5 0.1 0.1 0.3 0.1 *** 99.8 99.9 99.6 99.8 99.9 99.7 99.8 99.9 99.9 99.9 
D344SRF 1.3 1.3 1.3 1.2 1.3 0.6 0.2 0.2 0.4 0.2 0.2 *** 99.8 99.6 99.8 99.8 99.9 99.8 99.8 99.8 99.8 
 TX16 1.3 1.3 1.3 1.2 1.3 0.5 0.1 0.1 0.3 0.1 0.1 0.2 *** 99.6 99.8 99.9 99.7 99.8 99.9 99.9 99.9 
 E1039 1.3 1.2 1.3 1.1 1.2 0.7 0.3 0.3 0.3 0.3 0.4 0.4 0.4 *** 99.7 99.7 99.7 99.6 99.7 99.7 99.7 
 E1071 1.3 1.3 1.3 1.2 1.3 0.5 0.1 0.1 0.4 0.1 0.2 0.2 0.2 0.3 *** 99.9 99.7 99.8 99.9 99.9 99.9 
 E1162 1.3 1.3 1.3 1.2 1.3 0.5 0.1 0 0.3 0.1 0.1 0.2 0.1 0.3 0.1 *** 99.7 99.8 100 100 99.9 
 E1636 1.3 1.3 1.3 1.2 1.3 0.7 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 *** 99.8 99.7 99.7 99.7 
 E1679 1.3 1.3 1.3 1.2 1.3 0.6 0.2 0.2 0.4 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 *** 99.8 99.8 99.8 
 TX82 1.3 1.3 1.3 1.2 1.3 0.5 0.1 0 0.3 0.1 0.1 0.2 0.1 0.3 0.1 0 0.3 0.2 *** 99.9 99.9 
 TX0133A 1.3 1.3 1.3 1.2 1.3 0.5 0.1 0.1 0.3 0.1 0.1 0.2 0.1 0.3 0.1 0 0.3 0.2 0.1 *** 99.9 
 U0317 1.3 1.3 1.3 1.2 1.3 0.5 0.1 0.1 0.3 0 0.1 0.2 0.1 0.3 0.1 0.1 0.3 0.2 0.1 0.1 *** 
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TABLE 13. (continued) 
a 
The numbers in yellow are the percent identity and divergence scores of the CA strains 
b 
The numbers in blue are the percent identity and divergence scores of the hybrid strain 
c 
The numbers in green are the percent identity and divergence scores of the HA strains 
76 
 
 
 E1162
 TX82
 1231410
 TX0133A
 1230933
 C68
 1231502
 U0317
 TX16
 E1071
 E1679
 D344SRF
 E1636
 1231501
 E1039
 1231408
 Com15
 E980
 1141733
 Com12
 TX1330
0.0000.0010.0020.0030.0040.0050.006  
FIGURE 9. UPGMA phylogenetic tree of the concatenated amino acid sequence 
(35,606bp). The results are based on a pair-wise analysis of the concatenated 100 protein 
amino acid sequence for each of the 21 E. faecium strains using the Poisson correction method 
in MEGA4.0.2 software. An UPGMA tree was constructed depicting the evolutionary distance 
between these sequences. The tree is drawn to scale with the branch lengths representing the 
evolutionary distances, the scale can be seen at the bottom of the tree. Figure from (Galloway-
Pena et al., 2012). 
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[3.3.2] SNP analysis emphasizes clade-specific differences.   
5,932 SNP sites (5.6% of the total sequence) were identified in the 106,818 bp aligned 
sequences. Among these, 929 SNPs were strain specific SNPs (identified in only one 
strain) and the remaining 5,003 SNPs were identified in two or more E. faecium strains. 
Each SNP was concatenated into a continuous sequence; the percent identities and 
divergent scores for this analysis can be seen in Table 14 and the UPGMA tree seen in 
Figure 10. The percent identities of the concatenated SNP sequences among the CA 
clade strains ranged from 79-100% and the divergence scores from 0-26. Within the HA 
clade, the percent identities of the SNP sequences ranged from 82-100% and the 
divergence scores from 0-21. When the two clades were compared by pair-wise analysis 
of each strain to one another, the percent identities ranged from 24-37% and the 
divergence score was 350. For the hybrid strain 1231408, the identities ranged from 38-
42% and the divergence scores 23-39 with CA clade strains and 71-81% and 350 with 
HA clade strains.  
Of the 5,932 SNPs, 5,147 (86.8%) were synonymous SNPs, whereas 785 (13.2%) were 
non-synonymous and found in 87 out of the 100 genes.  Using the criteria described in 
the methods, 479 of the 785 non-synonymous SNPs were considered clade specific and 
were found in 72 of the 100 genes (Table 10). When searching through the KEGG map, 
the clade specific SNPs were found in 33 different metabolic pathways and 5 different 
genetic/ environmental/cellular processes (Table 10).  (Galloway-Pena et al., 2012) 
 
 
 
 
 
 
 
 
TABLE 14.  Percent identity and divergence score matrix of the concatenated SNP 
sequence. (on next page) Table from (Galloway-Pena et al., 2012). 
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 1141733 *** 96 81 79 96 42 27 28 32 28 24 26 27 30 28 27 28 27 26 25 28 
 Com12 4 *** 80 80 100 41 27 28 32 29 24 26 27 31 29 27 29 27 27 26 29 
 Com15 23 24 *** 85 80 38 27 28 32 29 24 26 27 32 29 27 29 28 27 26 29 
 E980 26 24 17 *** 80 39 32 33 37 34 29 31 32 36 33 31 34 32 31 31 34 
 TX1330 4 0 24 24 *** 41 27 28 32 29 24 26 27 31 29 27 29 27 27 26 29 
 1231408 350 350 350 350 350 *** 80 79 71 80 77 78 80 74 78 80 73 76 80 81 79 
 1230933 350 350 350 350 350 24 *** 98 86 97 93 94 99 86 92 97 88 92 97 97 97 
D
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1231410 350 350 350 350 350 26 2 *** 85 96 95 93 98 85 94 99 87 91 98 97 96 
1231501 350 350 350 350 350 39 16 18 *** 84 83 87 86 86 84 86 90 85 86 87 84 
1231502 350 350 350 350 350 25 3 4 19 *** 91 92 97 86 94 95 86 91 94 95 99 
C68 350 350 350 350 350 28 8 5 20 10 *** 91 93 82 91 96 85 89 96 94 90 
D344SRF 350 350 350 350 350 27 7 8 15 9 10 *** 94 86 91 94 94 95 94 96 91 
 TX16 350 350 350 350 350 25 1 2 16 3 7 6 *** 86 92 97 88 92 97 97 97 
 E1039 350 350 350 350 350 35 16 17 16 16 21 16 16 *** 86 85 91 85 85 86 86 
 E1071 350 350 350 350 350 28 8 7 19 6 10 10 8 16 *** 95 87 92 95 93 95 
 E1162 350 350 350 350 350 24 4 2 16 6 4 6 3 17 5 *** 89 92 100 98 94 
 E1636 350 350 350 350 350 36 13 14 12 15 17 6 13 10 14 12 *** 92 89 90 86 
 E1679 350 350 350 350 350 30 8 10 17 10 13 5 9 17 9 8 9 *** 92 94 91 
 TX82 350 350 350 350 350 24 4 2 16 6 4 6 3 17 5 0 13 9 *** 98 94 
 TX0133A 350 350 350 350 350 23 3 4 15 5 6 5 3 16 7 2 11 7 2 *** 95 
 U0317 350 350 350 350 350 25 3 5 19 1 10 9 4 16 6 6 15 10 6 6 *** 
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TABLE 14. (continued) 
a 
The numbers in yellow are the percent identity and divergence scores of the CA strains 
b 
The numbers in blue are the percent identity and divergence scores of the hybrid strain 
c 
The numbers in green are the percent identity and divergence scores of the HA strains 
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 E1162
 TX82
 1231410
 TX0133A
 1230933
 TX16
 1231502
 U0317
 E1071
 C68
 E1636
 D344SRF
 E1679
 1231501
 E1039
 1231408
 Com15
 E980
 1131733
 Com12
 TX1330
0.00.20.40.60.81.0  
 
FIGURE 10. UPGMA phylogenetic tree of the concatenated SNP sequence (5,392 bp). The 
results are based on a pair-wise analysis of the concatenated SNP nucleotide sequence for each 
of the 21 E. faecium strains using the Poisson correction method in MEGA4.0.2 software. An 
UPGMA tree was constructed depicting the evolutionary distance between these sequences. 
The tree is drawn to scale with the branch lengths representing the evolutionary distances, the 
scale can be seen at the bottom of the tree. Figure from (Galloway-Pena et al., 2012). 
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[3.3.3] Molecular clock determination using sSNP analysis shows an evolutionarily distant 
separation between the CA and HA clades.   
We estimated the time of divergence using sSNP (Foster et al., 2009; Lenski et al., 
2003; Pearson et al., 2009; Van Ert et al., 2007). The median number of sSNP in the CA 
clade was 979 (ranging from 1-1077), the median number of sSNPs in the HA clade was 
401 (ranging from 2-916), and the median number of sSNPs between the two clades 
was 3812 (ranging from 3368-4065). These numbers were used to calculate the 
molecular clock and the results are shown in Table 15. Using the E. coli synonymous 
mutation rate and a range of generation times of 100-300 per year, the molecular clock 
determination estimated that strains within the CA clade diverged from each other on 
the average of ~300,000 to 900,000 years ago, whereas strains within the HA clade 
diverged on the average of ~100,000-300,000 years ago. When we used the same 
formula to calculate the divergence between the two clades, it is estimated that the two 
clades diverged between one million and three million years ago.  Even with the faster 
mutational rate previously used with B. anthracis, the time of divergence was estimated 
at 300,000 years between the two clades (Table 15). (Galloway-Pena et al., 2012) 
 
 
TABLE 15. Molecular clock/time of divergence estimates based on sSNP analysis within 
and between clades. 
Based on the mutation rate of Escherichia coli (1.4 x 10
-10
) 
Generations/yr
 
Hospital Clade Community Clade Two clades 
100 380,535 929,036 3,617,453 
200 190,267 464,518 1,808,726 
300 126,845 309,679 1,205,818 
Based on the mutation rate of Bacillus anthracis (5.2 x10
-10
) 
Generations/yr
 
Hospital Clade  Community Clade  Two clades  
100  102,452 250,125 973,930 
200  51,226 125,063 486,965 
300  34,151 83,375 324,643 
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[3.3.4] 16S rRNA and ribosomal protein analyses show clade-specific SNPs and a similar 
time of divergence to the SNP analysis.  
One specific SNP at base-pair 61 out of 1569 differed between the strains following the 
CA and HA clade grouping as seen in the other analyses (Figure 11). CA clade strains 
had a thymine at this position, while HA clade strains had an adenine. Two other SNPs 
occurred at positions 103 and 193 in some of the strains (Figure 11). Ribosomal protein 
L32 gene (rpmF) (Figure 12), as well as ribosomal proteins L35, L21, S18 and S16 
showed that all CA clade strains differed from the HA clade strains by one to two 
nucleotides and there were no differences within a given clade. These results 
corroborated the molecular clock determination by SNP analysis. Using estimates of 
approximately 1% change every 25 million years in the 16S rRNA (Achtman et al., 
2004; Ochman et al., 1999; Ochman and Wilson, 1987), a one to two nucleotide change 
out of 1569 bp (0.06-0.1%) would approximate the time of divergence of the two clades 
as somewhere between 1.5 million to 2.5 million years ago. (Galloway-Pena et al., 
2012) 
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 D344SRF
 TX0133A
 E1636
 1231501
 1231502
 1231408
 C68
 U0317
 TX16
 E1039
 E1162
 E1071
 1231410
 TX82
 1230933
 E1679
 TX1330
 1141733
 E980
 Com15
 Com12
0.00000.00010.00020.00030.00040.0005  
FIGURE 11. An UPGMA tree representing the evolutionary relationship of the strains using the 16S rRNA nucleotide 
sequence for each of the 21 E. faecium strains. For all phylogenetic trees, the evolutionary distances were calculated using the 
Poisson correction method and UPMGA trees constructed using MEGA4.0.2 software. The trees are drawn to scale with the branch 
84 
 
lengths representing the evolutionary distances, the scale of each tree can be seen at the bottom of each respective tree. The table next 
to the tree indicates the changes in the 16S rRNA gene sequence at each nucleotide position for each branch of the tree. Figure from 
(Galloway-Pena et al., 2012). 
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 TX0133A
 U0317
 TX82
 E1679
 E1636
 E1162
 E1071
 E1039
 TX16
 D344SRF
 C68
 1231502
 1231501
 1231410
 1231408
 1230933
 1141733
 Com12
 Com15
 E980
 TX1330
0.0000.0010.0020.0030.0040.005  
FIGURE 12. An UPGMA tree representing the evolutionary relationship of the strains using the rpmF nucleotide sequence for 
each of the 21 E. faecium strains. For all phylogenetic trees, the evolutionary distances were calculated using the Poisson correction 
method and UPMGA trees constructed using MEGA4.0.2 software. The trees are drawn to scale with the branch lengths representing 
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the evolutionary distances, the scale of each tree can be seen at the bottom of each respective tree. The table next to the tree indicates 
the changes in the rpmF sequence at each nucleotide position for each branch of the tree.  Figure from (Galloway-Pena et al., 2012).
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[3.3.5] Phylogenetic, multi-locus sequence typing (MLST) and gene content similarity 
analysis.  
Analysis of the 21 E. faecium genomes (Table 9) showed that the isolates separate into 
two clades, one branch consisting mostly of CA isolates, with most HA isolates found 
in the other, as was noted in our previous study (Galloway-Pena et al., 2012) (Figure 
13A and B). When analyzing the phylogenetic distances among these 21 isolates using 
628 single-copy ortholog genes of the same length (Figure 13A), similar clade patterns 
were observed for the E. faecium strains as seen in the 100 core gene analysis by 
Galloway-Pena et.al (Galloway-Pena et al., 2012). All isolates predicted to be part of 
the CC17 genogroup (Leavis et al., 2006a; Top et al., 2008; Willems et al., 2011) 
cluster more closely together and branched more distantly than other HA-clade isolates 
(Figure 13A). The dendogram construction from the gene content dissimilarity 
represented by Jaccard distance (Figure 13B) also showed most hospital-isolated strains 
cluster together except hospital- isolated strain 1,141,733 which was shown genetically 
to belong to the CA clade. In addition, although E1039 is a community- isolated fecal 
strain, it is genetically closer to the HA strains. The phylogenetic and gene content 
dissimilarity analysis results all support the existence of two very distinct clades of E. 
faecium, which has been previously described using pyrosequencing, microarray, and 
the concatenation of a 100 core genes, estimated to have diverged anywhere from 
300,000 to 3 million years ago (Galloway-Pena et al., 2012; Leavis et al., 2007; van 
Schaik et al., 2010). (Qin et al., 2012) 
 
 [3.3.6] Mobile genetic elements.  
IS elements and transposases were found more frequently in HA strains than in CA 
strains. Previously, IS16 was suggested as a molecular screening marker to predict E. 
faecium pathogenicity because of its presence in clinical E. faecium isolates (Leavis et 
al., 2007; Werner et al., 2011). We performed a BLAST search of the 22 E. faecium 
genomes to identify the IS/transposase elements showing the same presence or absence 
patterns of IS16 (HMPREF0351_11812, _11855, _12352, and _12809) (Table 16). 
Many IS/transposase elements were found to have the same pattern of presence/absence 
in different strains as IS16; including ISEnfa3 (IS3/IS911 transposase: 
HMPREF0351_10172, _10364, _11866, and _11868), IS116/IS110/IS902 family 
transposases (HMPREF0351_11035, _11528, _12768, and _13088), IS66 transposases 
(HMPREF0351_10928, _11787, _11933, _12004, _12887, and_12948), and 
transposases (HMPREF0351_10878, _10880, _10927, _11934, and _12005). Therefore, 
all these IS elements and transposases (in addition to IS16) have potential as molecular 
markers to identify clinical E. faecium. However, these IS elements and transposases 
are not found in all HA-clade strains as 1,231,501; E1039; and E1071 do not have these 
IS elements and transposases, although they are present in all of the isolates considered 
to be part of the CC17 genogroup (Figure 13A). (Qin et al., 2012)
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TABLE 16. Hospital-associated clade unique mobile elements (IS elements/transposons) 
TX16 gene ID Present in 
numbers of 
isolates in the 
HA clade 
Start End Strand Predicted 
Gene 
Product 
Gene product name 
HMPREF0351_10172 13/16 169442 169978 - . IS3/IS911 family transposase 
HMPREF0351_10314 10/16 293413 294708 + . IS204/IS1001/IS1096/IS1165 family transposase 
HMPREF0351_10364 13/16 346595 347131 - . transposase IS3/IS911 
HMPREF0351_10606 10/16 604854 606317 - . transposase 
HMPREF0351_10878 12/16 857236 857526 + . IS3/IS911 transposase 
HMPREF0351_10880 13/16 858483 858977 - . transposase 
HMPREF0351_10925 12/16 902007 902753 - . transposase 
HMPREF0351_10927 13/16 903083 903448 + . transposon protein 
HMPREF0351_10928 13/16 903537 905084 + . transposase IS66 
HMPREF0351_10995 10/16 971959 973254 - . transposase 
HMPREF0351_11035 13/16 1020193 1021443 - . IS116/IS110/IS902 family transposase 
HMPREF0351_11079 10/16 1063888 1065183 + . transposase 
HMPREF0351_11528 13/16 1500554 1501804 + . IS116/IS110/IS902 family transposase 
HMPREF0351_11787 13/16 1754624 1756171 - . transposase IS66 
HMPREF0351_11788 12/16 1756260 1756625 - . transposon protein 
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HMPREF0351_11803 12/16 1770952 1771242 - . IS3/IS911 family transposase 
HMPREF0351_11806 9/16 1773745 1774866 - . transposase 
HMPREF0351_11807 9/16 1775185 1776603 + . transposase 
HMPREF0351_11809 9/16 1777456 1778493 - . conjugative transposon protein 
HMPREF0351_11812 13/16 1781818 1783005 - . IS256 family transposase 
HMPREF0351_11814 13/16 1785430 1785819 - . conjugative transposon protein 
HMPREF0351_11826 13/16 1797041 1797415 - . conjugative transposon protein 
HMPREF0351_11827 13/16 1797428 1797742 - . conjugative transposon protein 
HMPREF0351_11846 7/16 1815331 1816500 + . transposase 
HMPREF0351_11848 11/16 1816704 1817516 + . transposase 
HMPREF0351_11855 13/16 1821214 1822401 - . transposase 
HMPREF0351_11858 13/16 1826059 1826295 + . IS116/IS110/IS902 family transposase 
HMPREF0351_11859 13/16 1826261 1826491 + . IS116/IS110/IS902 family transposase 
HMPREF0351_11860 13/16 1826473 1826772 + . IS116/IS110/IS902 family transposase 
HMPREF0351_11861 13/16 1826769 1827311 + . IS116/IS110/IS902 family transposase 
HMPREF0351_11866 13/16 1829580 1830116 - . transposase IS3/IS911 
HMPREF0351_11868 13/16 1831575 1832111 + . transposase IS3/IS911 
HMPREF0351_11914 5/16 1872987 1873493 + . IS4 family transposase 
HMPREF0351_11915 5/16 1873490 1874071 + . IS4 family transposase 
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HMPREF0351_11933 13/16 1885081 1886628 - . transposase IS66 
HMPREF0351_11934 13/16 1886730 1887083 - . transposase 
HMPREF0351_12004 13/16 1960073 1961620 - . IS66 transposase 
HMPREF0351_12005 13/16 1961722 1962075 - . transposase 
HMPREF0351_12352 13/16 2296940 2298127 - . transposase 
HMPREF0351_12420 10/16 2359695 2360990 - . transposase 
 
Table from (Qin et al., 2012)
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FIGURE 13. Enterococcus faecium phylogenetics. 4A. A maximum-likelihood phylogenetic 
tree using 628 core genes. Distance bar indicates the sequence divergence. Strains isolated from 
the community are labeled with branches in red.  An asterisk (*) indicates a strain within the 
HA clade lacking IS16. 4B. A hierarchical clustering using Jaccard distance of gene content by 
unweighted pair group method with arithmetic mean (UPGMA) (see Materials and Methods). 
The core, distributed and unique gene counts are also presented in the right panel. 1:1 ortholog, 
orthologs present with one copy in all strains; N:N ortholog, orthologs present with multiple 
copies in all strains; N:M ortholog, orthologs present in some strains. Figure from (Qin et al., 
2012). 
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TABLE 17. Presence of genes encoding MSCRAMMs and pilins among 21 E. faecium genomes. 
 
  ebp operon fms11-fms19-fms16 cluster fms21-fms20 cluster 
Strain ebpA ebpB ebpC fms11 fms19 fms16 fms21 fms20 
HA 
Clade 
        
TX16 ebpA var. 1
a
 ebpB var. 1 ebpC var. 1 fms11 var. 1 fms19  var. 1(p)b fms16  var. 1(p) fms21 fms20 var. 1 
1,231,502 ebpA var. 1 ebpB var. 1 ebpC var. 1 fms11 var. 1 fms19  var. 1(p) fms16  var. 1(p) fms21 fms20 var. 1 
1,231,410 ebpA var. 1 (p) ebpB var. 1 ebpC var. 1 fms11 var. 1 fms19  var. 1(p) fms16  var. 1(p) fms21 (p) "fms20' var. 2c 
1,231,501 ebpA var. 1 ebpB var. 1 ebpC var. 1 fms11 var. 1 fms19  var. 1 fms16  var. 2d fms21 fms20 var. 1 
1,230,933 ebpA var. 1 ebpB var. 1 ebpC var. 1 fms11 var. 1 fms19  var. 1(p) fms16  var. 1(p) fms21 (p) fms20 var. 1 
C68 ebpA var. 1 (p) ebpB var. 1 ebpC var. 1 fms11 var. 1 fms19  var. 1(p) fms16  var. 1(p) fms21 fms20 var. 1 
D344SRF - - - fms11 var. 1 fms19  var. 1(p) fms16  var. 1(p) fms21 (p) 
fms21 (p) 
fms20 var. 1 
"fms20” var. 2 
U0137 ebpA var. 1 ebpB var. 1 ebpC var. 1 fms11 var. 1(p) fms19  var. 1 fms16  var. 1(p) fms21 fms20 var. 1 
E1162 ebpA var. 1 ebpB var. 1 ebpC var. 1 fms11 var. 1 fms19  var. 1(p) fms16  var. 1(p) fms21 "fms20" var. 2 
E1636 - - - - -  - fms21 (p) 
fms21 (p) 
fms20 var. 1 (p) 
E1679 - - - fms11 var. 1 fms19  var. 1(p) fms16  var. 1(p) - - 
TX82 ebpA var. 1 ebpB var. 1 ebpC var. 1 fms11 var. 1 fms19  var. 1(p) fms16  var. 1(p) - - 
TX0133A ebpA var. 1 ebpB var. 1 (p) ebpC var. 1 fms11 var. 1 fms19  var. 1(p) fms16  var. 1(p) fms21 "fms20" var. 2 
E1071 ebpA var. 1 (p)
e
 - ebpC var. 1 (p)
e
 - - - fms21 fms20 var. 1 
E1039 - - - fms11 var. 1(p) - - fms21 fms20 var. 1 
1231408
f
 ebpA var. 1 ebpB var. 1 ebpC var. 1  fms11 var. 1 fms19  var. 1(p) fms16  var. 1(p) fms21 fms20 var. 1 
CA 
Clade 
        
1,141,733 ebpA var. 2
g
 ebpB var. 2
h
 ebpC var. 2
i
 fms11 var. 2
j 
fms19  var. 2
k 
fms16  var. 2 fms21 fms20 var. 1 
TX1330 ebpA var. 1 (p) 
ebpA var. 2 (p) 
ebpB var. 1 
ebpB var. 2 (p) 
ebpC var. 1 
ebpC var. 2 
- - - fms21 fms20 var. 1 
Com12 ebpA var. 1 (p) 
ebpA var. 2 (p) 
ebpB var. 1 
ebpB var. 2 (p) 
ebpC var. 1 
ebpC var. 2 
- - - fms21 fms20 var. 1 
Com15 ebpA var. 1 (p) 
ebpA var. 2 (p) 
ebpB var. 1 
ebpB var. 2  
ebpC var. 1 (p) 
ebpC var. 2 (p) 
fms11 var. 2 (p) fms19  var. 2(p) fms16  var. 2(p) fms21 fms20 var. 1 
E980 ebpA var. 2 (p) ebpB var. 2 ebpC var. 2 (p) fms11 var. 2 (p) fms19  var. 2(p) fms16  var. 2 fms21 fms20 var. 1 
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  fms14-fms17-fms13 cluster         
Strain fms14 fms17 fms13 scm fms18 fms15 acm 
HA 
Clade 
       
TX16 fms14 var. 1 fms17 var. 1 fms13 var. 1 scm var. 1 fms18 var. 1 fms15 (p) acm 
1,231,502 fms14 var. 1 fms17 var. 1 fms13 var. 1 scm var. 1 (p) fms18 var. 1 
fms18 var. 2
l
 
fms15 (p) acm 
1,231,410 fms14 var. 1 fms17 var. 1 fms13 var. 1 scm var. 1 (p) fms18 var. 1 
fms18 var. 2 
fms15 (p) acm 
1,231,501 fms14 var. 1 fms17 var. 1 fms13 var. 1 scm var. 1 - fms15 (p) acm 
1,230,933 fms14 var. 1 fms17 var. 1 fms13 var. 1 scm var. 1 (p) fms18 var. 2 fms15 (p) acm 
C68 fms14 var. 1 fms17 var. 1 fms13 var. 1 scm var. 1 (p) fms18 var. 1 
fms18 var. 2 
fms15 (p) acm 
D344SRF fms14 var. 1 (p) fms17 var. 1 (p) fms13 var. 1 (p) scm var. 1 (p) fms18 var. 1 fms15 acm (p) 
U0137 fms14 var. 1 fms17 var. 1 fms13 var. 1 scm var. 1 (p) fms18 var. 2 fms15 (p) acm 
E1162 fms14 var. 1 fms17 var. 1 fms13 var. 1 scm var. 1 (p) fms18 var. 1 
fms18 var. 2 
fms15 acm 
E1636 fms14 var. 1 fms17 var. 1 (p) fms13 var. 1 (p) scm var. 1 (p) fms18 var. 2 fms15 acm (p) 
E1679 fms14 var. 1 fms17 var. 1 (p) fms13 var. 1 (p) scm var. 1 fms18 var. 1 
fms18 var. 2 
fms15 (p) acm (p) 
TX82 fms14 var. 1 fms17 var. 1 fms13 var. 1 scm var. 1 (p) - fms15 (p) acm 
TX0133A fms14 var. 1 fms17 var. 1 (p) fms13 var. 1 (p) scm var. 1 (p) fms18 var. 1 
fms18 var. 2 
fms15 (p) acm 
E1071 fms14 var. 1 fms17 var. 1 fms13 var. 1 scm var. 1 (p) fms18 var. 2 fms15 (p) acm (p) 
E1039 fms14 var. 1 (p) fms17 var. 1 fms13 var. 1 scm var. 1 (p) - fms15 (p) acm (p) 
1231408
f
 fms14 var. 2
m
 fms17 var. 2
n
 fms13 var. 2
o
 scm var. 1 (p) - fms15 (p) acm 
CA 
Clade 
       
1,141,733 fms14 var. 2 fms17 var. 2 fms13 var. 2 scm var. 2 (p)
p
 - - acm 
TX1330 fms14 var. 2 fms17 var. 2 fms13 var. 2 scm var. 2  - - acm (p) 
Com12 fms14 var. 2 fms17 var. 2 fms13 var. 2 scm var. 2 (p) - - acm (p) 
Com15 fms14 var. 2 (p) fms17 var. 2 fms13 var. 2 scm var. 2 (p) - - acm (p) 
E980 fms14 var. 2 fms17 var. 2 fms13 var. 2 - - - acm (p) 
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a
 var. 1, variant 1; var. 2; variant 2.  
Cut-off for var.2 was set at <95% aa identity versus TX16 using PBLAST.  
      
b
(p), partial, incomplete gene sequence or pseudogene  
     
c
 aa identities/similarities of proteins encoded by "fms20" var. 2 genes range between 39-43%/55-57% versus that of fms20 var. 1 of TX16 
d 
aa identities/similarities of proteins encoded by fms16 var. 2 genes range between 93-94%/96-98% versus that of fms16 var. 1 of TX16 
e
ebpA and ebpC are fused into a single ORF in E1071 (5' region of ebpA (nt 1-2757) joined to 3' region of ebpC (nt 1083-1875)) 
f 
Strain 1,231,408 is a hybrid of HA and CA clades; see text for details 
    
g
 aa identities/similarities of proteins encoded by ebpA var. 2 genes range between 85-90%/80-82% versus that 
of ebpA var. 1 of TX16 
        
h 
aa identities/similarities of proteins encoded by ebpB var. 2 genes range between 87-92%/92-95% versus that of ebpB var. 1 of TX16 
i
 aa identities/similarities of proteins encoded by ebpC var. 2 genes range between 90-94%/97-98% versus that of ebpC var. 1 of TX16 
 j 
aa identities/similarities of proteins encoded by fms11 var. 2 genes range between 79-92%/85-95% versus that of fms11 var. 1 of TX16 
k
 aa identities/similarities of proteins encoded by fms19 var. 2 genes range between 89-90%/94-95% versus that of fms19 var. 1 of TX16 
l
 aa identities/similarities of proteins encoded by fms18 var. 2 genes range between 90-93%/94-96% versus that of fms18 var. 1 of TX16 
m
 aa identities/similarities of proteins encoded by fms14 var. 2 genes range between 85-86%/92-94% versus that of fms14 var. 1 of TX16 
n
 aa identities/similarities of proteins encoded by fms17 var. 2 genes are 91%/96% versus that of fms17 var. 1 of TX16 
 
o 
aa identities/similarities of proteins encoded by fms13 var. 2 genes range between 66-68%/80-82% versus that of fms13 var. 1 of TX16 
p 
aa identities/similarities of proteins encoded by scm var. 2 genes range between 94-95%/96-97% versus that of scm var. 1 of TX16 
q
 TC6 was left out of this analysis as it is a transconjugant, and therefore not a unique genome 
 
Table from (Qin et al., 2012) 
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[3.3.7] Distribution of genes encoding MSCRAMM-like proteins, putative virulence genes, 
antibiotic resistance determinants, and CRISPRs.  
Previous studies of E. faecium TX16 identified 15 genes encoding LPXTG 
family cell-wall anchored proteins with MSCRAMM-like features, such as 
immunoglobulin-like folding; 11 of these were found in four gene clusters, each 
predicted/demonstrated to encode a different pilus, and four were found as individual 
MSCRAMM-encoding genes (Nallapareddy et al., 2003; Sillanpaa et al., 2008; 
Sillanpaa et al., 2009a). Our search for these genes in 21 unique E. faecium draft 
genomes in this study found all of the MSCRAMM-encoding genes to be widely 
distributed except fms18 (ecbA) and fms15 which were only in HA-clade isolates 
(although some are present as variants or pseudogenes within the HA-clade) (Table 17). 
Moreover, our analysis revealed that ebpA-ebpB-ebpCfm, fms14-fms17-fms13, fms20, 
scm, and fms18 (the latter present in only HA isolates) all have sequence variants in 
some of the 21 strains, with identities of the encoded variant proteins ranging from 39% 
(fms20 homolog) to 94% (ebpC) versus their counterparts in TX16 (Table 17). In 
general, most of the MSCRAMMS followed the CA/HA clade groupings with a variant 
representing each clade. Variant 1 of the fms11-fms19-fms16 locus was strictly found in 
the HA-clade, and variant 2 in the CA-clade except for 1,231,501 which only had one of 
the three proteins (fms16) as a CA-variant, suggesting recombination by this isolate. 
Variant 1 of fms14-fms17-fms13 was found in all but one HA clade isolate (1,231,408, a 
hybrid of HA and CA clades, has variant 2) and variant 2 in all 5 CA-clade strains.  
Variant 1 of scm was found to be exclusively carried by all 16 HA clade strains and 
variant 2 by 4 of the 5 CA clade strains. Although the differences between these 
MSCRAMMs in CA- vs. HA-clade strains are generally greater (ranging from 2-27% 
with an average of 10%) than the differences (3-4%) previously reported for the clade-
specific differences in a set of core genes that excluded predicted surface proteins, they 
are comparable to the differences seen in several other surface proteins that have been 
studied (Galloway-Pena et al., 2012; Galloway-Pena et al., 2011).  
Interestingly, the majority of HA clade strains (12/16, including TX16) were 
found to have variant 1 of the ebp pilus operon, while variant 2 was exclusively found 
in the 5 CA-clade strains in addition to variant 1 in three of the five isolates. In contrast, 
variation within fms20 was restricted to the HA clade; all CA clade isolates carried 
fms20 variant 1, but the percent identity between these two variants is much smaller 
(39%), possibly indicating the need for a new gene name. Also of note was the acm 
gene, which is present as a pseudogene in all of the CA-clade isolates except 1,141,733 
which is the only CA-clade isolate that is from a hospitalized patient; acm pseudogenes 
were also found in  non-CC17 HA-clade isolates (Table 17).  
We also searched the 21 E. faecium isolates for the presence and absence of 13 
resistance genes. Our data correspond to previously published data for some of the 
isolates (Palmer and Gilmore, 2010; van Schaik et al., 2010) . We observed that there is 
a clear distinction between the isolates of the genetically defined CA clade and those of 
the HA clade with none of the CA clade isolates having any of the antibiotic resistance 
determinants analyzed (Table 18). On the other hand, all of the HA-clade isolates have 
multiple resistance determinants, including the pbp5-R allele that confers ampicillin 
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resistance previously reported by Galloway-Pena et al. (Galloway-Pena et al., 2011), 
except for strains 1,231,501 and E1039. 1,231,501, which is in the HA-clade but lacks 
all antibiotic resistances including pbp5-R, may have lost the allele via recombination 
and acquired pbp5-S or may even represent a more ancestral isolate. Indeed, 1,231,501 
was shown to be a hybrid of HA and CA genomes by Palmer, et al., with the 
replacement (hybrid) region including pbp5-S, which could explain the origin of pbp5-S 
in this strain (Palmer et al., 2012). E1039, which has the pbp5-R allele but none of the 
other resistance genes, is genetically defined as a HA-clade isolate, but came from a 
healthy volunteer, perhaps explaining its lack of other antibiotic resistances.  
Interestingly, neither of these strains has IS16. D344SRF is the only other HA-clade 
isolate that lacks the pbp5-R allele; however, this strain is known to have spontaneously 
lost pbp5 and the surrounding region and contains many other resistances (Rice et al., 
2001). Of note, E1636 only has two of the 13 resistances analyzed (tetM and pbp5-R); 
however, this could possibly be explained by its early isolation in 1961. This again 
suggests that these isolates are more distantly related to the other strains within the HA-
clade.  
Two groups have previously analyzed CRISPR-associated genes within E. 
faecalis and E. faecium genomes (Palmer and Gilmore, 2010; van Schaik et al., 2010). 
Partial CRISPR-like loci were previously described in E1071, E1679, and U0317; 
however, these loci were within a gene and were considered non-functional (van Schaik 
et al., 2010). In addition, Palmer et al. identified CRISPR-cas predicted proteins in the 
Broad Institute strains Com12; 1,141,733; and 1,231,408 (Palmer and Gilmore, 2010). 
Similarly, we only found a CRISPR-cas locus in strain TX1330 (Table 19) out of the 6 
strains not previously studied (TX1330; TX16; TX82; TX0133A; D344SRF; and C68). 
In summary, out of the 22 available genomes, only one of the HA-clade isolates 
contained CRISP-loci, namely the hybrid strain 1,231,408. The three other strains 
containing CRISPR-loci of the CA-clade (Com12; 1,141,733; and TX1330) all lacked 
antibiotic resistance determinants. Therefore, our data coincide with the previous 
observation that members of the recently emerged high-risk enterococcal lineages lack 
CRISPR-loci and the inverse relationship between the presence of a CRISPR-cas locus 
and acquired antibiotic resistance (Palmer and Gilmore, 2010). (Qin et al., 2012) 
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TABLE 18. Antibiotic resistance gene profiles of the 21 E. faecium strains 
Gene cat ermA  ermB  aad6  aad9  aadE  
aacA- 
aphD 
tetL tetM vanA gyrA
b
 parC
c
  
pbp5-
R
d
  
 
Resistance 
CHL ERY ERY 
SPC/ 
STR 
SPC/ 
STR 
SPC/ 
STR 
GEN TET TET VAN CIP CIP AMP 
Strains 
             
1,141,733 
             
Com12 
             
Com15 
             
E980 
             
TX1330 
             
1,230,933 
  
X X 
 
X X 
 
X X X X X 
1,231,408 
  
X X 
 
X X 
   
X X X 
1,231,410 
  
X X 
 
X 
   
X X 
 
X 
1,231,501 
             
1,231,502 
  
X X 
 
X X 
  
X X X X 
C68 
  
X X 
 
X X 
 
X 
 
X X X 
D344SRF
a
 
  
X X 
 
X 
 
X X 
    
TX16 X 
 
X X 
 
X 
 
X X 
   
X 
E1039 
            
X 
E1071 X 
 
X X X X 
 
X 
 
X 
  
X 
E1162 
       
X X 
   
X 
E1636 
        
X 
   
X 
E1679 
 
X X X X 
 
X 
  
X X X X 
TX82 
  
X X 
 
X 
  
X X X X X 
TX0133A X 
 
X X 
 
X X 
 
X 
 
X X X 
U0317 
  
X X 
 
X X 
   
X X X 
a
 A rifampin- and fusidic acid-resistant derivative of clinical strain E. faecium D344S in which 
the spontaneous loss of pbp5 and its surrounding region resulted in an ampicillin-susceptible 
phenotype
 
b
 Amino acid change (E to K/G) in residue 87 or (S to R/Y/I) in residue 83 of GyrA     
c
 Amino acid change (E to K) in residue 86 or (S to R/I) in residue 82 of ParC  
d
 Consensus sequence of the pbp5-R allele encoding the low affinity Pbp5-R 
e
 TC6 was not included in this analysis as it is a transconjugant of C68 and D344SRF, so 
therefore is not a unique genome 
Table from (Qin et al., 2012) 
 
 
99 
 
TABLE 19. Summary of CRISPRs found in E. faecium sequenced strains. 
 
E. faecium strain  Locus Tag  
Conserved domain/ 
functional assignment  
   
TX1330  HMPREF0352_0914  TIGR01865/csn1  
 
HMPREF0352_0915  TIGR03639/cas1_NMENI  
 
HMPREF0352_0916  COG3512/cas2  
 
HMPREF0352_0917  pfam09711/csn2  
Com12
a 
EFVG_01552 TIGR01865/csn1 
 
EFVG_01553 TIGR03639/cas1_NMENI 
 
EFVG_01554 COG3512/cas2 
 
EFVG_01555 pfam09711/csn2 
1,141,733
a 
EFSG_02406 TIGR01865/csn1 
 
EFSG_02407 TIGR03639/cas1_NMENI 
 
EFSG_02408 COG3512/cas2 
 
EFSG_02409 pfam09711/csn2 
1,231,408
a 
EFUG_01572 TIGR01865/csn1 
 
EFUG_01573 TIGR03639/cas1_NMENI 
 
EFUG_01574 COG3512/cas2 
 
EFUG_01575 pfam09711/csn2 
   
a 
Previously published (Palmer et al., 2010) 
 
 Table from (Qin et al., 2012) 
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[3.4] CHAPTER 2 DISCUSSION 
Many publications have emphasized the importance of the accessory genome in 
distinguishing the two subpopulations of E. faecium, and have often assumed that the accessory 
genome was responsible for the ability to adapt to the nosocomial environment (Leavis et al., 
2007; van Schaik et al., 2010; van Schaik and Willems, 2010). However, in the previous 
chapter a considerable intra-species difference (3-10%) was noted in the sequences of pbp5, 
pbp2, wlcA, and gls20, with each of the gene sequences forming two distinct groups generally 
corresponding to HA and CA strains (Galloway-Pena et al., 2011). This led to our hypothesis 
that differences between the HA and CA groups may be at a more fundamental level (i.e., in the 
core genome). An extensive analysis determining the degree of the core genomic differences 
using the numerous E. faecium draft genome sequences and one closed E. faecium genome 
sequence had not been reported.  
   Our analysis presented above showed a difference in the concatenated sequences of 100 
genes between the two clades of approximately 3.5-4.2%. Greater than 90% of the 100 core 
genes analyzed separated into two distinct groups, representing a variety of metabolic and 
cellular processes (Table 10 and Figure 7). Interestingly, ~60% of the sequence changes seem 
to be clade-specific changes (sequence changes found in the majority of the strains in one 
clade, but not the other), while the rest were strain specific.  Even though the 21 whole genome 
analysis confirmed that there are differences in the accessory genomes of HA and CA strains 
(e.g. putative virulence genes, antibiotic resistance determinants, IS elements and transposons), 
the changes in genes encoding core metabolism and cellular processes could be another reason 
why some strains adapt better to the clinical environment.   
 Our comparison of the 21 E. faecium genomes found that the majority of the 15 
MSCRAMM and pilus encoding genes described in Chapter 1 (12/15) were enriched in HA 
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clade strains. If they were present in all strains, they had a different sequence variant associated 
with each clade, suggesting that these genes may have also contributed to the emergence of 
HA-clade E. faecium in the clinical setting. Also of note, all CA clade strains lacked all 
antibiotic resistance determinants analyzed in this study. Three of these CA clade strains 
contained the CRISPR-cas locus, supporting the hypothesis that there is an inverse correlation 
between the presence of CRISPR loci and acquired antibiotic resistance (Palmer and Gilmore, 
2010). Although IS16 presence was highly correlated with HA strains, it was not found in all 
HA-clade strains.  Interestingly, however, all HA-clade strains did contain the pbp5-R allele 
discussed in Chapter 1. The pbp5-R allele is also found in some animal and community isolates 
that are genetically within the HA-clade, but are not clinically associated, possibly arguing that 
it is a more reliable marker for HA-clade associated strains. The exceptions are D344SRF, 
which is a spontaneous deletion mutant of pbp5, and 1,231,501. 1,231,501 is a HA-clade isolate 
from the blood of a hospitalized patient, but has no resistance genes (contains the pbp5-S 
allele), supporting the hypothesis that the genomic content of a strain, not just antibiotic 
resistance, adds to the survival in the hospital environment. 
 However, not all strains that grouped genetically within the HA or CA clades had the 
indicated origin.  For example, the hospitalized patient blood culture isolate, 1,141,733, always 
grouped with strains in the CA clade, whereas E1039, a healthy volunteer fecal sample, belongs 
to the HA clade. 1,231,408 did not fall strictly into one clade, so it was categorized as a hybrid 
strain.  The SNP analysis determined that this strain recombined around ORF 10683, as its SNP 
sequence prior to ORF 10683 showed near identity with the concatenated SNP sequence of CA 
clade strains, whereas, after ORF 10683, its concatenated sequence showed close identity to the 
SNP sequence of HA strains.  
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  The general notion held by most was that HA isolates had evolved from CA isolates 
under the pressure of antibiotic use and the environment of the hospital setting. We tested this 
idea by estimating the time of separation of the HA and CA clades since the hypothesis of 
cladal separation held true for the majority of the isolates. Two main strategies used in a 
number of other publications, 16S rRNA and synonymous SNPs throughout the genome, were 
used to analyze the molecular evolution of E. faecium in this study (Achtman et al., 2004; 
Foster et al., 2009; Lenski et al., 2003; Ochman et al., 1999; Ochman and Wilson, 1987; Van 
Ert et al., 2007). Although 16S rRNA analysis is historically the accepted methodology to 
determine speciation, recent studies have expressed concerns regarding 16S rRNA being a 
reliable chronometer. sSNP sites of protein-encoding genes are not affected by selection or 
genetic drift and therefore are thought to reflect the underlying rate of mutation more reliably 
than 16S rRNA (Kuo and Ochman, 2009; Pearson et al., 2009) and to be more useful for 
species with high levels of recombination, such as E. faecium (Pearson et al., 2009). Therefore, 
both 16S rRNA and sSNP analysis were used. The 16S rRNA analysis shows a 0.06% to 0.1% 
difference between the two clades (Figure 11 and Table 15) which puts the time of divergence 
between 1.5-2.5 million years ago. The molecular clock estimate using sSNPs analysis and the 
mutation rate of E. coli has the strains within the HA clade diverging ~100,000 to 300,000 
years ago. Using the same formula, strains within the CA clade probably diverged from each 
other ~300,000 to 900,000 years ago. Even sSNP analysis using the mutation rates up to 1000 
fold higher estimated for B. anthracis estimated divergence time between the two clades at 
approximately 300,000 years ago.  
These data together (core genes, SNPs and 16S rRNA) indicate a large divergence 
between CA-clade isolates and HA-clade isolates. Although the estimates for the time of 
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divergence are crude, they indicate that the CA clade and HA clade isolates diverged long 
before the modern antibiotic era. Nonetheless, the molecular clock calculations do support the 
hypothesis that HA clade strains stem from a relatively recent ancestor and are the more 
recently evolved genogroup. This analysis highlights that core genomic differences, in addition 
to the accessory genomic differences, may be why some strains adapt to the nosocomial 
environment and become opportunistic pathogens, while others do not.  
Using these data as well as other previous publications (Galloway-Pena et al., 2012; 
Galloway-Pena et al., 2011; Leavis et al., 2007; Palmer et al., 2012), scenarios for the evolution 
of the two clades of E. faecium are depicted in Figure 14. One may hypothesize that a 
primordial type of E. faecium split many millennia ago into two early groups with distinct 
differences between their genes (i.e. the pbp5-S or pbp5-R alleles). These lineages could 
recombine with each other resulting in hybrid strains (i.e. 1,231,408 and 1,231,501) (scenario 
1). These lineages continued to evolve, eventually reaching a core genomic difference of 
approximately 3-4%, creating a HA clade, which includes AREfm community-based isolates as 
well as most of the hospital-associated isolates (scenario 2). This clade is separate from the CA 
clade consisting of mostly community-derived isolates. A few scenarios exist for the evolution 
of AREfm clones. One scenario, is that community and hospital AREfm isolates split from the 
same ancestor (scenario 2). However, it is possible that AREfm clones evolved from the animal 
reservoir (scenario 3) or that the AREfm isolates found in animals are HA clade AREfm 
transferred from humans to their pets (scenario 4).  
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4
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Hospital-Associated Clade
 
 FIGURE 14. The projected evolution of the two clades of E. faecium. A figure addressing 
the possible scenarios that may have occurred in the evolution of Enterococcus faecium 
resulting in the HA-clade and CA-clade. Specifically, a primordial type of Enterococcus 
faecium split into early community isolates which had homologous core genomes with 
significant sequence differences (e.g., the pbp5-S or pbp5-R allele). These early community 
groups further segmented into a hospital-associated clade and the community clade. Scenario 
one depicts that these lineages could recombine with each other (represented by the bent dashed 
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arrow) resulting in hybrid strains, scenario two depicts community and hospital AREfm isolates 
splitting from the same ancestor, scenario three depicts AREfm clones evolving from the 
animal reservoir, and scenario four depicts animal AREfm isolates representing descendants of 
hospital ARE transferred from humans to their pets. Figure from (Galloway-Pena et al., 2012). 
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[4] CHAPTER 3 
Defining the Role of “WxL” Proteins in Enterococcus faecium 
[4.1] CHAPTER 3 INTRODUCTION 
 With the availability of numerous draft genomes and one closed genome (TX16) of E. 
faecium, we performed a search throughout these genomes looking for MSCRAMMS 
(discussed in the Background section and in Chapter 2) and other surface proteins that might be 
potential virulence factors contributing to the initiation of disease. One newly described class of 
surface protein was included in this search, called the “WxL” proteins.  
 Genes encoding proteins with the “WxL” motif were first described in Lactobacillus 
plantarum. A novel gene cluster thought to encode cell-surface proteins was identified and 
found to be conserved in a subset of Gram positive bacteria. Proteins encoded within each 
cluster had a signal peptide for secretion via the Sec-dependent pathway.  Some of these had 
cell-surface anchoring motifs similar to MSCRAMMs, and others contained a novel “WxL” 
domain (each cluster contained 2 of these). In addition, putative domains for sugar binding and 
degradation, CRE-sites upstream or inside the gene clusters, and transcriptome analysis 
showing higher expression levels of these gene clusters in a glucose-grown ccpA (catabolite 
control protein A) mutant, suggested that these proteins formed cell surface protein complexes 
involved in carbon source acquisition and stress survival adaptation. However, all of these data 
were from in silico genomic and transcriptome analysis, and none of the speculations were 
experimentally proven (Siezen et al., 2006).  
 In another publication, a homolog of the proteins containing the WxL domain found in 
Lactobacillus coryniformis was purified, and shown to mediate co-aggregation with itself and 
107 
 
other pathogens like E. coli and C. jejuni. It was therefore named Cpf (Co-aggregation 
promoting factor). Cpf could be removed from the surface of the cell and released into the 
supernatant using 5M LiCl, suggesting a non-covalent attachment, and then reattached to the 
cell surface to restore the co-aggregation phenotype. It was suggested that the co-aggregation 
phenotype found in this publication had a competition effect in the gastrointestinal tract by 
preventing other pathogens from adhering to host cells (Schachtsiek et al., 2004).  
 In 2007, the clinical strain E. faecalis V583 was analyzed for novel cell surface 
proteins. Twenty-seven of the proteins found possessed the C-terminal WxL domain earlier 
described in lactobacilli. By generating fusion constructs between the C-terminal region of two 
of the WxL proteins (using only the WxL domain) and a nuclease reporter gene, the authors 
were able to show that the WxL domain conferred localization to the cell wall fraction. The 
localization was eliminated or lessened when this domain was absent or truncated. These 
recombinant protein fusions were also shown to bind other Gram positive bacteria, supporting 
the coaggregation findings with Cpf discussed above. Furthermore, it was shown that 
peptidoglycan was the binding ligand for the WxL domain attachment to the surface. 
Therefore, the WxL domain itself was considered a novel cell-wall binding domain in E. 
faecalis (Brinster et al., 2007a).  
 The same group took the E. faecalis studies further by deleting one of the 27 genes 
encoding WxL proteins, named ElrA (enterococcal leucine-rich protein A). This gene was 
chosen because it had both a WxL domain and a leucine-rich repeat (LRR) domain which is 
characteristic of proteins (internalins) from Salmonella, Shigella, and Listeria spp. involved in 
host-pathogen interactions and host cell invasion. Disruption of the elrA gene lead to significant 
attenuation in a mouse peritonitis model and reduced bacterial dissemination to the spleen, 
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liver, and host macrophages. Furthermore, RT-PCR analysis showed that elrA gene expression 
was induced in vivo (Brinster et al., 2007b).  
The research contained within this chapter aimed to tests the hypothesis that proteins 
containing the WxL domain are important for virulence/colonization in E. faecium using the 
following specific aims: 1) To determine the localization of WxL proteins of E. faecium and the 
possible interactions of the proteins encoded by the same locus, 2) To determine if any of the 
WxL operons affect colonization or virulence associated functions, and 3) To determine if WxL 
proteins are antigenic during natural infection and if antibodies to the WxL proteins confer a 
protective role. 
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[4.2] CHAPTER 3 MATERIALS AND METHODS 
TABLE 20. Bacterial strains and plasmid used in this study.  
Strain or Plasmid Relevant Characteristics Reference 
TX1330 E. faecium fecal isolate from a healthy volunteer (Qin et al., 
2012) 
TX1330RF Rifampin and fusidic acid resistant version of 
TX1330 
(Arias et al., 
2009) 
TX82 Endocarditis isolate Van
R
, Erm
R 
(Nallapareddy 
et al., 2006) 
M15(pREP4) E. coli strain for expression of recombinant proteins, 
Kan
R
 
Qiagen 
pQE30 Recombinant protein expression vector Amp
R
  
TX6116 M15 containing fragment of DufA45-309 from TX82 
cloned into pQE30 
Qiagen 
TX6117 M15 containing fragment of LwpC10-562 from TX82 
cloned into pQE30 
This Study 
TX6118 M15 containing fragment of LwpA33-716 from TX82 
cloned into pQE30 
This Study 
TX6119 M15 containing fragment of SwpA26-226 from TX82 
cloned into pQE30 
This Study 
TX6120 M15 containing fragment of SwpC25-243 from TX82 
cloned into pQE30 
This Study 
TX6121 M15 containing fragment of LwpC35-587 from 
TX1330 cloned into pQE30 
This Study 
TX6122 M15 containing fragment of SwpC26-243 from 
TX1330 cloned into pQE30 
This Study 
TX6123 M15 containing fragment of LwpA33-772 from 
TX1330 cloned into pQE30 
This Study 
TX6124 M15 containing fragment of SwpA26-227 from 
TX1330 cloned into pQE30 
This Study 
CK111 E. faecalis strain used as a donor for mating in 
mutant production 
(Kristich et al., 
2007) 
pHOU1 pCJK47 derivative used to make markerless non-
polar  deletions in E. faecium, Gen
R 
(Panesso et al., 
2011) 
TX5725 CK111 containing WxL Locus B constuct to create a 
deletion in TX82 
This Study 
TX6125 CK111 containing WxL Locus A constuct to create a 
deletion in TX82 
This Study 
TX6126 CK111 containing WxL Locus C constuct to create a 
deletion in TX82 
This Study 
TX6106 WxL Locus A deletion in TX82 This Study 
TX6107 WxL Locus C deletion in TX82 This Study 
TX6115 WxL Locus B deletion in TX82 This Study 
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[4.2.1] Strains, plasmids, and cultivation of bacteria. All relevant characteristics of bacterial 
strains, antibiotic growth conditions, and plasmids used in this study can be found in Table 20. 
Unless otherwise stated, all E. coli cells were grown in LB broth/agar and all E. faecalis or E. 
faecium cells in BHI agar and broth at 37C.  
 [4.2.2] Sequencing of loci and in silico genomic analysis. The genome sequence of TX16 
was first searched for ORFs with the potential to encode proteins with the WxL domain using 
NCBI BLAST. Initially, ORFs were predicted with Glimmer 2 and protein domains determined 
with InterProScan. All ORFs generated through BLAST longer than 150 amino acids were then 
searched for the “WxL” motif (and other conserved residues; see section 4.3.1. Figure 15) 
within the C-terminal 150 amino acid residues. The WxL domain was confirmed using 
CLUSTALW alignment with previously predicted WxL proteins (Siezen et al., 2006). The 
gene organization of the ORFs surrounding the predicted “WxL” ORFs were also analyzed to 
determine if they resembled what was previously reported (Siezen et al., 2006). InterProScan 
was used to determine protein family, domains, and functional sites. TMHMM v2.0 and 
TMpredServer were used to determine possible transmembrane domains. Signal P v3.0 was 
used to determine the presence of N-terminal signal sequences. SoftBerryBPROM and 
SoftBerryFindTerm as well as RNA secondary structure predictor (www.genebee.msu.eu) were 
used to determine the predicted promoters and terminators of the loci. Secondary and tertiary 
structures were predicted using PHYRE. DisEMBL v1.5 was used to predict intrinsic protein 
disorder. NCBI BLAST was then used to find the WxL loci in TX1330 and TX82 using the 
sequence from TX16. Confirmatory sequencing of the WxL loci using the genomic DNA from 
the E. faecium strains TX1330 and TX82 were performed using the primers found in Table 21.  
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TABLE 21. Primers used for the re-sequencing of the WxL loci.  
Oligonucleotide
a 
Sequence 5-3 
Locus A   
WxL27seqF1 CACAGCATCCATCGTTTGGC 
WxL27seqR1BBB CAGCCACGAGGTTCCAAGTCAAATC 
WxL27toDUF916Fwd GTAAAGCAAGTGCAGCGACACC 
WxL27toDUF916Rev CGCCGGATTAACAGAGACCTCAAATG 
DUF916seqF1 GTAACGAGTGATGGTGGAACGATC 
DUF916seqR1 CAACGAAATCACCTCATCG 
DUF916toWxL16Fwd CAGGTGACAGTAATGAATGGCG 
DUF916toWxL16Rev CAGTTAGTTGGACAAGCTTCCC 
WxLHyb1and6Fwd TTCGGCAGAAGCTGTTGGAGCAA 
WxLHyb1and6Rev CCACGTATTTATCTCTGCACTTGCAG 
WxL16seqF2 GCTCCAGCTGCAGGTAGATTTTATC 
WxLseq16R2BBB CTGAAGCCAATGCAGGTAGTGTAG 
WxL16seqF3 CTACACTACCTGCATTGGCTTCAG 
WxL16seqR3BBB GTTGCCAAGGAGACGTGCTTGGAAG 
WxL16seqF4 CAATTCTTGTCCCCAAACAAG 
WxL16seqR4 GGTAGACCGATCGATTGATAAGCG 
Hypo1seqF1 GGCCAATCAGCTAAGTGATCAG 
Hypo1seqR1 CGATTCAATTGAGCCACTACGTCATC 
Hypo1seqF2 CCATTATGAAGAAACGGATGCGCTG 
Hypo1toOx2Rev GTCACAGAAGTCCGCTAAAG 
Hypo1toOx2Fwd CCTCAGAAGTGAGGATGAGCTGATG 
Ox2seqR1 GACCATCACAGTGTCGTCCTCATAC 
Ox2seqF1 GGGTTAGAATTAGCAGATGC 
Ox2seqR2 GCTTATCAGCTGTCCACCAATG 
Ox2toABCtransFwd CTGTTGGGTTGACAGAAGACGAAG 
Ox2toABCtransRev GACTCCTGGAGTTTGGGCAAGATAG 
Locus B  
WxL410seqF1 AAACGTCAGAGAGGATGGTG 
WxL410seqR1 CTGTTTCCCCAAAAATCGGA 
WxL 410 F #2 CGATGGAAATGCCATTATCATTGC 
WxL 410 R # 2 CTCCAGCCATTTTGACCGAGATTTGTCC 
WxL410seqF2 GCCTGCAAGGAGATTCTAG 
WxL410seqR2 TTCATTCCGGCACCTGTCTGAGC 
WxL410seqF3 CGATCAATGGAACCGACTTAG 
WxL410seqR3 TCTTGCGTCAACCCAGTTGC 
WxL410toCWAFwd CCAAACTCGATTGTGGTCAGATC 
WxL410toCWARev GAGGAGGAACAGTTATTTCTCCCAC 
CWAseqF1 CGGTGTGATCGAATATGGAG 
CWAseqR1 GGCTGAGCTCTTATTCTCAG 
WxLHyb3and11Fwd GCATTAAGTACCGTTCTAGCTGG 
WxLHyb3and11Rev CTGTAGGAGCATCTGTTAACGACC 
WxL311seqF1 GCCGTAGACAACTACGTTTC 
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WxL311seqR1 GTGGAAGTCTCGTCCTGTATCCTC 
Up410F1 CATTCTCCACCATCCTCTCTGACG 
Up410R1 GTTCGGGATAAGGGACTGTGACAAGAC 
Locus C  
WxL5A9seqF1 GAAGGAAACCGCGACACCTATTG 
WxL5A9seqR1 GATCTTCCGGATCAACTGGAGGAG 
WxL 5A9 F #2 ACATTTGAAGCAGGAGATGAGGG 
WxL 5A9 R #2 AAGTCCCCACACCTGTTCCTGATTTAGC 
WxL5A9toWxL5B8Fwd GCTAAATCAGGAACAGGTGTGG 
WxL5A9toWxL5B8Rev CCAAATAGCTCCTCTTTGAGACC 
WxLHyb5Band8Fwd GGATCGTGCTCATTTTAAGCAG 
WxLHyb5Band8Rev CCATTCGATCAGAAGAACCACTA 
WxL5B8seqF1 CGCAAATGCACTCTCGATTG 
WxL5B8seqR1 ACACCTTCTGTATTCGCTGA 
5B8toDUF916#2Fwd GATTCAGCGAATACAGAAGG 
5B8toDUF916#2Rev CGTTTGAATTAGTCGTTGCGC 
DUF916seqF1 CGATCTCCAACTTGTTCCAG 
DUF916R1 CAGCGCTTCTAAGATGTAGATCC 
DUF916toCWA0757Fwd GGATCTACATCTTAGAAGCGC 
DUF916toCWA0757Rev GCGAGATAATAGGGCATTACTAG 
CWA0757seqF1 CTGTTAGTGAATTGGTGATATGTTTGG 
CWA0757seqR1 TATCTAGTGGAAATTCATCC 
CWA0757seqF2 CGGTTACCGAAAGAAACGAG 
CWA0757seqR2 CACCACGTCTTGTACACGCACTACTTC 
WxL5A9seqR1BBB CCCTCATCTCCTGCTTCAAATG 
Oligos for Gaps in 
Sequencing
 
 
LA1401-1902F GAAGAAATAAGAGAAGCAGGCGGG 
LA1401-1902R CGCTGTCAAACACGATTGGTAC 
LA1857-2463F GTGGCAGAAGCAGTAGATAAACG 
LA1857-2463R GCCGCCTAGAAGAAGTGTTGAAAG 
LA2440-2957F CTTTCAACACTTCTTCTAGGCGGC 
LA2440-2957R GCTGCTGTAAATATTGGTGTCGCTGC 
LA3352-3755F CCGGAACAAAATCAGACACTGG 
LA3352-3755R GATCCGGTTCTATCGTCTCTTGAC 
LA5964-6807F CGATCTCATCAAATAATGGCGGC 
LA5964-6807R CCGCTTAATTCTTGACCTTGATC 
LA7201-7824F GAGGAAAAAGGAGAGATCTCTG 
LA7201-7824R CAATCCAACAGGAAGATTAC 
LA9690-10370F GTGCCTGTTCTTGTTCAGGAGAG 
LA9690-10370R AGAACGATCGAATCTGCCTC 
LA10321-11024F CAAGACAATCGAACGGCGGTTGAC 
LA10321-11024R CCTTGGGCTTTCATTACACC 
LB5081-5665F CTTTCCCTTCTGTAGGAGCATCTG 
LB5081-5665R GCAGTAGAGATCATCAATCGG 
LB5645-6120F CCGATTGATGATCTCTACTGC 
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LB5645-6120R GTCACCACCATCAAAGCTATACAACC 
LC496-1020F GCTGTCTTATGATGCAACCATTCC 
LC496-1020R CCATCGCTCCCGTAGTAATAAC 
a
WxL proteins were named differently when experiments first began. WxL27 is SwpA, WxL16 
is LwpA, WxL410 is LwpB, WxL311 is SwpB, WxL5A9 is SwpC, WxL5B8 is LwpC. 
b
 LA is Locus A, LB is Locus B, and LC is Locus C 
 
TABLE 22. Primers for probes used in hybridizations of genes encoding WxL proteins. 
Oligonucleotide
a 5’-3’ Sequence Size of Probe 
WxLHyb16Fwd TTCGGCAGAAGCTGTTGGAGCAA  
WxLHyb16Rev CCACGTATTTATCTCTGCACTTGCAG 798bp 
WxLHyb27Fwd TTCTTCTAGGCGGCTTGGCAA  
WxLHyb27Rev AGCCACGAGGTTCCAAGTCAAA 625bp 
WxLHyb311Fwd GCATTAAGTACCGTTCTAGCTGG  
WxLHyb311Rev CTGTAGGAGCATCTGTTAACGACC 729bp 
WxL 410 F #2 CGATGGAAATGCCATTATCATTGC  
WxL 410 R # 2 CTCCAGCCATTTTGACCGAGATTTGTCC 679bp 
WxL 5A9 F #2 ACATTTGAAGCAGGAGATGAGGG  
WxL 5A9 R #2 AAGTCCCCACACCTGTTCCTGATTTAGC 474bp 
WxLHyb5B8Fwd GGATCGTGCTCATTTTAAGCAG  
WxLHyb5B8Rev CCATTCGATCAGAAGAACCACTA 669bp 
a
WxL proteins were named differently when experiments first began. WxL27 is SwpA, WxL16 
is LwpA, WxL410 is LwpB, WxL311 is SwpB, WxL5A9 is SwpC, WxL5B8 is LwpC. 
[4.2.3] Colony hybridization. Preparation of colony lysates on nylon membranes and 
hybridization under high-stringency conditions were performed as described previously (Coque 
et al., 1995). Briefly, E. faecium isolates were replica plated on nylon membranes from 96-well 
microtiter plates and then placed on BHI plates and grown overnight at 37C. The colonies were 
lysed using a treatment with lysozyme (10mg/ml) and mutanolysin (4units/ml) for 30 minutes 
at 37C. The genomic DNA left on the membrane was denatured with 0.5M NaOH for 10 
minutes at room temperature. The membranes were then washed with 1M Tris (pH7.6), 0.5M 
Tris (pH7.6) + 1.5M NaCl, chloroform, then 95% EtOH. The DNA was then fixed by baking 
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the membranes at 80C for 4 hours. Hybridizations were performed under high stringency 
conditions using radiolabelled probes (RadPrime DNA Labeling System Invitrogen) in 
hybridization buffer containing 50% formamide, 5× Denhardt's solution, 5× SSC (1× SSC is 
0.15 M NaCl plus 0.015 M sodium citrate, pH 7.2), 0.1% SDS, and 100 μg/ml calf thymus 
DNA at 42°C overnight, followed by three washes with 2× SSC and 0.1% SDS at room 
temperature (15 min each) and two washes with 0.1× SSC and 0.1% SDS at 50°C (15 min 
each). DNA probes for the WxL loci genes were obtained with primers listed in Table 22. 
[4.2.4] RNA extraction and RT-PCR. Total RNA was isolated from TX1330 and TX82 
grown to mid-log phase in 10mL of BHI using RNAwiz according to manufacturer’s 
instructions (Ambion). Briefly, 500µl of RNAwiz was added to the bacterial pellet, and the 
mixture vortexed using 0.5g of silica beads for 5 minutes. After centrifugation, an additional 
500µl of RNAwiz was added and vortexed again. 300µl of chloroform was then added and 
incubated at RT for 10 minutes. The mixture was then centrifuged at 4C for 15 minutes, and the 
supernatant collected. The RNA was then ethanol precipitated. The RNA pellets were 
resuspended in 100µL of water and treated twice with 20U RQ1 DNase (Promega) for 1 hour at 
37C. DNase was then removed using the RNeasy Mini kit purification protocol (Qiagen). The 
total RNA was then reverse-transcribed with the specific primers found in Table 23 using the 
SuperScript One-Step RT-PCR with Platinum Taq kit (Invitrogen) using the manufacturer’s 
instructions. Reactions without reverse transcriptase were used to verify that there was no DNA 
contamination and reactions with genomic DNA were used to verify the effectiveness of the 
primers.  
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TABLE 23. Primers used for RT-PCR of the intergenic regions of WxL loci. 
Oligonucleotide
a,b 5’-3’ Sequence 
Locus A TX1330  
Ox1toWxL27Fwd GGTCATGCAATTAGCTGGAACG 
Ox1toWxL27Rev CCAAACGGCAATTCGGGAACTAC 
WxL27toDUF916Fwd GTAAAGCAAGTGCAGCGACACC 
WxL27toDUF916Rev CGCCGGATTAACAGAGACCTCAAATG 
DUF916toWxL16Fwd CAGGTGACAGTAATGAATGGCG 
DUF916toWxL16Rev CAGTTAGTTGGACAAGCTTCCC 
WxL16toHypo1Fwd CCAACAAGGACAAAACACGATG 
WxL16toHypo1Rev CCATAACAAGTTTCTGCCGATC 
Hypo1toOx2Fwd GTCACAGAAGTCCGCTAAAG 
Hypo1toOx2Rev CCTCAGAAGTGAGGATGAGCTGATG 
Ox2toABCtransFwd CTGTTGGGTTGACAGAAGACGAAG 
Ox2toABCtransRev GACTCCTGGAGTTTGGGCAAGATAG 
Locus C TX1330  
Aldolase to WxL5A9F GATGAATACACAAGGACGAG 
Aldolase to WxL5A9R CGAAAGTCGTACTTACTGCC 
WxL5A9toWxL5B8Fwd GCTAAATCAGGAACAGGTGTGG 
WxL5A9toWxL5B8Rev CCAAATAGCTCCTCTTTGAGACC 
5B8toDUF916#2Fwd GATTCAGCGAATACAGAAGG 
5B8toDUF916#2Rev CGTTTGAATTAGTCGTTGCGC 
DUF916toCWA0757Fwd GGATCTACATCTTAGAAGCGC 
DUF916toCWA0757Rev GCGAGATAATAGGGCATTACTAG 
CWA to Glycerol MIP F CCAAGAAGAGAAATACAAAGACAGC 
CWA to Glycerol MIP R GGTACCCGTTGTTGCACCTATCTGTGC 
Locus A TX82  
TX82Hydro to WxL27 F GTTTGACAGCGGTGTACGAC 
TX82Hydro to WxL27R GCTGGCTCTACTGGTTTTGAAG 
WxL27toDUF916Fwd*
c 
GTAAAGCAAGTGCAGCGACACC 
TX82WxL27 to LA DUF R CCACCATCACTCGTTACCGC 
DUF916toWxL16Fwd* CAGGTGACAGTAATGAATGGCG 
DUF916toWxL16Rev* CAGTTAGTTGGACAAGCTTCCC 
TX82WxL16 to TransRegF GATCAAGGTCAAGAATTAAG 
TX82WxL16 to TransRegR TGCTGCTATATTTCCATGTCTG 
Hypo1toOx2Fwd* GTCACAGAAGTCCGCTAAAG 
TX82TransReg to Ox R GAGGATGAGCTGATGTTTGTCTGG 
TX82Ox to ABC F CAAAAC AGTAAATGCA AAGC 
TX82Ox to ABC R CTTCTTCTGTACTGTCTTTACTAG 
Locus B TX82  
TX82Kinase to WxL410 F GCAAAAGTGGATGATGGTAAG 
TX82Kinase to WxL410 R CTTGTCTTATTTTCTTCTTGCC 
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TX82WxL410 to DUF916 F CAAGAAAGGAGAGGAGTATCAA 
WxL410toCWARev* GAGGAGGAACAGTTATTTCTCCCAC 
CWAtoWxL311Fwd* GGGACATTATCAAGCGGTTGTG 
TX82DUFtoWxL311 R GTAGTCAAGCCGAACATATAAGAAGC 
TX82WxL311toTransReg F CAAAGGTGAAATTCAAAAACGCC 
TX82WxL311toTransReg R GATGAATAAGAGCTGAGACGTAAG 
Locus C TX82  
TX82Metalo to WxL5A9 F GTTTTTGGCCATACGCATCGTCGC 
TX82Metalo to WxL5A9R CCATAATCAATCGATAATGCCCCTCC 
WxL5A9toWxL5B8Fwd* GCTAAATCAGGAACAGGTGTGG 
WxL5A9toWxL5B8Rev* CCAAATAGCTCCTCTTTGAGACC 
WxL5B8toDUF916Fwd* GGATATCTATTTTTATTACAG 
TX82WxL5B8toDUF916 R CTTCTTTTTCTGTATCATTTC 
TX82DUF to CWA F AGGAAATGAAAATGAAAATGGA 
TX82DUF to CWA R CCTGAAAGAAAGCCAATACC 
TX82CWA to MIP F GAATAGGAATAATCTATATGAAGAAAG 
TX82CWA to MIP R TTCTTTGGTTCATTCGTTTTATTC 
 
a
WxL proteins were named differently when experiments first began. WxL27 is SwpA, 
WxL16 is LwpA, WxL410 is LwpB, WxL311 is SwpB, WxL5A9 is SwpC, WxL5B8 is LwpC. 
b
 Oligonucleotide pairs are listed in the order in which they were used for each Locus to 
amplify intergenic regions, i.e. the gene order 
c
 Asterisks indicate an oligonucleotide used for the RT-PCR of both TX1330 and TX82 
[4.2.5] Construction of expression plasmids and purification of recombinant proteins. The 
genomic DNA of E. faecium was extracted from TX1330 and TX82 cells grown overnight at 
37C in 10 mL of BHI using DNAeasy Blood and Tissue Kit (Qiagen). DNA regions of 
SwpA26-227 TX1330, SwpA26-226 TX82, LwpA33-772 TX1330, LwpA33-716 TX82 DufA45-309 TX82, SwpC26-243 
TX1330, SwpC25-243 TX82, LwpC35-587 TX1330 and LwpC10-562 TX82 were amplified using the primers 
found in Table 24 (all are recombinant proteins lacking the signal peptide, LwpA and LwpC 
lack the WxL domain, and DufA lacks the transmembrane domains). These fragments were 
cloned into the expression vector pQE30 (Qiagen) and transformed into M15 (pREP4) (Qiagen) 
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to obtain the plasmids and strains found in Table 20. The constructs were confirmed by 
sequencing. Recombinant proteins with N-terminal His6-tags were then expressed by 
inoculating 4L of Luria Broth (LB) with 40mL of overnight culture of the respective expression 
strains. 1mM (for 4-6hr induction) 2mM (for overnight induction) IPTG was added to induce 
protein expression after cells reached mid-log phase (OD600=0.6). Bacteria were harvested by 
centrifugation, the supernatant decanted, and the cell pellet washed and resuspended in 50mL 
of Buffer A (25mM Tris, 100mM NaCl, and 1mM DTT pH 7.9). The cells were then lysed 
using a French Press at 1300 psi and cell debris removed by ultracentrifugation at 40,000rpm 
for 30 minutes. The supernatant was then filtered through a 0.22µm membrane. The 
recombinant proteins were then purified using nickel affinity chromatography. A 5ml HisTrap 
chelating column was connected to an FPLC and charged with 100mM Ni
2+
 and equilibrated 
with Buffer A. The cell lysate was applied to the column and washed with 10 bed volumes of 
Buffer A, then the bound protein was eluted with a continuous linear gradient of imidazole in 
Buffer A (5-200mM; total volume 150mL) at a flow rate of 4.5mL/min. Fractions determined 
to have protein by absorbance at 280nm and SDS-PAGE were pooled, dialyzed into 25mM Tris 
and 1mM EDTA, pH 8.0, and applied to a 5mL HiTrap Q Column for anion exchange 
chromatography. Bound protein was eluted with a continuous linear gradient of NaCl (0-0.5M; 
total volume 200mL). Fractions containing purified recombinant protein were identified using 
SDS-PAGE, and dialyzed against PBS. Molecular masses were determined with MALDI-TOF 
MS. Predicted molecular weights, theoretical pI, and extinction coefficients were determined 
using the ExPASy ProtParam tool.  
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TABLE 24. Primers used to make WxL recombinant proteins. 
Oligonucleotides
a 
5-3’ Sequenceb 
TX1330   
WxL27PQE30F CGCGGATCCGAAGGTCAAGCAACTTCAAA 
WxL27PQE30R GCGTCGACCTATGCTACTGGGCCAGCC 
WxL16PQE30F CGCGGATCCGTTGGAGCAACGCCTCCTAC 
WxL16PQE30R GCGTCGACACATCAAAAGAAAAATCGCC 
WxL5A9PQE30F CGCGGATCCGCTGAAGTATACCCAAAGGA 
WxL5A9PQE30R GCGTCGACCTAGTTATTGGGTGTATCTTC 
WxL5B8PQE30F CGCGGATCCTATTCTTTGGAATCGAATCAG 
WxL5B8PQE30R GCGTCGACATTTTCAATCCACCTGAGAAC 
TX82  
pQE30LAWxL27TX82F CGCGGATCCGAGGGTCAAGCGACTTCAAAAG 
pQE30LAWxL27TX82R GCGTCGACTGCTACTGGGCCAGCCACGAGGTTC 
LApQE30DUFTX82F CGCGGATCCCCAGAGAACCAAATAGATAAAG 
LApQE30DUFTX82R GCGTCGACTGGGAAAGATTGTTCTTGTACTG 
pQE30LAWxL16TX82F CGCGGATCCGTTGGAGCAACGCCTCCTGCC 
pQE30LAWxL16TX82R GCGTCGACGCCTTTTGCTTCATAATAACTTG 
pQE30LCWxL5A9TX82F CGCGGATCCTCTGCAACTGAAGTATACCCAAAG 
pQE30LCWxL5A9TX82R GCGTCGACGTTGTTAGGTGTATCTTCTAATG 
WxL5B8TX82pQE30F CGCGGATCCTACTCTTTGGAATTGAATCAG 
WxL5B8TX82pQE30R GCGTCGACATTTTCAACCCACCTGAGAAC 
a
WxL proteins were named differently when experiments first began. WxL27 is SwpA, WxL16 
is LwpA, WxL410 is LwpB, WxL311 is SwpB, WxL5A9 is SwpC, WxL5B8 is LwpC. 
b
 Enzyme restriction sites used for cloning are underlined 
 
 [4.2.6] Fluorescence and Circular Dichroism (CD). Steady-state intrinsic tryptophan 
fluorescence spectra were obtained on a Spectrofluorimeter LS 50B (Perkin-Elmer).  Proteins 
were incubated in PBS (8 mM Na2HPO4, 2 mM KH2PO4, 3 mM KCl, 137 mM NaCl, pH7.4) 
or low salt PBS (4 mM Na2HPO4, 1 mM KH2PO4, 1.5 mM KCl, 68 mM NaCl, pH7.4) at RT 
for 1 hr before measurement.  Samples were excited at 280 nm or 295 nm, and emission spectra 
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were collected, with an excitation slit of 5 nm and an emission slit of 5 nm. All spectra were 
corrected by subtraction of the appropriate blanks.  
CD measurements in the far UV region (190-260 nm) were carried out at ambient 
temperature on a Jasco J-720 spectropolarimeter (Easton, MD) with a 0.5 mm cell.  Proteins 
were dialyzed in phosphate buffer (0.8 mM Na2HPO4, 0.2 mM KH2PO4, 0.3 mM KCl, 13.7 
mM NaCl, pH7.4)).  Ten scans were collected and averaged at a scan speed of 100 nm/min, 
with a time constant of 2 s and band width of 1 nm.  The spectra were background corrected 
with the CD signal obtained from the buffer.  Deconvolution of the spectra was performed on 
DichroWeb server.  Secondary structure composition for each protein are average of the 
deconvolution results from SELCON, CDSSTR, and CONTINLL using database 4. 
[4.2.7] Production of polyclonal antibodies and purification of antigen-specific antibodies. 
Production of antiserum was performed at previously described (Singh et al., 2012). Briefly, 
two Sprague-Dawley rats per antigen were immunized by intradermal injection three times over 
a six week period with 100µg of antigen in 200µL total volume of PBS and Freund’s complete 
adjuvant (FCA) (1
st
 immunization) or Freund’s incomplete adjuvant (FICA) (2nd and 3rd 
immunization). Rats were sacrificed and the anti-serum collected. Antisera were tested for 
antibody titers by ELISA (Nallapareddy et al., 2000). Briefly, 96-well plates were coated with 
1µg of recombinant protein in 0.05M carbonate buffer, pH 9.6. Rat sera were tested in triplicate 
with serial dilutions from 1:50 to 1:128,000, followed by detection with AP-conjugated anti-rat 
secondary antibody and 1-step PNPP (Thermo Scientific). The reaction was stopped with 2M 
NaOH and absorbance read at 405nm. Antigen specific antibodies were then purified as 
described previously (Sillanpaa et al., 2008). Briefly, the corresponding antigen was coupled to 
CNBr-activated Sepharose 4B according to the manufacturer’s instructions (GE Healthcare). 
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The antibodies were eluted from the column using 0.1M glycine, pH 2.8, neutralized with 1M 
Tris-HCl, pH8.0, and dialyzed against PBS. The antibodies were concentrated by ultrafiltration 
using the appropriate molecular mass cut off filter, and concentrations determined via 
absorption spectroscopy.  
[4.2.8] Whole-cell ELISA for detection of WxL proteins on the bacterial cell surface. The 
presence of SwpA, LwpA, SwpC, and LwpC on the surface of bacterial cells was detected 
using affinity purified antigen specific antibodies in a whole-cell ELISA as previously 
described (Nallapareddy et al., 2003). Briefly, overnight cells of each bacterial strain were 
resuspended in carbonate buffer to an OD600=1.0, and coated in 96-well plates overnight at 
4C. The cells were then washed with PBST and blocked with 2% BSA. A 1:200 dilution of 
each respective antibody in 100µl of 1% BSA was added to each well and incubated for 2hrs at 
37C. Wells were then washed again with PBST, followed by the addition of 100µl of 1:2000 
dilution of goat anti-rat IgG conjugated to HRP for 1hr at 37C. The wells were washed, TMB 
chromogenic solution added, then stopped with 2M sulfuric acid after 15 minutes, and 
absorbance read at 450nm. Antiserum against formalin-killed TX16 cells was used as a positive 
control to verify approximately equal binding of whole-cells to the microtiter plate wells. 
Statistical significance (p-values) of the surface exposure of each WxL proteins tested between 
the clinical and community groups of strains was calculated using an unpaired t-test.  
[4.2.9] Mutanolysin cell-wall extraction and western blot analysis. Mutanolysin extracts 
were prepared as described previously (Gao et al., 2010; Nallapareddy et al., 2000). Briefly, 
TX82 cells were grown in BHI at 37C to late exponential phase and cell wall associated 
proteins extracted with mutanolysin (5U per each OD600=1 cells). Mutanolysin extracts were 
lyophilized to concentrate the extract, eluted in 200µl PBS, and protein concentrations 
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determined via BCA assay according to manufacturer’s instructions (Pierce). Equal amounts of 
mutanolysin cell wall extracts were run on 4-15% gradient SDS-PAGE gels under reducing 
conditions, transferred to PVDF membranes, and probed using the specific antibodies to SwpA, 
LwpA, SwpC, and LwpC, followed by HRP-conjugated anti-rat IgG antibodies, and detected 
with Supersignal West Pico chemiluminescent substrate (Thermo Scientific). Antisera from 
pre-immune rats were used as a control.  
[4.2.10] Immunogold electron microscopy. Immunogold electron microscopy was performed 
as described previously (Mandlik et al., 2008). Briefly, TX82 cells were grown on BHI agar 
overnight. The cells were harvested from the plates by scraping and then washed with 0.1M 
NaCl. For immunogold labeling, the bacterial suspension was spotted and fixed onto carbon 
grids, washed three times with 2% BSA in PBS, and blocked with 0.1% gelatin for 1hr. The 
samples were then incubated with the specific anti-WxL antibody (anti-SwpC, anti-LwpC, or 
pre-immune serum) in a 1:100 or 1:50 dilution for 1 hr, followed by washing and blocking as 
above. Then the samples were treated with 12-nm or 18-nm gold anti-rat IgG (1:20 dilution) in 
2% BSA in PBS for 1 hr. The samples were then washed with water and stained with 1% 
uranyl acetate and viewed using a Jeol 1400 transmission electron microscope.  
[4.2.11] ELISA-type ligand-binding assays and Surface Plasmon Resonance (SPR). 
Binding of recombinant His-tagged proteins from Locus A to ECM proteins was tested as 
previously described (Nallapareddy et al., 2003). Briefly, Immunoblon 4HBX 96-well plates 
were coated with 1µg of ECM protein in 100µl of PBS at 4C overnight. After washing with 
PBST and blocking with 2% BSA, wells were incubated with 20µM of His-tagged recombinant 
protein at 37C for 4 hours. After washing unbound recombinant protein with PBST, the bound 
His-tagged recombinant proteins were detected with mouse anti-His followed by AP-
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conjugated anti-mouse antibody and detected with 1-step PNPP according to manufacturer’s 
instructions (Thermo Scientific). The reaction was stopped with 2M NaOH and the absorbance 
read at 405nm. 
SPR-based Biacore binding experiments were performed at 25
o
 C on a Biacore 3000 
(GE Healthcare). Fibronectin and Hep2-40K (Millipore) were immobilized on CM3 sensor 
chip, and type I collagen, DufA, SwpA, and LwpA were immobilized on CM5 sensor chip 
using amine coupling procedure as recommended by the manufacturer.  A reference surface 
was prepared with activation and deactivation treatments but no protein coupled. PBS including 
0.005% Tween 20 was used as running buffer.  Soluble proteins at different concentrations 
were injected onto the immobilized ligand surface to obtain SPR response curves 
(sensorgrams).   
Baseline corrected sensorgrams (with buffer blank run further subtracted) were globally 
fitted to two-state model using BIAevaluation software (Version 4.1).  The association rate 
constant (ka1) and dissociation rate constant (kd1) for the binding state, forward rate constant 
(ka2) and backward rate constant (kd2) for the conformational change state were derived from 
global fitting.  The apparent dissociation constant (KD
app
) was calculated according to the 
formula KD = 1 / ((ka1 / kd1) * (1+ka2 / kd2)).  
 [4.2.12] Single cross-over insertion mutants and non-polar markerless deletion mutants. 
All mutants were created using an altered PheS* system as described previously (Kristich et al., 
2007; Panesso et al., 2011). For single-cross over insertion mutants, small fragments of the first 
gene of each operon of TX1330 flanked by rho-independent terminators were amplified by 
PCR using the primers in Table 25, and cloned into pHOU1. The correct insert was confirmed 
by sequencing using plasmid specific primers AB142 and AB143 (Table 25) and the plasmid 
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electroporated into E. faecalis CK111. Blue colonies were recovered on BHI Gentamicin 
125µg/mL, X-Gal 200µg/mL plates. These recombinant plasmids were then introduced into 
TX1330RF through filter mating with CK111 as the donor. Single-cross over integrants were 
then selected on BHI Gentamicin 125µg/mL, Rifampin 100µg/mL, Fusidic Acid 25µg/mL 
plates and confirmed using the primers AB142 and the reverse primer specific to the Locus, as 
well as AB143 and the forward primer specific to the Locus (Table 25).  
TABLE 25. Primers used for single cross-over insertion mutants in TX1330. 
Oligonucleotide 5-3’ Sequencea,b 
Locus A  
271XoverF TTGCGGCCGCAAAAAAGCGGCCAAAGGCCTGCCACCAGGCC
AAAGGCCGCTTTTTTACTTCTTCTAGGCGGCT 
271XoverR CCGGAATTCAAAAAAATTGAAGCAAGTGTTTCCACCATTGCT
TCAATTTTTTACACCTCGACGATCTGAT 
Locus B  
4101XoverF TTGCGGCCGCAAAAAAGCGGCCAAAGGCCTGCCACCAGGCC
AAAGGCCGCTTTTTTCGTGCAACTGTCACATTAG 
4101XoverR CCGGAATTCAAAAAAATTGAAGCAAGTGTTTCCACCATTGCT
TCAATTTTTTATTCCGCGATTGTTGTC 
Locus C  
5A91XoverF TTGCGGCCGCAAAAAAGCGGCCAAAGGCCTGCCACCAGGCC
AAAGGCCGCTTTTTTTTGAAGCAGGAGATGAGG 
5A91XoverR GCGGGATCCAAAAAAATTGAAGCAAGTGTTTCCACCATTGCT
TCAATTTTTTTCTGTGCTCCAACTAGTTC 
To confirm 
sequence/ 
plasmid insertion 
 
AB142 AAGAAAGCCTACCCTTGG 
AB143 CACGAACGAAAATCAAGC 
a
 Restriction enzyme sites for cloning are underlines 
b
 Terminator sequences are in bold 
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TABLE 26. Primers used for markerless non-polar deletions on the WxL Loci in TX82. 
Oligonucleotide 5-3’ Sequence 
Locus A Deletion in TX82  
LocusA6geneDelUpF1 TTGCGGCCGCCGTATTGACAGCGGATGCAACAG 
LocusA6geneDelUpR2 ACTCTATTGCATGTCCCAATCATGTTCTTTTTCAT 
LocusA6geneDelDownF3 ATTGGGACATGCAATAGAGTAGATAAAAGACTGTGA 
LocusA6geneDelDownR4 GCGGGATCCACCGCATCAGGTAGAACAAG 
LAUDInternalF GCTGGAACACAAACAGTAGAAG 
LAUDInternalR CTTAGTAATCATGGACATCCCTAG 
LAOutsideUpF GAAGAGATAAGAGAAGCAGGC 
LAOutsideDownR CTAACACAGCTACTACCAGCATC 
Locus B Deletion in TX82  
LocusBDelUpF1 TTGCGGCCGCCGTATTGACAGCGGATGCAACAG 
LocusBDelUpR2 TGATATGATTTCTCCACCATCCTCTCTGACGTTTT 
LocusBDelDownF3 ATGGTGGAGAAATCATATCAACGATTTCAGGGAGT 
LocusBDelDownR4 GCGGGATCCCAGGTATTGATGTCGCCGAACAAAT 
LBUFInternalF  GCTGGAACACAAACAGTAGAAG 
LBDFInternalR CTTAGTAATCATGGACATCCCTAG 
LAOutsideUpF GAAGAGATAAGAGAAGCAGGC 
LAOutsideDownR CTAACACAGCTACTACCAGCATC 
Locus C Deletion in TX82  
LocusCDelupF9 TTGCGGCCGCGATCGGATGATTTGTAACTCG 
LocusCDelupR10 CTCTTTTCCGATTTCTTTTTTCATCATTGACATTCC 
LocusCDelDownF11 GAAATCGGAAAAGAGAAAGTTGACGAGAGTATAA 
LocusCDelDownR12 GCGGGATCCCTTTAGTGACTAGAGTTTGCAC 
LocusCOutsideUpF AATCAGCGAATGTTTATTT 
LocusCOutsideDownR CTTTAGTGACTAGAGTTTGCAC 
Locus C Internal F GTACTAGATGCAAGCGTGTATTC 
Locus C Internal R CATTCATAGGGAAGTCCTCTTTTC 
 
For deletion of WxL loci, the deletion construct fragments (upstream and downstream 
fragments amplified together by cross-over PCR) amplified using the primers found in Table 
26 and cloned into pHOU1. The correct insert was confirmed by sequencing and the plasmid 
electroporated into E. faecalis CK111. Blue colonies were recovered on BHI Gentamicin 
125µg/mL, X-Gal 200µg/mL plates. These recombinant plasmids were then introduced into 
TX82 through filter mating with CK111 as the donor. Single cross-over integrants were then 
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selected on BHI Gentamicin 125µg/mL, Vancomycin 50µg/mL or BHI Gentamicin 125µg/mL, 
Erythromycin 200µg/mL plates, replica plated on BHI Gentamicin 125µg/mL, Ampicillin 
125µg/mL plates, and confirmed using the primers in Table 26. Positive colonies were then 
streaked onto MM9YEG 10mM p-Chl-Phe plates and incubated at 37C. Colonies that grew on 
p-Chl-phe were then replica plated on BHI Gent125µg/mL to confirm excision of the plasmid. 
Colonies susceptible to gentamicin were then screened by PCR for the deletion (Table 26), 
sequenced, and PFGE performed to confirm the correct parental background.  
[4.2.13] Whole-cell ligand binding assay, biofilm assay, and bile-salt assay. Whole-cell 
binding of TX82 and WxL locus mutants were tested by an ELISA-like binding assay as 
described previously (Pinkston et al., 2011). Immunoblon H4BX 96-well plates were coated 
with 1µg of ECM protein in 100µl of PBS overnight at 4C. Wells were blocked with 2% BSA 
0.1% Tween20 in PBS. E. faecium cells were cultured in BHI overnight at 37°C, then the 
overnight bacterial cultures were diluted in BHI to an OD600 of 0.05 and grown to mid-log 
phase (~ 4 hours) at 37°C. The cells were pelleted, washed twice with PBS, and resuspended in 
1%BSA 0.05% Tween20 to an OD600=1. 100µl of cells were added to each well and incubated 
for 2hrs at RT. Non-bound cells were removed by washing with PBS, and the remaining cells 
were fixed using 100µl/well of Bouin’s fixative for 30 minutes. The wells were washed and 
bound cells stained with 1% crystal violet 100µl/well for 30 minutes. Extraneous dye was then 
washed away with water, and then solubilized using 100µl of ethanol/acetone (80:20) for 20 
minutes. The absorbance was read at 570nm. To compare the mean values of the adherence 
results, an unpaired t-test was used. 
 Biofilm formation by TX82 and WxL locus mutants was assayed as described 
previously (Mohamed et al., 2004). Briefly, cells were grown overnight in 10 mL of TSBG (all 
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normalized to an OD600=1 with the addition of fresh TSBG). The cells were then diluted 1:100 
in TSBG and 200µl of each dilution added to 96-well plates. After incubation for 24hrs at 37C, 
unbound cells were removed by washing with PBS, followed by adding 200µl/well of Bouin’s 
fixative for 30 minutes. The wells were washed and biofilm cells stained with 1% crystal violet 
200µl/well for 30 minutes. The extraneous dye was then washed away with water, and then 
solubilized using 200µl of ethanol/acetone (80:20) for 20 minutes. The absorbance was read at 
570nm.  
 Resistance to bile salts was determined using the protocol described previously (Teng et 
al., 2005). Briefly, cells were grown for 24hrs at 37C in BHI. The cells were then pelleted, 
washed with PBS, and resuspended in the same volume of fresh BHI. 20µl of the overnight 
suspension was then added to 1ml of BHI containing 0.3% bile salts. After 30 minutes of 
incubation at 37C, E. faecium cells were serially diluted and plated on BHI agar for colony 
forming units (CFU) counts.  CFUs were counted after 24hrs and the percent survival was 
calculated by comparing CFUs after 30 minutes to CFUs at time zero using the equation 
previously described (Teng et al., 2005). Percent survival= {[(CFU of mutant)t=30)/(CFU of 
mutant)t=0]}/ {[(CFU of TX82)t=30)/(CFU of TX82)t=0]} multiplied by 100. Wild-type and 
mutant cells were then compared in their survival percentage of wild-type after bile salt 
exposure. To compare the mean survival values of the mutant versus TX82, an unpaired t-test 
was used. 
[4.2.14] Detection of antibodies to WxL proteins in patient sera and immunization/ 
protection studies. Detection of antibodies in patient sera was performed at described 
previously (Nallapareddy et al., 2008b). Briefly, recombinant SwpA, LwpA, SwpC, and LwpC 
were run on 12% SDS-PAGE gels and transferred to PVDF membranes. The membranes were 
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blocked with 2% milk and 0.1% Tween20 and then incubated with either endocarditis patient 
serum or healthy volunteer serum (1:2000) at RT for 2hrs. After washing with PBST, 
antibodies were detected with goat anti-human IgG (1:5000) conjugated to HRP at RT for 1hr.  
The western was developed using Supersignal West Pico chemiluminescent substrate (Thermo 
Scientific). 
 Active immunization and challenge with bacterial endocarditis was performed as 
previously described (Singh et al., 2012). Briefly, Sprague Dawley rats were immunized 
intradermally with either 1) a mix of recombinant LwpA and LwpC in FCA or FICA 2) sham 
immunization (FCA and FICA) or 3) not immunized, creating three groups. Group 1 received 
an initial dose of 100µg of recombinant LwpA and 100µg of recombinant LwpC in Fruend’s 
complete adjuvant (FCA), followed by two boosters at two week intervals of the same dose of 
LwpA and LwpC in Fruend’s incomplete adjuvant (FICA). Sham immunizations were 
performed without recombinant protein in the same manner. Rats were then challenged by 
creating sterile vegetations in the heart valves of the three groups of rats. Rats were induced 
with experimental endocarditis and catheterized as described previously (Singh et al., 2012), 
then 24hrs post catheterization, inoculated via i.v. tail vein injection with 10
9
 cells of TX82. 
The animals were then sacrificed 48hrs post infection and the vegetations harvested and 
processed as described previously (Singh et al., 2012). CFUs in the vegetations were then 
determined between the three groups. Differences in the bacterial log10 CFU (geometric mean) 
of the heart vegetations from the three groups were analyzed by unpaired t-test. The Fisher’s 
exact test was then used to compare the total number of infected vs. non-infected in the three 
groups. Graph Pad Prism 4.0 was used to determine the statistical values.  
128 
 
[4.3] CHAPTER 3 RESULTS 
As discussed in the previous chapters, hospital outbreaks and the global dissemination 
of multi-resistant E. faecium have been attributed to a hospital-associated clade (Galloway-
Pena et al., 2012). HA-clade isolates contain higher rates of putative virulence determinants 
encoding surface-associated proteins (Galloway-Pena et al., 2009; Sillanpaa et al., 2009a). 
Among these are genes encoding MSCRAMM (microbial surface components recognizing 
adhesive matrix molecules)-like proteins harboring domains which include a secretion signal 
sequence, ligand-binding domains with Ig-like folds, and a C-terminal cell-wall anchoring 
domain with an LPxTG-like motif (Hendrickx et al., 2009b). Surface protein-mediated 
attachment to host tissues and subsequent colonization is a requirement for pathogenesis 
(Hendrickx et al., 2009b). Therefore, proteins of this nature, or proteins within the same 
operon, could contribute to a selective advantage in the nosocomial environment by increasing 
the colonizing ability of strains (Galloway-Pena et al., 2009; Hendrickx et al., 2009b; 
Nallapareddy et al., 2008b; Nallapareddy et al., 2003; Sillanpaa et al., 2008; Sillanpaa et al., 
2009a). 
Proteins containing the newly described WxL-domain in their C-termini were recently 
identified in 17 low G+C content gram positive species, including the close relative of E. 
faecium, E. faecalis (Bourgogne et al., 2008; Brinster et al., 2007a; Siezen et al., 2006). A 
recent study demonstrated that the C-terminal region of two WxL proteins in E. faecalis 
conferred surface localization and that the WxL domains are necessary for interactions with the 
cell wall. This study also showed that these WxL domains could bind the cell-wall fraction of 
six other species of gram-positive bacteria and the purified peptidoglycan of Bacillus subtilis. 
Furthermore, when the WxL domain was deleted, the interaction with other bacterial species 
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and purified peptidoglycan was abolished. Therefore, the WxL domain has been proposed as a 
novel cell-wall binding domain (Brinster et al., 2007a).  
Previous studies have found that some WxL proteins exist in clusters in which most 
proteins encoded within the cluster contain a signal peptide for secretion by the Sec-dependent 
pathway and most clusters also contain genes encoding the following, i) a small protein with a 
cell-wall binding LPxTG motif, ii) a small WxL protein with Trp-x-Leu, Asp-x-Arg-Gly, and 
proline rich domains, iii) a large WxL protein with possible concanavalin A-like lectin domains 
and iv) a DUF916 family membrane protein with a C-terminal transmembrane helix (Brinster 
et al., 2007a; Siezen et al., 2006). Due to the fact that these WxL genes have been proposed to 
encode novel cell-wall binding domains and exist in tandem with LPxTG proteins, it seems 
likely there is some form of assembly of these proteins on the cell surface. Although previous 
studies have elucidated that these genes are co-transcribed (Brinster et al., 2007a; Siezen et al., 
2006), no studies have examined the possible interactions between the proteins encoded by the 
genes within the putative operon.  
 Interestingly, while we were looking for putative MSCRAMMS in the E. faecium strain 
TX16 as discussed in Chapter 2, we noticed some genes encoding atypical MSCRAMMs, one 
of these had been named fms6 and was found in a locus with putative WxL proteins (Locus A). 
The gene fms6 encodes a protein that contains typical MSCRAMM motifs and domains such as 
a signal sequence, an LPxTG-like motif (FPETN), a membrane spanning region, and C-
terminal positive residues. However, the predicted Fms6 protein is only 116 amino acids, which 
is much smaller than other studied MSCRAMMs that are usually greater than 650 amino acids. 
Due to the fact that the WxL domain was suggested to be a novel cell-wall binding domain and 
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that two of these were found in a locus with an atypical MSCRAMM, we decided to look for 
more of these proteins within the E. faecium genomes.  
[4.3.1] Six genes encoding WxL proteins in three different loci are found in E. faecium 
genomes. Our group recently sequenced three E. faecium genomes, two clinical endocarditis 
isolates TX16 (DO) and TX82, and a community fecal isolate, TX1330. Upon sequencing these 
three genomes, six genes encoding proteins with the WxL domain were found in each genome 
(Figure 15). In silico analysis showed that there are three clusters in each genome resembling 
the pattern found in E. faecalis and L. plantarum (Brinster et al., 2007a; Siezen et al., 2006) 
flanked by predicted rho-independent terminators (Figure 16). All three loci (named WxL 
Locus A, B, and C) contain genes that encode i) a small WxL protein (SwpA-C) with Trp-x-
Leu, Asp-x-Arg-Gly, and proline rich domains, ii) a large WxL protein (LwpA-C) with 
possible concanavalin A-like lectin domains and, iii) a DUF916 family protein (DufA-C) with 
2 transmembrane helices. Locus A (named arbitrarily) contains an LPxTG-like protein (fms6), 
but the other two loci do not contain a definitive LPxTG-like protein. Locus A and Locus C 
both have Mga-like transcriptional regulators associated with the loci, whereas Locus B has a 
LytR-family transcriptional regulator directly upstream of the predicted operon.  
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FIGURE 15. The WxL domain of 6 WxL proteins in E. faecium. An alignment of the C-
terminus of the 6 WxL proteins found in E. faecium. Highly conserved residues are in black, 
moderately conserved residues are in grey, and the red boxes highlight the 2 “WxL” motifs.  
Lines 1) SwpC 2) SwpB 3) SwpA 4) LwpB 5) LwpA 6)LwpC.  
 
Line 1 
Line 2 
Line 3 
Line 4 
Line 5 
Line 6 
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FIGURE 16. The organization of the three putative operons containing WxL genes in 
Enterococcus faecium. A pictorial representation of the 3 WxL putative operons found in E. 
faecium based on in silico analysis. Each arrow represents a predicted ORF named for the 
protein it encodes. Predicted terminators and promoters are also labeled.  
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RT-PCR of the individual WxL genes and the intergenic regions was performed on 
TX1330 and TX82 to confirm these genes are expressed and co-transcribed and therefore most 
likely in an operon. These results can be found in Figure 17 and 18. 
A.                                         B.                                                C. 
 
 
 D.    E.    F. 
 
 
FIGURE 17. RT-PCR of intergenic regions of Locus A and C in TX1330 (CA-clade 
strain). Panels A through C show the RT-PCR analysis of the WxL Locus A of TX1330. 
Lanes: 1, 1KB Plus DNA Ladder; 2, OG (outside gene) to swp; 3, swpA to dufA; 4, dufA to 
lwpA; 5, lwpA to trmA; 6, trmA to pnoA; 7, pnoA to OG2. Panel A represents the reactions 
containing the reverse transcriptase and RNA, Panel B represents the reactions containing Taq 
polymerase and RNA, and Panel C represents the reactions containing Taq polymerase and 
genomic DNA. Panels D through F show the RT-PCR analysis of the WxL Locus C of 
TX1330. Lanes: 1, 1KB Plus DNA Ladder; 2, OG to swpC 3; 3, swpC to lwpC; 4, lwpC to 
dufC; 5, dufC to lwpC; 6, lwpC to OG2. Panel D represents the reactions containing the reverse 
transcriptase and RNA, Panel E represents the reactions containing Taq polymerase and RNA, 
and Panel F represents the reactions containing Taq polymerase and genomic DNA. 
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A.            B.     C. 
 
 
D.    E.    F. 
 
 
G.    H.    I. 
 
 
FIGURE 18. RT-PCR of intergenic regions of Locus A, B, and C in TX82 (HA-clade 
strain). Panels A through C show the RT-PCR analysis of the WxL Locus A of TX82. Lanes: 
1, 1KB Plus DNA Ladder; 2, OG to swpA; 3, swpA to dufA; 4, dufA to lwpA; 5, lwpA to trmA; 
6, trmA to pnoA; 7, pnoA to OG2. Panel A represents the reactions containing reverse 
transcriptase and RNA, Panel B represents the reactions containing Taq polymerase and RNA, 
and Panel C represents the reactions containing Taq polymerase and genomic DNA.  Panels D 
through F show the RT-PCR analysis of the WxL Locus B of TX82. Lanes: 1, 1KB Plus DNA 
Ladder; 2, OG1 to lwpB; 3, lwpB to dufB; 4, dufB to swpB; 5, swpB to OG2. Panel D represents 
the reactions containing the reverse transcriptase and RNA, Panel E represents the reactions 
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containing Taq polymerase and RNA, and Panel F represents the reactions containing Taq 
polymerase and genomic DNA. Panels G through I show the RT-PCR analysis of the WxL 
Locus C of TX82. Lanes: 1, 1KB Plus DNA Ladder; 2, OG1 to swpC; 3, swpC to lwpC; 4, 
lwpC to dufC; 5, dufC to trmC; 6, trmC to OG2. Panel G represents the reactions containing the 
reverse transcriptase and RNA, Panel H represents the reactions containing Taq polymerase 
and RNA, and Panel I represents the reactions containing Taq polymerase and genomic DNA.   
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[4.3.2] The phylogenetics and prevalence of WxL genes throughout E. faecium genomes. 
Further analysis of the distribution and homology of the genes in the WxL loci of the other 
sequenced E. faecium genomes (Chapter 2) found that all the genes within the three loci have 
homologs. Most of the homology ranges from ~86-100% nucleotide sequence identity, and 86-
100% amino acid identity. The absence of homologs in some strains may be explained by the 
fact that they are incomplete genomes. Because we had found that swpC (named wlcA in 
previous paper) showed cladal separation (Chapter 1 and (Galloway-Pena et al., 2011)), we 
tested the other genes encoding WxL proteins for their phylogeny (Figure 19).  
Interestingly, the predicted genes found upstream and downstream of the predicted 
operons varied from strain to strain, but had some consistency within strains of the same clade. 
These results can be found in Figure 20. In all strains analyzed, upstream of Locus A is a 
putative FMN-dependent alpha hydroxyl acid dehydrogenase and downstream is a putative 
ABC transporter. Upstream of Locus B, all the HA clade strains and the CA clade strains 
TX1330 and Com12, have a putative diaglycerol kinase directly, whereas in 1,231,408 and 
Com15, there is a transposon between the WxL Locus B and the diglycerol kinase gene. 
1,141,733 is different in that it has three hypothetical proteins between the putative diaglycerol 
kinase and the WxL Locus B and lacks the transposon. Downstream of WxL Locus B, all the 
HA clade strains, and two of the CA clade strains (TX1330 and Com12), have a putative 
histidine kinase, a conserved hypothetical protein, and a sortase (corresponding to SrtA2 in 
TX82), whereas in the CA clade isolates 1,141,733 and Com15, and the hybrid isolate 
1,231,408, have a putative ABC-Transporter ATP-binding protein. For WxL Locus C, HA and 
CA clade isolates differ as to what is upstream, both have a major intrinsic protein downstream, 
as well as other genes downstream that are the same, HA clade isolates have a putative 
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metallophosphoesterase upstream (and other genes that are different) whereas the CA clade 
isolates have a tagatose-1,6-diphosphate aldolase and other genes that are different from the 
clinical clade upstream of WxL Locus C. 
In addition to looking at sequenced genomes, colony hybridizations were performed 
under high stringency conditions with probes for each individual WxL gene using 54 clinical, 
10 fecal, and 20 endocarditis isolates from our collection. All of the WxL genes were found to 
be present in all of the strains except for the absence of lwpB, swpB, and lwpC from several 
strains, which could possibly be explained by specificity of the probe (Figure 21). 
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FIGURE 19. UPGMA phylogenetic trees and identities of WxL loci genes throughout the 
E. faecium genomes. The results are based on a pair-wise analysis of each gene’s nucleotide 
sequence for each of the 21 E. faecium strains using the Poisson correction method in 
MEGA4.0.2 software. An UPGMA tree was constructed depicting the evolutionary distance 
between these sequences. The tree is drawn to scale with the branch lengths representing the 
evolutionary distances, the scale can be seen at the bottom of the tree. The largest nucleotide 
and amino acid differences between any two alleles are noted. ND denotes nucleotide 
difference. AA denotes amino acid.  
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FIGURE 20. Variations upstream and downstream of the WxL loci. The genes upstream 
and downstream of the WxL loci of all Broad Institute strains and the strains sequenced by our 
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laboratory were analyzed. The genes upstream and downstream of WxL Locus A encoded the 
same predicted proteins in all of the strains. Panel A depicts the variants of the WxL Locus B 
surrounding region. The asterisk next to strain 1,141,733 denotes that it lacks the transposase 
and has 3 hypothetical proteins between the WxL Locus B and the putative diaglycerol kinase. 
Otherwise it has the same genes upstream and downstream as 1,231,408 and Com 15. Panel B 
depicts the variants of the WxL Locus C surrounding region. Strain 1,231,502 did not have a 
complete sequence in this region, and therefore could not be analyzed.  
 
FIGURE 21. Colony hybridizations for the genes encoding WxL proteins show that these 
genes are ubiquitous in E. faecium strains and do not depend on origin. Colony 
hybridizations were performed with probes for each individual WxL gene using 54 clinical, 10 
fecal, and 20 endocarditis isolates from our collection. The graph shows the percentage of 
isolates in each group that were positive for each gene.  
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[4.3.3] The predicted structure of the WxL proteins. The protein sequences used to make 
recombinant proteins of TX82 were analyzed through different protein servers; the expected 
molecular weights, theoretical PIs, and summary of number of aromatic residues can be found 
in Table 27. The recombinant proteins made from TX82 Locus A and Locus C were further 
analyzed for secondary structure. Using Phyre2, neither SwpA, LwpA, or SwpC could be 
modeled to a template with any reasonable confidence. It was found that all three were highly 
disordered (using DisEMBL) (data not shown), which could explain the lack of a template 
structure. Both DufA and DufC modeled to the same template as a protein-glutamine 
glutamyltransferase, specifically the three-dimensional model of the human transglutamase 32 
enzyme with the highest confidence level (98.8%) using 52% and 59% of the protein sequence 
for DufC and DufA, respectively. LwpA modeled to a Concavalin A-like lectin with 100% 
confidence for 30% of the protein. This is similar to what was found in L. plantarum which 
described concavalin-A like lectin domains in the large WxL proteins (Siezen et al., 2006). 
The WxL Locus A recombinant proteins purified using the sequences from TX82 were 
further analyzed for structure experimentally. The UV absorbance spectra from 250nm to 
320nm were taken for SwpA, DufA, and LwpA (Figure 22). LwpA had the UV spectra of a 
pure protein (a peak at 280nm), whereas DufA and SwpA had high absorbance readings 
between 250nm and 260nm (although they had another peak at 280nm). High absorbance at the 
260nm wavelength is normally indicative of a protein binding to DNA or contamination with 
DNA; however, these proteins were treated with DNase. Another characteristic that may cause 
the abnormal UV spectra could be the very high percentage of phenylalanine in these proteins 
or the binding of ions. 
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TABLE 27. Summary of Locus A recombinant protein characteristics. 
Protein  MW  pI  Tryptophan  Tyrosine  Phenylalanine  
DufA  39178  5.18  1  6  13  
LwpA  74560  6.13  9  29  23  
SwpA  21593  4.69  3  3  6  
 
 
 
 
FIGURE 22. The UV absorbance spectra of purified TX82 WxL Locus A recombinant 
proteins. The UV absorption readings for each recombinant protein was taken at 5nm intervals 
from 250nm to 350nm on a spectrophotometer.  
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Circular dichromism was also performed for SwpA, DufA, and LwpA; the spectra and 
secondary structure content can be found in Figure 23 and Table 28, respectively. All three 
proteins contain 53-55% β-structures (sheets and turns) and 34-38% unordered structure, but 
very little α-helical structure (5-12%).  Considering that β-sheets are aggregation drivers and 
proteins that bind ECM typically have disordered protein structure (personal communication 
with Xiaowen Liang), we can speculate a pathogenesis-related function for these proteins. 
Interestingly, through CD and steady-state intrinsic tryptophan fluorescence, one can see the 
difference in conformation/folding between the monomer and the dimer form of SwpA (Figure 
23 and Figure 24). This probably explains the functional difference between the two moieties 
discussed later (the monomer being inactive whereas the dimer is active). Fluorescence also 
detected different folding of SwpA, DufA, and LwpA under different salt conditions (with 
speculation that these proteins might be involved in salt stress discussed later) (Figure 24). 
 
TABLE 28. Secondary-structure content of WxL proteins determined by CD.   
Protein  α-helix (%)  β-structure (%) 
(sheet & turn)  
Unordered (%)  Total  
LwpA 5.4  55.3  38.4  99.4  
DufA 12.3  53.1  34.6  99.9  
SwpA(monomer) 6.6  53.1  37.7  97.4  
SwpA(dimer) 8.5  54.1  37.5  100  
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FIGURE 23. Circular dichromism spectra of purified TX82 WxL Locus A recombinant 
proteins. CD measurements in the far UV region (190-260 nm) were performed at ambient 
temperature on a Jasco J-720 spectropolarimeter with a 0.5 mm cell.  Ten scans were collected 
and averaged at a scan speed of 100 nm/min, with a time constant of 2 s and a band-width of 1 
nm.   
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 FIGURE 24. Steady-state intrinsic tryptophan fluorescence spectra show differences 
between the monomer and dimer forms of SwpA as well as differences under different 
salt concentrations for SwpA (dimer), DufA, and LwpA. Panel A depicts the different 
folding/conformational changes as can be measured by emission intensity in steady-state 
intrinsic tryptophan fluorescence between the monomer and dimer form of SwpA at the same 
condition. Panel B depicts the different folding/conformational changes measured by emission 
intensity in steady-state intrinsic tryptophan fluorescence of each individual protein under 
different salt concentrations (PBS and ½ PBS) at 295nm.  
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[4.3.4] The WxL proteins are expressed on the surface of bacterial cells, although they are 
differentially exposed depending on the clade of the strain. Mutanolysin was used to treat 
cells to obtain cell wall extracts. The cell wall extracts of TX82 cells were then run on SDS-
PAGE gels and probed with specific antibodies to the WxL proteins. SwpA, LwpA, SwpC, and 
LwpC were all found in the cell wall fraction (Figure 25).  
To confirm this, immunogold electron microscopy was performed on TX82 cells. SwpC 
and LwpC were expressed on the surface of TX82 cells as can be seen in the electron 
micrographs pictured in Figure 26. Cells labeled using the pre-immune sera gave no signal. Six 
HA and six CA isolates were then tested by whole-cell ELISA to determine if all isolates 
expressed WxL proteins at a similar level. Although all strains expressed the WxL proteins 
from Locus A and C on the surface of the cell, HA strains gave higher optical densities 
(approximately two fold higher) than CA strains for SwpA, LwpA, and LwpC (Figure 27). 
These differences were statistically significant. Although the results for SwpC were not 
statistically significant, the trend was similar to the other WxL proteins.  
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FIGURE 25. Western blots for WxL proteins of Locus A and C of mutanolysin cell wall 
extracts from TX82 cells. Western blots were performed and probed for SwpA, LwpA, SwpC, 
and LwpC in mutanolysin cell wall extracts of TX82 cells. Panel A depicts the western blot 
analysis for Locus A. Lanes: 1, anti-LwpA antibody; 2, anti-SwpA antibody; 3, pre-immune 
sera control. Panel B depicts the western blot analysis for Locus C. Lanes: 1, anti-LwpC 
antibody; 2, preimmune sera control; 3, anti-SwpC antibody.  
 
    1              2              3           1            2          3 
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FIGURE 26. Immunogold electron microscopy shows the WxL Locus C proteins on the 
surface of TX82 cells. Immunogold electron microscopy was performed on TX82 cells using 
specific antibodies against SwpC and LwpC followed by 18nm gold conjugated anti-rat 
antibody. Panel A is the pre-immune sera control at a 1:50 dilution. Panel B used anti-SwpC 
antibody at a 1:50 dilution. Panel C used anti-LwpC at a 1:50 dilution.  
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FIGURE 27. The differences in surface display/expression of WxL proteins between 
community clade isolates and hospital clade isolates. Whole-cell ELISA of native cells using 
6 CA and 6 HA E. faecium strains was performed and surface display of WxL proteins detected 
using specific antibodies to SwpA, LwpA, SwpC, or LwpC. Standard deviation was negligible 
so error bars cannot be seen. Unpaired t-test was used to determine the statistical significance 
between the community and clinical groups for each WxL protein.  
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[4.3.5] Recombinant proteins from the WxL Locus A bind a variety of extracellular 
matrix proteins. ELISA-type ligand binding assays were performed to determine if the 
recombinant proteins from the WxL Locus A could bind immobilized extracellular matrix 
proteins (Figure 28). All three recombinant proteins SwpA, DufA, and LwpA bound a number 
of ECMs. SwpA bound fibronectin and fibrinogen with the highest OD readings. DufA bound 
collagen I, collagen IV, and laminin with the highest OD readings. LwpA bound collagen V, 
fibronectin, and fibrinogen with the highest OD readings.  
 
FIGURE 28. Binding of extracelluar matrix proteins by recombinant proteins from WxL 
Locus A. The binding of recombinant proteins from WxL Locus A (20µM) to different ECM 
proteins (1µg) immobilized to an ELISA plate detected with AP-conjugated anti-His 
antibodies. The background values of BSA bound to each ECM protein were subtracted.  
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Surface plasma resonance (SPR) was then performed using Biacore to screen for 
binding response in different ECMs, as well as to see which forms of SwpA were active 
(Figure 29 and Table 29). SwpA showed binding responses for collagen I, collagen IV, laminin, 
fibrinogen, and fibronectin. The dimer form of SwpA was the most active, showing a greater 
binding response in all instances than the multimer form, whereas the monomer form showed 
no binding to any of the ECMs. DufA also showed a binding response to collagen I, collagen 
IV, laminin, fibrinogen, and fibronectin. LwpA only showed binding responses for collagen IV 
and fibrinogen.  
Concentration-dependent Biacore analysis was then used for the two ECMs, collagen I 
and fibronectin (also to the C-terminal Hep2-40K chain of fibronectin), to determine the 
apparent equilibrium disassociation constants (KD). The binding affinities (equilibrium 
disassociation constants) to collagen I and fibronectin for the three recombinant proteins from 
Locus A are summarized in Table 29 and the response curves can be seen in Figures 30, 31, 
and 32. Soluble SwpA (dimer) bound both immobilized collagen I and fibronectin, as it did in 
the ligand binding assays. However, SwpA bound collagen I with a higher affinity than 
fibronectin (both when soluble and immobilized), whereas in the binding assays, fibronectin 
gave the highest OD reading. In addition, soluble SwpA bound full-length fibronectin with a 
greater affinity than the Hep2-40K chain, but did not bind the N-terminal NTD-70K chain. This 
differed from the result when SwpA is immobilized, where the binding affinity was greater for 
the Hep2-40K than full-length fibronectin. 
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FIGURE 29. An initial screen using Surface Plasmon Resonance shows binding responses for Locus A recombinant proteins to 
different immobilized ECMs. Biacore was used to test for any binding response (not concentration dependent) for the Locus A 
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recombinant proteins to immobilized type I collagen, type IV collagen, laminin, fibrinogen, and fibronectin. For all assays, the 
concentration of DufA was 55µg/ml, SwpA monomer was 164µg/ml, SwpA dimer was 35µg/ml, SwpA multimer was 64µg/ml, and 
LwpA was 75µg/ml as determined by BCA assay. For fibronectin, only SwpA (dimer), DufA, and LwpA were used.  
 
TABLE 29. Surface Plasmon Resonance analysis shows recombinant proteins from Locus A bind host ECM proteins.  
Soluble  DufA  SwpA  LwpA  Fibronectin  Hep2-
40K
c
  
Collagen 
I 
Immobilized       
Fibronectin  5  200  No     
Hep2-40K  75  600  No     
Collagen I 630  76  No     
Collagen IV Yes Yes Yes     
Laminin  Yes  Yes  No     
Fibrinogen Yes Yes  Yes     
DufA  26  No   1400  320  5  
SwpA  20  No   1900  240  5  
LwpA  13  No   360  Yes  No  
a
The numbers are apparent KD values in nM concentrations.   
b
Yes/No answers denote whether or not there was a binding response, but the KD values have yet to be determined.  
c
Hep2-40K is a specific portion of the C-terminal region of fibronectin.  
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FIGURE 30. Surface Plasmon Resonance shows interactions between type I collagen, DufA, and SwpA. Biacore sensorgrams 
were generated (shown in black) with the lower curve corresponding to lowest concentration of soluble protein injected. Kinetic 
analysis (the fitted curves are shown in colored lines) was performed to obtain the rate constants, specifically the KD
app
 values. 
Concentrations for soluble human type I collagen binding to immobilized DufA and SwpA ranged from 1-64nM. Concentrations for 
soluble DufA binding to immobilized human type I collagen ranged from 0.05-1.6µM. Concentrations for soluble SwpA binding to 
immobilized human type I collagen ranged from 25-800nM. 
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FIGURE 31. Surface Plasmon Resonance shows interactions between fibronectin, DufA, SwpA, and LwpA. Biacore 
sensorgrams were generated (shown in black) with the lower curve corresponding to lowest concentration of soluble protein injected. 
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Kinetic analysis (the fitted curves are shown in colored lines) was performed to obtain the rate constants, specifically the KD
app
 values. 
Concentrations for soluble fibronectin binding to immobilized DufA, SwpA, and LwpA ranged from 0.01-1.28 µM. Concentrations 
for soluble DufA binding to immobilized fibrinogen ranged from 5-80nM. Concentrations for soluble SwpA binding to immobilized 
fibrinogen ranged from 0.025-0.4 µM. 
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FIGURE 32. Surface Plasmon Resonance shows specific interactions between of DufA and SwpA with the Hep2-40K chain of 
fibronectin. Biacore sensorgrams were generated (shown in black) with the lower curve corresponding to lowest concentration of 
soluble protein injected. Kinetic analysis (the fitted curves are shown in colored lines) was performed to obtain the rate constants, 
specifically the KD
app
 values. Concentrations for soluble Hep2-40K chain of fibronectin binding to immobilized DufA and SwpA 
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ranged from 1-256nM. Concentrations for soluble DufA binding to immobilized fibrinogen ranged from 5-160nM. Concentrations for 
soluble SwpA binding to immobilized fibrinogen ranged from 0.025-0.4 µM.
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Soluble DufA also bound both immobilized collagen I and fibronectin (Figures 29-32). 
Interestingly, DufA bound fibronectin with a higher affinity than collagen using Biacore, but 
bound collagen with high OD and didn’t bind fibronectin at all in the ELISA ligand-binding 
assays. On the other hand, when DufA was immobilized, it bound collagen I at a greater 
affinity than fibronectin. Similar to SwpA, soluble DufA bound the full-length fibronectin with 
a greater affinity than the Hep2-40K chain, and did not bind the N-terminal NTD-70K chain. 
Also similar to SwpA, immobilized DufA had a greater binding affinity for the Hep2-40K than 
full-length fibronectin.  
Interestingly, you can see that the binding affinities are a result of different kinetics 
depending on the ECM protein used or which protein was immobilized or soluble. Soluble type 
I collagen binding to both immobilized DufA and SwpA had similar kinetics and binding 
affinites. However, when collagen was immobilized, the binding affinity to SwpA was stronger 
due to the increase in the stability of the reaction (slow dissociation), despite the 
association/recognition being slower (Figure 30).  
Fibronectin binding to immobilized Locus A proteins resulted in similar binding 
affinities for DufA and SwpA where the association constant (Ka) was relatively high; however, 
the binding was very unstable as can be seen by the very quick dissociation. There was a 
slightly better affinity for the binding of fibrinogen to LwpA compared to DufA and SwpA, 
which seems to be a result of a slower dissociation, despite slower recognition/ association. The 
binding of recombinant DufA and SwpA resulted in a much better binding affinity as a result of 
slower dissociation than when fibronectin was soluble (Figure 31). Similar kinetics were 
observed when comparing the soluble Hep2-40K portion of fibronectin to immobilized Hep2-
40K portion of fibronectin, as was seen with the full-length fibronectin (Figure 32). 
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[4.3.6] DufA shows self-association and association with both SwpA and LwpA. Because it 
was hypothesized that the proteins from the same operon might make a cell surface complex, 
Biacore was used to detect binding between the recombinant proteins from Locus A. As seen in 
Table 30 and Figure 33, soluble DufA could bind immobilized SwpA, LwpA, and itself. 
However, if DufA was immobilized, it could only bind itself. SwpA and LwpA could only bind 
DufA if DufA was immobilized, but not when DufA was soluble, and they could not bind each 
other. Also, DufA binding response seemed to be affected by salt concentration, as it only 
produced a binding response in ½ PBS buffer.  
 When comparing the kinetics of the interactions (although the binding affinities seem to 
be relatively similar for all three protein-protein interactions when DufA is soluble), it seems 
that the interaction with LwpA is the most stable as it dissociated the slowest, whereas SwpA 
dissociates the quickest. SwpA, however, does seem to have the quickest association/ 
recognition to DufA. 
 
TABLE 30. Surface Plasmon Resonance analysis shows recombinant proteins from Locus 
A bind each other. 
Soluble DufA SwpA LwpA 
Immobilized    
DufA 26  No  No  
SwpA 20  No  Yes 
LwpA 13  No  Yes 
a
The numbers are apparent KD values in nM concentrations.   
b
Yes/No answers denote whether or not there was a binding response, but the KD values have 
yet to be determined.  
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FIGURE 33. Surface Plasmon Resonance shows specific interactions between DufA with 
itself, SwpA and LwpA that is dependent on salt concentration. Panel A. Biacore 
sensorgrams were generated (shown in black) with the lower curve corresponding to lowest 
concentration of soluble protein injected. Kinetic analysis (the fitted curves are shown in 
colored lines) was performed to obtain the rate constants, specifically the KD
app
 values. 
Concentrations for soluble DufA binding to immobilized DufA, SwpA, and LwpA ranged from 
1-64nM. Panel B. SPR analysis using Biacore to determine if salt concentration affects the 
binding response of DufA to itself, SwpA, and LwpA.  
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[4.3.7] WxL Locus A and WxL Locus C mutants are attenuated in type I collagen 
binding, but not type V collagen binding or biofilm formation. Nonpolar, markerless 
deletions were made of each putative WxL operon in TX82. Since recombinant proteins from 
Locus A were shown to bind collagen I, the WxL Locus A and WxL Locus C mutants were 
tested for their ability to bind type I collagen. As seen in Figure 34, the WxL Locus A and WxL 
Locus C mutants were attenuated in binding to type I collagen, but not type V collagen 
compared to the parent strain TX82. These attenuations were statistically significant and not 
due to a growth defect (data not shown). 
 
FIGURE 34. The WxL Locus A and WxL Locus C deletion mutants are attenuated in 
binding to type I collagen.  Whole-cell ELISA analyzing the binding of WxL Locus mutants 
versus the parent strain (TX82) to collagens I and V (1µg). Cells were detected using crystal 
violet. TX82 empABC deletion is a mutant of a pilus operon which has known attenuation in 
ECM binding (unpublished data). Asterisks indicate a statistically significant difference. Type 
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V collagen was used as a negative control, as recombinant WxL proteins were not shown to 
bind this ECM.  
 
We next tested the mutants for biofilm formation. However, neither the Locus A or 
Locus C mutant were attenuated in biofilm formation compared to the parental strain, as can be 
seen in Figure 35.  
 
FIGURE 35. The WxL Locus A and C mutants are not attenuated in biofilm formation. 
Biofilm formation of TX82 and WxL Locus mutants was assayed using biofilm cells fixed with  
Bouin’s fixative and stained with 1% crystal violet solubilized using ethanol/acetone (80:20) 
and absorbance was read at 570nm. The empABC deletion mutant was used as a control.  
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[4.3.8] WxL Loci could be involved in bile and salt stress response. After analyzing the 
transcriptomic analysis of lactobacilli, it was found that their WxL genes are regulated in 
response to bile, salt, and lactate stress (Siezen et al., 2006). Of interest, different salt 
concentrations changed the conformation of the recombinant proteins from WxL Locus A 
change and DufA’s interaction with immobilized SwpA and LwpA was also affected by salt 
concentration (Figure 24 and 33). Additionally, the Locus B mutant was tested in the bile salt 
assay and it was found that the Locus B mutant survives better in bile salt stress conditions than 
the parental strain (Figure 36).  
 
FIGURE 36. The WxL Locus B mutant survives better that the wild-type after bile salt 
exposure. E. faecium cells were exposed to BHI with 0.3% bile salt concentration for 30 
minutes. CFUs were determined at t=0 minutes and t=30 minutes for the WxL Locus B mutant 
and TX82 (WT) in three separate experiments. Panel A shows the percent survival after 30 
minutes of exposure to bile of the WxL Locus B mutant relative to the wild-type. Panel B 
shows the fraction of cells that survived after 30 minutes of bile salt exposure compared to t=0 
for both the WxL Locus B mutant and TX82. An unpaired t-test determined the difference in 
mean survival between the two to be statistically significant.  
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[4.3.9] WxL proteins are antigenic, and may have use in protection against E. faecium 
infections. One of the aims of this study was to determine if WxL proteins are antigenic during 
infection. A way to test this is to determine if patients with E. faecium infection have antibodies 
to WxL proteins. Serum was previously collected from five patients with endocarditis due to E. 
faecium. Using western blot analysis, we were able to determine that endocarditis patients had 
antibodies to all four WxL proteins analyzed (SwpA, LwpA, SwpC, and LwpC) as can be seen 
in Figure 37A. This differs from healthy volunteers who either lack antibodies to any of the 
WxL proteins (3/7), or have antibodies to only 1 of the 4 WxL proteins. Interestingly, this was 
always to one of the large WxL proteins, three to LwpA and one to LwpC (Figure 37B). 
We next actively immunized rats with an equal mix of LwpA and LwpC in order to 
determine if prophylactic immunization with the two large WxL proteins could be protective 
against E. faecium endocarditis infections. In order to confirm that one antigen did not produce 
significantly more antibodies than the other, serum was taken from the immunized rats to 
perform antibody titers (data not shown). All rats immunized had an antibody titer >1:12800 
for each antigen.  
In the first experiment when immunized rats were challenged with E. faecium 
endocarditis infection with TX82 (Figure 38), 7 of the 8 rats that were immunized were 
uninfected, compared to non-immunized rats (2), which had 10
5 
- 10
6
 CFU/gm of vegetation. 
However, 2 of the 3 sham rats (only immunized with FCA/FICA, no recombinant protein) had 
low levels of bacteria (between 10
1
 and 10
2
) with only one sham rat having CFU counts relative 
to the non-immunized. A second experiment was done to see if the sham effect was real or a 
technical error. Unfortunately, in this experiment the opposite of the desired effect occurred. 
Non-immunized rats again had average CFU/gm of vegetation around 10
6
. However, the 
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immunized rats had a higher average CFU/gm than those immunized with the adjuvant alone. 
When the two experiments were combined, although there was a statistically significant 
difference between the non-immunized and immunized groups, it appears that this is due to the 
adjuvant instead of the recombinant proteins themselves.  
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FIGURE 37. The WxL proteins of Locus A and Locus C are antigenic in patients. 
Recombinant proteins (Lanes: 1, LwpA; 2, SwpA; 3, SwpC; 4, LwpC) were run on 12% SDS-
PAGE gels and transferred to PVDF membranes. Each membrane was incubated with either 
endocarditis patient serum (Panel A) or healthy volunteer serum (1:2000) (Panel B). This was 
followed by goat anti-human IgG conjugated to HRP and developed using Supersignal West 
Pico chemiluminescent substrate (Thermo Scientific). The first gel of each panel is a 
commassie stained gel. The numbers underneath each gel represent the patient number 
arbitrarily assigned. 
171 
 
 
 
FIGURE 38. Protection against TX82 endocarditis after active immunization with LwpA and LwpC.  
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Rats were actively immunized with a mix of LwpA and LwpC, a sham control (FCA and FICA only), or not at all. After heart 
catheterization, animals were challenged with 10
9 
cells of TX82 via tail vein injection. After 48 hours, vegetations were collected and 
CFUs determined. Differences in the bacterial log10 CFU (geometric mean) of the heart vegetations from the three groups were 
analyzed by unpaired t-tests. The Fisher’s exact test was then used to compare the total number of infected vs. non-infected rats in the 
three groups.
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[4.4] CHAPTER 3 DISCUSSION 
Although proteins with the WxL domain have been found in 17 low-G+C content Gram 
positive species, with up to 27 proteins in E. faecalis, they have only been characterized in a 
few bacterial species (Brinster et al., 2007a; Brinster et al., 2007b; Schachtsiek et al., 2004; 
Siezen et al., 2006). Even so, these studies are limited, only describing the arrangement of the 
genes and the possible role of the WxL domain, with inadequate characterization of the full 
length proteins and little experimental data to support the proposed function of these genes 
(Brinster et al., 2007a; Brinster et al., 2007b; Schachtsiek et al., 2004; Siezen et al., 2006).  
Brinster and colleagues reported the first characterization of an E. faecalis WxL protein 
encoded by the EF2686 locus, which they named ElrA. Inactivation of the elrA gene 
significantly reduced virulence in the mouse peritonitis model as well as reduced dissemination 
in the liver, spleen, and peritoneal macrophages. Furthermore, it was shown that ElrA has a role 
in eliciting the IL-6 response (Brinster et al., 2007b). In addition, another group identified an 
ElrA homolog in Lactobacillus coryniformis, named Cpf, and found that it mediated 
coaggregation with other bacterial species (Schachtsiek et al., 2004). To our knowledge, these 
are the only functional studies of WxL proteins excluding genomic and transcriptional analysis.  
When looking at genome distribution, these clusters are also found in Listeria, 
Lactococcus, Pediococcus, and Bacillus species, but are interestingly missing from 
Streptococcus, Staphylococcus, and Clostridium species, suggesting these proteins may be 
needed for a specific niche (Siezen et al., 2006). Between the species that contain these 
clusters, the number of clusters varies widely from nine clusters in L. plantarum to one cluster 
in Bacillus species. Moreover, not all WxL proteins are contained in clusters (Siezen et al., 
2006).  
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In E. faecium, sequence analysis determined that the nucleotide and amino acid identity 
between the alleles of different strains ranged from 86-100%. Interestingly, this differs from E. 
faecalis strains analyzed (OG1RF and V583) where the identity ranged from 21-88% 
(Bourgogne et al., 2008).  The relative conservation of these genes in E. faecium may be 
correlated with the relative low number of these genes in this species compared to E. faecalis 
V583 which contains eight clusters and 27 WxL genes (Brinster et al., 2007a), and L. 
plantarum WCSFI with nine clusters and 22 WxL proteins (Siezen et al., 2006).  
The E. faecium WxL genes were found to be ubiquitous throughout the genomes 
(Figure 21) and strains studied by genomic analysis or colony hybridization, regardless of the 
origin of the strain. Therefore, these are different from some of the other surface proteins 
studied in the previous chapters, which are enriched in the hospital clade. Although these genes 
segregated into the two clade pattern found in Chapter 2 (Figure 19), there was a larger 
difference between the CA and HA clade strains in their WxL alleles compared to other genes 
analyzed in the genome (Galloway-Pena et al., 2012; Galloway-Pena et al., 2011). This is 
possibly due to the fact that they are surface proteins and seem to be antigenic, as discussed 
below. Moreover, even though the genes are ubiquitous among the strains studied, there was a 
difference in surface expression/exposure of the WxL proteins depending on the origin of the 
strain (Figure 27). These differences in surface exposure could be due to the variation in the 
sequences we see between the CA and HA clade, resulting in altered expression or processing 
at the cell surface. In addition, this greater surface exposure could be reflected in a greater 
capacity for virulence (i.e., better able to bind host ECM).   
The RT-PCR and in silico analysis indicate that WxL proteins exist in operons in E. 
faecium (Figure 17 and Figure 18). The presence of a small LPxTG protein within these 
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operons (although only Locus A in E. faecium) may indicate some novel assembly process at 
the cell surface. Indeed, the WxL proteins were found in cell wall extracts (Figure 25) and 
could be visualized on the surface of the cell (Figure 26). Although immunogold micrographs 
using double labeling with two different sized gold particles did not show colocalization of 
SwpC and LwpC (data not shown), we cannot rule out that they co-localize as the same 
secondary antibody was used for detection (anti-rat). Labeling the proteins using fluorescent 
markers and fluorescence microscopy could be used to better detect co-localization. Also in 
support of assembly of these proteins, is the binding of DufA to itself, SwpA, and LwpA as 
seen by SPR (Figure 33). Indeed, aggregates were seen in the waste solution after Biacore 
analysis (a mix of the three recombinant proteins in solution) also suggesting their association 
with each other (data not shown). However, the specific interactions of the proteins encoded 
within the same operon would need to be confirmed using methodologies such as pull down 
assays. Interestingly, although an LPxTG-like protein, which is covalently linked to the cell 
surface, is found within Locus A, it is assumed that the WxL proteins are non-covalently linked 
to the bacterial cell surface. The WxL proteins, at least in lactobacilli, can be dispersed from 
the cell surface via LiCl and reattached (Schachtsiek et al., 2004). 
Looking at the predicted structures of the WxL Locus A and C proteins, it is apparent 
that there are a number of domains and characteristics that would lead one to speculate that 
these proteins may be involved in specific functions. The concavalin-A like lectin domain 
found in LwpC, apparently missing from LwpA, could support the speculation of involvement 
in carbohydrate metabolism or catabolism in general. Indeed, WxL proteins are regulated by 
the CcpA (catabolite control protein A) in lactobacilli (Siezen et al., 2006). Concavalin-A binds 
structure on sugars, glycoproteins, and glycolipids, and can bind metallic ions, which perhaps 
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explains the conformation, folding changes, and different binding affinities seen in different 
salt concentrations (Figure 24 and Figure 33). Concavalin A has also been reported to interact 
with immunoglobulins and agglutinate erythrocytes, also suggesting a pathological function for 
the WxL proteins harboring this domain.  
The presence of β-structures and disordered domains also leads to speculation regarding 
pathogenicity function. The two highly ordered β-sheets with a linker in between seen in the 
predicted structures of DufA, DufC, and LwpC are very similar to the structure of the binding 
domains of MSCRAMMs (Hendrickx et al., 2009b). In addition, MSCRAMMS also have 
highly disordered regions, which leads to their ability to bind different host ECMs; SwpA, 
DufA, LwpA, and SwpC are predicted to also have these regions (data not shown).  
Indeed, we found that the recombinant proteins SwpA, DufA, and LwpA bind a variety 
of extracellular matrix proteins (Figure 28 thru Figure 32). ELISA-type ligand binding assays 
were used as an original screen to detect binding to ECMs. When binding to host ECM was 
further investigated through SPR, there were some differences between the ELISA-type assay 
and the SPR analysis. SwpA gave binding responses using Biacore analysis for type I collagen, 
type IV collagen, laminin, fibrinogen and fibronectin, whereas in the ELISA-like ligand 
binding assay it did not bind type IV collagen. DufA bound all ECM proteins tested by SPR as 
well, but did not bind fibronectin in the ELISA-like assay. These discrepancies are probably 
due to the differences in nature of the two assays. SPR is more sensitive and can detect more 
transient or “quick” interactions, whereas in the ELISA-type ligand binding assay, the 
recombinant proteins incubate over a 1-2 hour period before binding is measured. LwpA is the 
opposite in that it bound all ECMs tested in the ELISA-type assay, but did not give binding 
responses for type I collagen, laminin, or fibronectin using SPR. This discrepancy could be due 
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to the differences in folding of LwpA in different solutions; perhaps it needs a particular pH or 
salt concentration to bind host ECM; the buffers used for the two assays had different pH and 
salt concentration. 
In addition, differences were seen in the binding affinities depending on whether the 
ECM analyzed was soluble or immobilized (Table 29). For both DufA and SwpA, the binding 
affinity was greater when type I collagen is soluble. This is probably due to the fact that there 
are more binding sites when type I collagen in soluble and therefore the bound recombinant 
proteins can bind to multiple places in a single collagen nolecule. The opposite was true for 
fibronectin, for which the binding affinities were greater when fibronectin was immobilized. 
This was probably due to the conformational changes that occurred when fibronectin was 
bound to the chip. The recombinant proteins may need fibronectin chains to be in a specific 
fold, conformation, and/or proximity to bind with the highest affinity.  
Preliminary data determined that DufA and SwpA bind a C-terminal fragment of 
fibronectin, that is, the Hep2-40K region (Table 29 and Figure 32). This differs from most 
MSCRAMMs and fibronectin binding proteins (FnBPs), which bind the N-terminal NTD-70K 
region (Henderson et al., 2011), to which SwpA and DufA did not bind at all (data not shown). 
To our knowledge, out of the many FnBPs that have been identified, only a few bind the Hep2-
40K region. It would be interesting to characterize the binding specificity/affinities of SwpA 
and DufA to regions of fibronectin, as the Hep2-40K and NTD-70K regions of fibronectin were 
the only two tested in addition to full-length fibronectin. It is reasonable to think that another 
region of fibronectin is involved in these interactions as the affinity to immobilized full length 
fibronectin was greater than the binding affinity to immobilized Hep2-40K alone. Of note, 
bacterial FnBPs often have binding sites for multiple host ligands, and it is not uncommon for 
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FnBPs to preferentially bind insoluble fibronectin over soluble fibronectin (Henderson et al., 
2011); we see these characteristics in SwpA and DufA.  
Mutants were made by deleting the whole WxL loci individually in E. faecium TX82. 
The involvement of these loci in binding to type I collagen (seen in vitro with recombinant 
proteins) was confirmed in whole-cell binding assays where Locus A and Locus C deletion 
mutants were attenuated compared to the parental strain in binding to type I collagen. This was 
specific to type I collagen, as significant attenuation was not seen in either mutant in binding to 
type V collagen (Figure 34). The WxL Locus A and C deletion mutants were also tested for 
biofilm formation, but they were not attenuated (Figure 35). However, we cannot rule out that 
the WxL loci are involved in biofilm formation since there is much redundancy in contributions 
to biofilm and many different proteins are known to be involved (Heikens et al., 2007; Heikens 
et al., 2011; Hendrickx et al., 2009a; Sillanpaa et al., 2010).  
Similar to lactobacilli, it seems that the E. faecium WxL genes are involved in response 
to bile salt stress and affected by salt concentrations. Transcriptomic analysis of lactobacilli 
found that WxL genes are regulated in response to bile, salt, and lactate stress (Siezen et al., 
2006). We found that, not only do recombinant proteins undergo conformational changes under 
different salt concentrations (Figure 24), but salt concentrations also affect their ability to bind 
to each other (Figure 33). In addition, we found that the WxL Locus B mutant actually survives 
better than the parental strain TX82 after bile salt exposure (Figure 36).  
Since the WxL proteins are found on the bacterial cell surface and have some functions 
potentially related to virulence, this suggested the probability that these proteins would be 
antigenic during infection. Indeed, we found that serum from all five of the patients with E. 
faecium endocarditis tested had antibodies to SwpA, LwpA, SwpC, and LwpC (Figure 37). On 
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the other hand, seven healthy volunteers were also tested. None of them contained antibodies to 
all four WxL proteins tested, as the endocarditis patients did, however, some contained 
antibodies to one of the four. Three healthy volunteers cariied antibodies to LwpC and one to 
LwpA while three of the healthy volunteers had no antibodies to the WxL proteins. Since E. 
faecium are commensals of the GI tract and these proteins seem to be expressed on the surface 
of the bacterial cell regardless of their clinical association, it appears that healthy individuals 
are exposured and make antibodies to these proteins as well. This finding supports the fact that 
WxL proteins are antigenic.  
Due to the fact that antibodies to LwpA and LwpC were found in both healthy and 
infected patients and are the two largest proteins, we hypothesized that these two were 
potentially the most antigenic, and therefore might be the most effective in prophylactic 
immunization. We did two different experiments in which rats were immunized with a mix of 
LwpA and LwpC over a six week period, then challenged with TX82 in a rat endocarditis 
infection model via tail vein injection (Figure 38). Although in the first experiment all 8 
immunized rats were protected versus the non-immunized, 2 out of 3 sham-immunized (just 
FCA and FICA) rats were as well. The second experiment confirmed that sham-immunized rats 
were protected as well as immunized rats, and therefore we could not confirm or deny the 
effectiveness of immunization with LwpA and LwpC. To circumvent the situation of the 
adjuvant resulting in a protective effect, passive immunization for protection could be used or 
perhaps an adjuvant that stimulates the immune system less.  
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[5] CONCLUDING REMARKS  
The purpose of this work was to further the understanding of how an organism that was 
practically non–existent in the clinical setting 40 years ago could become one of the most 
common gram positive organisms in nosocomial infections, as well as one of the most difficult 
to treat. Before becoming a “no ESCKAPE” pathogen (as deemed by the IDSA), E. faecium 
was used as a probiotic, a cheese starter, and as a food additive.  The first hint of a change in E. 
faecium strains was reported in a retrospective study showing an increase in beta-lactam and 
gentamicin resistance from 1968 to 1990 within one hospital (Grayson et al., 1991). The work 
presented in this dissertation has demonstrated that HA isolates have been circulating in the 
United States as early as 1982, where HA isolates mostly belonged to distinct MLST types 
different from CA isolates and were characterized by increasing ampicillin MICs (Chapter 1 
Section 2.3.1 and (Galloway-Pena et al., 2009)).  At first, these increases seen in ampicillin 
MICs were thought to have evolved from point mutations occurring in the ampicillin 
susceptible strains over time. However, our analysis of the pbp5 sequences of these outbreak 
strains, as well as susceptible strains, showed that the nucleotide differences (~5%) between 
CA and HA isolates were throughout the protein and not just amino acid changes resulting in 
increased ampicillin resistance (Chapter 1 Section 2.3.3 and (Galloway-Pena et al., 2011). 
Upon extending our analysis to 3 more genes besides pbp5 (Chapter 1 Section 2.3.3 and 
(Galloway-Pena et al., 2011)) and then 100 core genes (Chapter 2 Section 3.3.1 and (Galloway-
Pena et al., 2012)), a 3-10% nucleotide difference was found between these genes in the HA 
subgroup versus the CA subgroup. The molecular clock analysis using the synonymous SNPs 
of the 100 core genes predicted the divergence between the HA and CA clades likely occurred 
hundreds of millennia ago, or longer (Chapter 2 Sections 3.3.2, 3.3.3, and (Galloway-Pena et 
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al., 2012)). A number of studies had previously suggested that the driving force behind the 
recent success of E. faecium in hospitals was the gain of mobile genetic elements carrying 
antibiotic resistance determinants, virulence and/or colonization factors. However, showing that 
E. faecium strains belong to one of two subpopulations, the HA-clade or the CA-clade, that 
differ at the core genome level provides evidence that acquired elements are not the only 
factors behind the recent success of E. faecium.  
In addition to the differences at the core genome level seen between CA and HA 
isolates, some acquired genes and putative virulence genes are indeed associated with HA 
isolates but uncommon in CA isolates. The presence of putative virulence factors such as 
espEfm, and the hylEfm-containing plasmid were almost exclusively associated with HA clade 
strains. It was also found that the fms genes (putative pili or adhesins) were more often 
associated with HA isolates than CA isolates (Chapter 1 Section 2.3.1 and (Galloway-Pena et 
al., 2009)). This is further supported by the epidemiology of VRE in South America, in which 
the population genetics mirror that early United States isolates (Chapter 1 Section 2.3.2  and 
(Panesso et al., 2010)).  
The differences between the CA and HA clades were further supported by the 
completion of the TX16 genome, providing insight into the genomic features of E. faecium. By 
analyzing the TX16 genome and comparing it to 21 draft genomes, we were able to confirm the 
differences between HA-clade and CA-clade isolates at the core genome level as well as the 
differences in the presence of  IS elements, transposons, antibiotic resistance determinants, and 
CRISPRS (Chapter 2 Sections 3.3.5, 3.3.6, 3.3.7, and (Qin et al., 2012)). All of this information 
together has helped to further the understanding as to what factors most likely contributed to 
the emergence and success of this organism in the hospital environment. 
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These studies also provide insight into the question, “what is the difference between the 
epidemiology of VREfm seen in the United States versus Europe”? As discussed in the 
Background Section, there is a discrepancy between the epidemiology of VREfm seen in the 
United States and Europe. VREfm are, and have been for the past 20 years, a common cause of 
healthcare associated infections in the United States, yet VREfm are not found in the 
community in the United States (Coque et al., 1996). On the other hand, VREfm are a rare 
(albeit now an increasing) cause of infection in the European Union, yet they are commonly 
found in fecal samples of animals and healthy individuals (Bonten et al., 2001; Willems et al., 
2000; Willems et al., 2005). We can now conclude that the differences between these two 
geographical areas were due to the differences between CA and HA strains as well as a 
contribution of ampicillin resistance. It seems from our data that, in the United States, E. 
faecium strains containing pbp5-R allele of the HA clade acquired vancomycin resistance. 
Conversely, in the EU, E. faecium strains containing pbp5-S of the CA clade were the first to 
acquire vancomycin resistance which was then perpetuated and increased due to the use of 
avoparcin in animal husbandry. Therefore, it seems the EU VREfm were not as likely to 
survive in hospitals as the United States isolates due to their lack of multiresistance, putative 
virulence factors, and the advantage that comes with being a HA clade strain.  
After sequencing three genomes (TX16, TX1330, and TX82) within our own 
laboratory, we furthered our analysis by looking for novel pili, adhesins, and surface proteins. 
The discovery of an atypical LPxTG-like protein (fms6) led to the finding of three apparent 
operons in E. faecium encoding proteins with the recently identified WxL motif. Further in 
vitro and in vivo characterization showed complex proteins that localize to the surface of the 
bacterial cell and bind each other, possibly making a novel cell surface complex. The protein 
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conformation, folding, and binding affinities seem to be affected by salt concentration. 
Analysis also suggests that these operons bind numerous host extracellular matrix tissues and 
could be involved in bile stress, making these operons multifunctional. In addition, the fact that 
these proteins are highly antigenic may give hope for novel candidates for immunization, which 
will help us to bypass the lack of effective antibiotics available for enterococcal infections.  
 The study of the WxL proteins opens many doors to future experiments and analyses to 
further understand these complex proteins. One area would be to understand if the function of 
the WxL proteins actually influences virulence. A second line of investigation would be to 
compare the expression of these proteins between community and clinical strains at the 
transcript level. Furthermore, one could determine the in vitro versus in vivo expression, i.e., 
are these proteins expressed more during infection. A third line of investigation would be to 
determine which residues of the WxL domain are important for cell surface localization and 
which regions are responsible for interactions with host tissues. In addition, one could further 
investigate if the proteins within the same operon actually interact and/or colocalize and create 
novel cell surface complexes.  
 In conclusion, although E. faecium is now an important hospital-associated pathogen, 
research on how this historically commensal organism initiates disease and causes infection 
within the host is deficient when compared to other Gram positive pathogens. Determining the 
specific genomic features that contribute to pathogenicity and persistence in the hospital 
environment is key to understanding E. faecium’s transition between the community and 
hospital niches. This includes both genes that are unique or enriched in the HA clade, as well as 
core genomic differences. Furthermore, assessment of the importance of putative surface 
proteins (i.e those with the “WxL” motif) in virulence, protein-protein interactions, and the 
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expression of the genes within the host may enhance the very limited knowledge of the 
mechanisms for pathogenicity of this organism, and possibly provide alternatives for the 
prevention and/or treatment of enterococcal infections.   
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